Text mining and information extraction for the life sciences : an enhanced science approach by Fleuren, W.W.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/106938
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Text mining and information extraction for the life 
sciences: an enhanced science approach
Proefschrift
ter verkrijging van de graad van doctor
aan de Radboud Universiteit Nijmegen
op gezag van de rector magnificus prof. mr. S.C.J.J. Kortmann,
volgens besluit van het college van decanen
in het openbaar te verdedigen op donderdag 16 mei 2013
om 10.30 uur precies
door
Wilco Wilhelmus Maria Fleuren 
geboren op 8 april 1978
te Nijmegen
Promotor 
 Prof. dr. J. de Vlieg
 
Copromotor
 Dr. W.B.L. Alkema (NIZO food research BV)
Manuscript-commissie
 Prof. dr. S.S. Wijmenga
 Prof. dr. H.G. Brunner
 Prof. dr. A.J. van Gool
 
This work was performed within the NBIC BioRange project “A Systems Bioinformatics 
Approach For Evaluating And Translating Drug-Target Effects In Disease Related 
Pathways” (BR4.2) and continued within the Netherlands eScience project “Creation 
of food specific ontologies for food focused text mining and knowledge management 
studies” (027.011.306).
Title: Text mining and information extraction for the life sciences: an enhanced science 
approach. 
Copyright © 2013 Wilco Fleuren, Nijmegen, The Netherlands
ISBN/EAN: 978-90-9027438-6
Cover design: Walter van Rooij, Buro Brandstof
Printed by: CPI Wöhrmann Print Service, Zutphen
        
"Vorsprung durch Technik", Audi AG
        
TABLE OF CONTENTS
Chapter 1
 General introduction          6
Chapter 2
 CoPub update: CoPub 5.0 a text mining system to answer     22
 biological questions
Chapter 3
 Identification of new biomarker candidates for glucocorticoid     34
 induced insulin resistance using literature mining
Chapter 4
 Prednisolone-induced changes in gene-expression     56 
 profiles in healthy volunteers
Chapter 5
 Prednisolone induces the Wnt signaling pathway in 3T3-L1     80 
 adipocytes
Chapter 6
 Prednisolone-induced differential gene expression in mouse liver  106
 carrying wild type or a dimerization-defective glucocorticoid 
 receptor 
Chapter 7
 Identification of T lymphocyte signal transduction pathways  134
Chapter 8
 Functional annotation of microorganisms using text mining  166
Chapter 9
 General discussion      190
Summary        200
Samenvatting        206
Dankwoord        213
Curriculum vitae        217
Bibiliography        219
CHAPTER 1
General introduction

9General introduction
 
Ch
ap
te
r 1General introduction
Products for human consumption and intake need to be safe and should not be harmful. 
Hence the pharmaceutical and food industry spent millions of dollars on research and 
development (R&D) to develop better and safer products. The safety of drugs and food 
products is tested in experiments before they are marketed. These experiments result 
in enormous amounts of biological data that need to be analyzed in order to draw 
conclusions, to initiate follow-up studies, and to generate new hypothesis. This so-called 
data driven research is becoming more and more important in these industries and 
requires specialists which are able to extract useful information out of these biological 
data. Results from experiments are published in scientific papers and reports for which 
the abstracts often are deposited in the publicly available Medline database. Medline 
contains over 22 million of journal citations and abstracts from biomedical literature and 
is growing exponentially each year. Extraction of useful knowledge from these abstracts 
in order to annotate results from experiments requires methods which can do this 
extraction automatically.
Text mining and Information extraction
Text mining (TM) and automatic information extraction (IE) has evolved over the years 
into a sophisticated and specialized discipline in the bio medical sciences. The process of 
TM and IE involves high quality information extraction from literature and subsequently 
linking this information to experimental data. 
Currently, the most used approaches to retrieve knowledge from text are by co-
occurrences and by natural language processing (NLP) [1]. 
Co-occurrence-based methods
Co-occurrence based methods use the simple concept that two keywords that co-occur 
in the same body of text often are functionally related. For example the co-occurrence of 
retinol-binding protein 4 (RBP4) and insulin resistance suggests a functional relationship 
between the gene and the disease [2, 3]. However, also many keywords co-occur in text 
without being functionally related. Therefore these methods often use a statistically 
scoring based on frequency of occurrence of both keywords, to add a degree of 
significance to the relationship. Co-occurrence based methods do not provide information 
about the type of relation between keywords but are therefore able to detect any type 
of relationship. 
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NLP-based methods
NLP based methods use prior knowledge to retrieve information out of text. This prior 
knowledge can be for instance how language is structured or specific knowledge on how 
biological information is mentioned in the literature. NLP is defined as "the processing of 
natural language, i.e. human languages by computers". In contrast to co-occurrence based 
systems, NLP systems are phrase based and include information about the relationship 
between two keywords, e.g. gene A inhibits gene B or gene C is involved in disease Y. 
NLP based systems are very suitable to search for specific relationships. However these 
systems are limited to predefined relationships and are often very computationally 
intensive.
Drug discovery
The first part of this thesis describes the application of bioinformatics and especially IE 
and TM to study drug (side) effects. 
The development of a new drug is very complex, time-consuming and expensive. On 
average the development of a drug takes about twelve years and costs are in the order 
of 1 billion US dollars. Already in the United States only, approximately just one out of 
six drugs that enter the clinical testing pipeline will eventually obtain approval to be 
marketed [4]. Despite the increasing investment in research and development (R&D), the 
attrition rate of drug candidates increases. Therefore early detection of failure of drug 
candidates is essential to reduce the drug development costs. 
Traditionally, the drug development process can be divided into distinct phases starting 
with the target discovery phase and eventually leading to the successful market approval 
of a drug candidate (Figure 1).
Target discovery
In the first phase possible new therapeutic targets will be identified. Information about 
the function and the role of these targets in the development of the disease will be 
gathered and subsequently used to get an overview of the pathways and genes/proteins 
that are involved. This step is very important since it gives insight into the biological 
context of the target and its relation to the disease. Typically in this phase information 
Figure 1 A schematic representation of the drug development pipeline.  The process ranges 
from the identification of potential drug targets in the Target discovery stage to the successful 
introduction of the drug on the market in the Marketing & sales stage.   
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Promising targets will be validated in both in vitro and in vivo experiments in which the 
therapeutic effect and the relation of the target to the disease will be further investigated. 
Lead discovery and lead optimization
Once possible targets have been detected and verified, screening of large compound 
libraries starts to identify so called lead compounds, which are able to modulate the 
biological activity of targets. Subsequently in the lead optimization phase these identified 
compounds will be chemically modified to improve their potency, selectivity and efficacy. 
The efficacy of compounds will be determined in genome-wide association studies using 
microarray technology, in which changes in gene expression are measured as a result of 
compound treatment. These expression profiles can be compared with expression profiles 
from other compounds and can also be used to get an insight into the mechanisms and 
pathways affected. 
In the target discovery, lead discovery and lead optimization phases is it important to 
gather as much as possible information about the target, its biologcal surrounding and 
the compound to predict (side) effects. TM and IE are important techniques to retrieve 
this information from the scientific literature.
Pre-clinical development
Compounds which showed a promising effect on the biological target will move to the 
pre-clinical development phase were they will be further tested for efficacy and safety. 
Compounds are tested on toxicity in animal models. Furthermore in pharmacokinetics 
experiments the compounds are tested for their absorption, distribution, metabolism, 
and excretion (ADME) properties in the body. The pre-clinical development phase is 
important because the ultimate safety profile of compounds will determined. Based on 
this safety profile decisions will be made to move the compounds to the next phase in 
which they will be tested in humans. 
Approximately two third of the compounds fail in the pre-clinical development phase 
because of poor toxicity and/or pharmacokinetics properties.
Clinical trials
In the last phase compounds also called drug candidates will be tested in humans in so 
called clinical trials. Clinical trials are normally taking place in four phases. In phase I in 
a small group of healthy volunteers (20 - 80) the toxicity and possible side effects of the 
drug candidate will be tested together with assessment of the correct dosage. These tests 
will continue in phase II, but in larger groups (100-300) of both healthy volunteers and 
patients. The effectiveness of the drug candidate will be further tested. In phase III the 
drug candidate will be administered to large groups of people (1000-3000) to continue to 
investigate the effectiveness and to compare the effects with commonly used treatments. 
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The results from these phases will be documented and reviewed by agencies such as the 
European Medicines Agency (EMEA) and the US Food and Drug Administration (FDA) to 
get market approval for the drug candidate. Phase IV trials are post-market studies in 
which long-term treatment is monitored to assess long-term effects of the drug. 
Clinical trials are time-consuming taking several of years and account for 50-70% of the 
total drug development costs. 
Studying drug effects on different levels
With the rising drug development costs and the increasing pressure by governments to 
introduce safer and more valuable drugs on the market, the pharmaceutical industry 
faces a challenge to reduce these costs in order to keep delivering affordable drugs on the 
market. Therefore early detection of failure of drug candidates is essential. To predict the 
effects of drug candidates it is important to understand which drug targets they are able 
to modulate, and what the biological surrounding of these targets are. Many drug targets 
influence multiple phenotypic traits, genes, proteins and pathways. 
The techniques used in this thesis to study drug effects on genes, pathways and proteins 
Figure 2 Techniques used in the studies described in this thesis to study drug effects.
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Genome-wide expression profiling
Genome-wide association studies enable to study gene expression profiles of thousands 
of genes simultaneously. In this way drug effects can be studied by looking at changes in 
gene expression as a result of treatment with a drug or compound. Gene expression is 
measured using microarray technology. A microarray consists of spots on which pieces 
of DNA called probes are attached to the surface of the array. Extracted RNA from the 
biological sample will be labelled with a fluorescent tag and hybridized to the probes 
on the microarray. Subsequently, the hybridized chip is scanned to measure fluorescent 
intensities. Typically, drug effects on gene expression are studied by comparing the gene 
expression from a drug treated sample with gene expression from a control sample.
Protein profiling using anti-body arrays
Differentially expressed proteins can be measured using anti-body arrays. This enables 
to study drug effects on proteins. Instead of using DNA probes, protein arrays consist 
of antibodies that are attached to the microarray surface. These antibodies are able to 
detect target proteins from the biological sample, by means of specific labelled secondary 
antibodies. Currently, protein arrays can only hold a couple of hundreds of antibodies, 
this in contrast to DNA microarrays. However with the introduction of antibody arrays 
the gap between the effects seen at gene expression level and the effects seen at protein 
level can be decreased. 
Text mining to interpret experiments
Co-occurrence based TM methods have been successfully used to analyze microarray 
data, identifying gene-disease and gene-drug relationships [5-8].
 We developed CoPub a text mining tool that is able to search for occurrences of different 
types of keywords from a wide variety of thesauri, e.g. gene names, disease names, drug 
names and pathway names, in Medline abstracts. CoPub uses the principle that a co-
occurrence of two keywords in the same abstract is an indication of a functional relation 
between both keywords. The significance of a found relation is described by the R-scaled 
score, which is an indication of the strength of a co-occurrence of two keywords given 
their individual frequencies of occurrence [9]. CoPub has originally been developed for 
the interpretation of microarray data [5, 9] and its technology has been expanded to 
other areas, such as the identification of novel hidden relations [10]. In chapter 2 of this 
thesis we describe CoPub 5.0, which combines all CoPub technologies with extensive 
search and filter algorithms that can be used to answer a variety of biological questions. 
Gene literature networks
Studying genes which are related to a disease or potential drug target enables to better 
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understand which mechanisms are involved. For this it is important to study genes in 
their functional context. Typically such a functional context can be the biological process 
in which the gene is involved. Examples of such a biological process can be for instance 
the glycolysis in which in ten steps glucose will be converted into pyruvate. The functional 
context of phosphofructokinase, an enzyme in the glycolysis, can be defined by the other 
enzymes in this process. Although the functional context for phosphofructokinase in this 
example is straight forward and well defined, in most cases the functional context of a 
gene is not that straight forward. 
Another way to define a functional context for a gene is to search for co-occurrences of 
this gene with other genes in Medline abstracts. Hence in this way a literature network 
of co-occurring genes can be created. This network can be used to study drug effects 
by means of mapping drug induced gene expression data or by mapping drug related 
information from the literature onto the network. This approach not only enables to study 
the effects of a drug on a single gene but also on the genes with which it is functionally 
related in the network. In chapter 3 of this thesis this approach is used to study the effects 
of dexamethasone, a synthetic glucocorticoid used as an anti inflammatory agent for the 
treatment of inflammatory diseases, on a network of insulin resistance (IR) related genes.
Glucocorticoids
The studies described in chapters 3-5 of this thesis focus on the metabolic side effects as 
a result of treatment with synthetic glucocorticoids (GCs). 
GCs are naturally occurring hormones which are released by the adrenal cortex in 
response to stress. They are part of the feed-back mechanism of the immune system in 
response to inflammation. The most abundant form in the human body is cortisol, which 
binds with high affinity to the glucocorticoid receptor (GR). This receptor is expressed 
in almost every cell in the body and unbound GR is mainly present in the cytosol of the 
cell.  Studies indicated that GR regulates up to 10 -20% of the human genome in different 
cell types, thus showing the important role of this receptor. GC effects can roughly be 
divided into two types [11, 12]. The best studied effects are the so called genomic effects, 
in which the GC-GR complex moves into the nucleus of the cell, where it regulates gene 
expression. The GR-GC complex enhances or represses gene transcription by direct 
binding as a homodimer to the glucocorticoid-responsive-element (GRE), by binding to 
other transcription factors or by direct GRE binding and interactions with transcription 
factors bound to neighboring sites of a gene (Figure 3). 
These genomic effects take place within a couple of hours. However GCs induce also 
rapid effects which are taking place within minutes. These so called non-genomic effects 
are far less well studied and are thought to be mediated by affecting the properties of cell 
membranes or through the binding of intracellular or membrane-bound glucocorticoid 
receptors [13, 14].
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Because of their immunosuppressive properties, GCs are the most commonly prescribed 
anti-inflammatory drugs for the treatment of inflammatory diseases since the mid 1950s, 
with the introduction of prednisolone, dexamethasone and betamethasone. Patients 
suffering from rheumatoid arthritis, asthma and psoriasis are often treated with GCs. In 
fact up to 60% of the rheumatoid arthritis patients are more or less continuously treated 
with GCs [15, 16]. 
Although the treatment of these inflammatory diseases with GCs is very successful, 
it is hampered by dose-dependent side effects, such as osteoporosis, skin atrophy, 
hypertension and severe metabolic disturbances such as insulin resistance which 
Figure 3 General mechanisms of Action of glucocorticoids and the glucocorticoid receptor in the 
inhibition of inflammation. TNFa denotes tumor-necrosis factor a, HSP heat-shock protein, mRNA 
messenger RNA, and P phosphate. The three mechanisms are nongenomic activation, DNAdependent 
regulation, and protein interference mechanisms (e.g., NFk B elements). Black arrows denote 
activation, the red line inhibition, the red dashed arrow repression, and the red X lack of product 
(i.e., no mRNA). Reproduced with permission from [12] , Copyright Massachusetts Medical Society.
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eventually leads to diabetes and obesity. This limits the long-term usage of these 
synthetic GCs. 
The general assumption is that the immunosuppressive effects of GCs are mainly driven 
by transrepression, in which the GC-GR complex, together with other transcription 
factors, prevents the transcription of pro-inflammatory genes. The unwanted side-effects 
are mainly driven by the act of transactivation of gene expression. 
A lot of effort has been put into the development of novel GC ligands with an improved 
efficacy/side effect ratio compared to conventional GCs. This requires knowledge about 
the mechanisms behind GC induced metabolic side effects.
In the studies described in this thesis, a combination of microarrays, antibody arrays, 
bioinformatics and TM/IE are used to characterize GC induced metabolic side–effects in 
both in vitro and in vivo studies.
Studying microorganisms in food production and health
IE and TM have successfully been used in drug discovery to study drug effects and can 
also be used in other areas, such as in the microbiology.
Microorganisms play crucial roles in processes ranging from waste-product degradation in 
ecosystems to industrial processes where they are used for the development of fermented 
foods and beverages. Furthermore, microorganisms are also the main contributor to food 
spoilage and can be harmful causing diseases.
Microorganisms in food
The biggest contribution of microorganisms to food development is in the process of 
fermentation, in which organic compounds are transformed under the influence of 
bacteria and yeasts. Louis Pasteur was one of the first scientists who discovered that 
yeasts were responsible for alcohol fermentation [17]. This discovery initiated the 
scientific and industrial interests in food microbiology and resulted in that fermentation 
nowadays is a highly industrialized process. 
Lactic acid bacteria (LAB) are very important for the fermentation of food. For instance 
Lactobacillus bulgaricus subsp. delbrueckii and Streptococcus thermophilus strains are 
used for making yoghurt [18]. Lactobacillus lactis contributes to the  flavor development 
of cheese [19, 20], and Oenococcus oeni is important for malolactic fermentation in 
the process of wine making, giving wine its characteristic taste and aroma [20, 21]. 
Estimations indicate that about one third of the human diet consists of fermented foods 
and drinks [22]. In addition to these food-characteristics, some LAB strains have proven 
health-promoting effects on humans and are used as probiotics. 
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Probiotics are defined as "live microorganisms which when administered in adequate 
amounts confer a health benefit on the consumer". The possible contribution of probiotics 
to human health has been proposed in a number of ways:  via competitive exclusion 
of pathogenic bacteria, via enhancement of epithelial barrier function by modulation 
of signaling pathways that lead to enhanced mucus, or by modulation of the immune 
system of the host [23]. Probiotic effects have been established in the prevention of 
number of diseases including diarrhea, necrotizing enterocolitis and pouchitis. However 
probiotic effects have not been consistently observed in studies to other diseases such 
as irritable bowel syndrome, atopic dermatitis, and inflammatory bowel disease. This 
requires that more scientific research is needed to improve the industrial application of 
probiotics towards stimulation of human health.
Community profiling studies
In order to use microorganisms in industrialized processes for food production 
and to develop cures against pathogenic microorganisms, relationships between 
microorganisms and a given process or treatment needs to be studied. Metagenomics is 
a well established technique to study the dynamics of microbial communities in so-called 
community profiling studies. Metagenomics is the genomic analysis of microbial DNA that 
is extracted directly from environmental samples, by means of pyrosequencing of 16S 
rRNA genes and has been proposed as the most accurate approach for the assessment of 
taxonomy composition [24]. One of the outcomes of these metagenomics experiments 
are lists of microorganisms that are affected by a given process or treatment. Annotation 
of these lists is essential to understand how these microorganisms are involved in the 
studied processes.
Microorganism focused text mining and knowledge building
Similar to the usage of TM for the annotation of drug induced gene expression, in 
chapter 8 of this thesis, we describe how TM can be used to get a quick insight into the 
biological properties of microorganisms. Thesaurus based TM is used to annotate lists of 
microorganisms that are the result from community profiling studies. Furthermore TM 
without using thesaurus is used to study LAB to gain insight into the biological processes 
in which they are involved. 
 
18    Chapter 1
Thesis outline
This thesis consists of two parts. Both parts focus on the development and application of 
TM and IE for the annotation of biological experiments.
In the first part bioinformatics and IE/TM are used to study the effects of drugs in order 
to unravel the underlying mechanisms and affected pathways. The majority of the studies 
described in this thesis focus on the mechanisms that underlie the unwanted metabolic 
side effects of glucocorticoid treatment.
In the second part we demonstrate that knowledge of the usage of TM in drug discovery 
can be used to retrieve information from literature in order to study microorganisms. A 
schematic summary of the work in this thesis is depicted in Figure 4.
In Chapter 2 we describe CoPub 5.0, a publicly available text mining system, which uses 
Medline abstracts to calculate robust statistics for keyword occurrences. In CoPub 5.0 all 
available CoPub technology has been integrated into a single application with a renewed 
user interface. CoPub 5.0 enables to answer a variety of biological questions ranging 
from microarray data analysis and keyword enrichment to the search for new biological 
relations.
Chapter 3 describes CoPubGene a method to mine Medline abstracts for functional gene-
Figure 4 Outline of this thesis.
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related to insulin resistance, a known side-effect of glucocorticoid treatment for which 
the mechanisms are not completely understood. The study gave new insights into these 
mechanisms and indicated a possible involvement of the sex-steroid synthesis pathway 
in the development of GC induced IR.
Chapter 4 describes a genome wide expression profiling study to identify prednisolone 
induced gene signatures in CD4+ T lymphocytes and CD14+ monocytes derived from 
healthy volunteers and to link these signatures to underlying biological pathways involved 
in metabolic adverse effects as a result of prednisolone treatment.
Chapter 5 describes the usage of genome wide expression data and adipokine profiling 
in combination with literature mining techniques to study mechanisms and signaling 
pathways involved in prednisolone induced metabolic disturbances in murine 3T3-L1 
adipocytes. We found the wnt signaling pathway to be involved in metabolic disturbances 
in adipocyte cells and we suggested this pathway for follow-up experiments to study its 
role in GC-induced metabolic effects.
Chapter 6 describes a genome wide gene expression profiling study to examine the role of 
GR dimerization in the regulation of gene expression in mouse liver. Biological pathways 
targeted by prednisolone in the liver of wild type (WT) mice and mice lacking the ability 
to form glucocorticoid receptor dimers (GRdim) have been identified and compared.
Chapter 7 describes a study that identifies pathways and genes involved in the 
differentiation of Jurkat T cells towards Th1 and Th2 subtype cells, using various stimuli 
and pathway inhibitors. Specific gene profiles of IL-2, associated with a Th1 type of 
response, and CCL1, associated with a Th2 type of response, have been identified. TM 
analysis was used to find additional evidence for these Th1 and Th2 specific fingerprints.
In Chapter 8 the usage of TM to add meaning to results of metagenomics experiments is 
demonstrated. Abstracts, in which microorganisms occur, are automatically analyzed to 
retrieve useful keywords that can be used to understand the biology of microorganisms 
and their involvement in the processes studied. 
In Chapter 9 a short discussion and some concluding remarks with regard to this thesis 
are described.
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Abstract
In this article, we present CoPub 5.0, a publicly available text mining system, which uses 
Medline abstracts to calculate robust statistics for keyword co-occurrences. CoPub was 
initially developed for the analysis of microarray data, but we broadened the scope by 
implementing new technology and new thesauri. In CoPub 5.0, we integrated existing 
CoPub technology with new features, and provided a new advanced interface, which 
can be used to answer a variety of biological questions. CoPub 5.0 allows searching 
for keywords of interest and its relations to curated thesauri and provides highlighting 
and sorting mechanisms, using its statistics, to retrieve the most important abstracts in 
which the terms co-occur. It also provides a way to search for indirect relations between 
genes, drugs, pathways and diseases, following an ABC principle, in which A and C have 
no direct connection but are connected via shared B intermediates. With CoPub 5.0, it is 
possible to create, annotate and analyze networks using the layout and highlight options 
of Cytoscape web, allowing for literature based systems biology. Finally, operations of 
the CoPub 5.0 Web service enable to implement the CoPub technology in bioinformatics
workflows. CoPub 5.0 can be accessed through the CoPub portal http://www.copub.org.
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Introduction
Medline abstracts are a very useful source of biomedical information covering topics 
such as biology, biochemistry, molecular evolution, medicine, pharmacy and health care. 
This knowledge is useful to better understand the complexity of living organisms and can, 
for instance, be used to study groups of genes or metabolites in their biological context. 
In the 2008, Web Service issue of NAR, we presented CoPub as a publicly available text 
mining system. This system uses Medline abstracts to calculate robust statistics for 
keyword co-occurrences, to be used for the biological interpretation of microarray data 
(1,2). Since then, CoPub has been intensively used in the analysis of several microarray 
experiments and toxicogenomics studies [3–8]. However, literature data can be applied 
far beyond questions related to microarray studies. Therefore, we broadened the scope 
of CoPub by implementing new technology and adding new thesauri to the database. 
We developed a new technology called CoPub Discovery, which can be used to mine 
the literature for new relationships following a simple ABC-principle, in which keyword 
A and C have no direct relationship, but are connected via shared B-intermediates [9]. 
This technology can, for instance, be used to study mechanisms behind diseases, connect 
new genes to pathways or to find novel applications for existing drugs. To reflect all 
these developments, we created CoPub 5.0, which has a complete new user interface 
and in which we integrated all CoPub technologies. CoPub 5.0 enables the use of CoPub 
functionality in a very dynamic interactive manner by easily switching between multiple 
analysis modes and is very suitable to answer a variety of biological questions. It is also 
accessible using operations of the CoPub 5.0 Web Service (SOAP or JSON), which makes it 
possible to embed the CoPub functionality into bioinformatics workflows. CoPub 5.0 and 
the CoPub 5.0 Web Service can be accessed at the CoPub portal http://www .copub.org.
Methods
CoPub 5.0 has three analysis modes. A ‘term search’ mode that retrieves abstracts and 
Figure 1 Schematic representation of CoPub. The CoPub database holds co-occurrence information 
between categories in Medline Abstracts. The CoPub functionality can be used via three modes 
using the web interface or via the CoPub web services either via SOAP or JSON.
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keyword relations for a single term, a ‘pair search’ mode that analyzes known or new 
relations between a pair of terms and a set of terms mode that deals with the relation 
between multiple terms (Figure 1). 
‘Term search’ mode
The ‘term search’ mode provides a way to search for keywords and subsequently showing 
their relations with other categories in the CoPub database. This mode provides a table and 
cloud view which can be used to answer questions such as ‘to which diseases is this gene 
related?’ or ‘in which biological processes is my metabolite involved?’ For instance, the 
cloud view in which strongly connecting terms [i.e. high R-scaled score (1)] are displayed 
with a larger font, can be used to immediately show the most important relations of 
the term with keywords from one or more categories in the database (Figure 2A). The 
evidence for these relations lies in the Medline abstracts in which both terms occur. 
CoPub retrieves these abstracts, highlights both terms in them and ranks the abstracts 
which has the most term occurrences as first (Figure 2B). In the example, in Figure 2, it 
is shown that CXCR4 is strongly connected to its ligand CXCL12 and to CXCR7, with which 
it forms a heterodimer, and it mediates HIV infections. Besides co-occurrences, it is also 
possible to search for new hidden relations between the term and selected categories via 
shared intermediates using the ‘open discovery’ mode (see ‘Hidden Relations’ section). 
From the ‘term search’ mode, it is possible to add a term to the current set and switch to 
the ‘set of terms’ mode. 
Figure 2 An example of the term search view for the human chemokine receptor 4. In the cloud 
view, it is immediately clear, by the large font of the terms, that CXCR4 is strongly connected to its 
ligand CXCL12 and CXCR7, with which it forms a heterodimer (A). Also, CXCR4 is strongly connected 
to ‘HIV infections’ (category: disease), which is mediated by CXCR4 and to ‘stromal’ cell, to which 
CXCR4 is linked because of its stromal derived ligand CXCL12. In B an example is shown of the 
underlying abstracts for the co-occurrences.
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‘Pair search’ mode
The ‘pair search’ mode can be used to search for specific relations between existing 
keywords in the CoPub database, e.g. to search for a relation between a gene and a 
drug. A wizard will guide the user in its search for relations between terms. CoPub will 
first search for co-occurrences and if no co-occurrence is found, the user can search for 
hidden relations using the ‘closed discovery’ mode (see ‘Hidden Relations’ section). The 
pair search mode can be useful to search the literature for more evidence which supports 
relations found in experiments, for instance, between a drug and a pathway or between 
a gene and a pathway or which supports hypothesis.
‘Set of terms’ mode
Biological research often involves a better understanding of the complexity of living 
organisms, for instance, to better understand the development of a disease or to gain 
more insight into complex signaling pathways [10,11]. This requires a systems approach 
in which groups of genes or metabolites are studied in relation to a disease, drugs or 
pathways. In CoPub 5.0, we provide such a systems approach via the ‘set of terms mode’. 
In this mode, a set of keywords can be uploaded either by copy–pasting them or by 
uploading a text file. Terms can belong to multiple categories (e.g. insulin belongs to the 
category human gene and to the category drug), which can be further specified to only 
the desired categories using the ‘Members of category’ option. An uploaded set of terms 
can be analyzed in a number of ways. 
Set enrichment analysis. 
To see with which categories the set has significant relations, an enrichment analysis can 
be performed. In this analysis, the relation of a given term from a category with the set 
is tested using the Fisher exact test against a background set. The calculated P-values are 
corrected using the Benjamini–Hochberg multiple testing correction method. In case the 
set consists of multiple categories, only one type of category can be chosen to be used as 
a background set. For each enriched term, the number of contributors of the set is shown 
and the contributors can be accessed by clicking on this number. All statistical tests are 
done using the R Statistics package (http://www.r-project.org). 
Set annotation. 
A set of terms can be annotated by searching for co-occurrences between the set and 
categories in the database. The cloud view immediately shows for each term in the set, 
the most significant associated terms (in larger font) per category. Categories from the 
database can be added or removed from this view. All co-occurring annotation can be 
downloaded from this view using the download button.
29CoPub 5.0 a textmining system to answer biological questions
 
Ch
ap
te
r 
2
Network. 
To analyze the relations between terms in the set, a literature network of the set can be 
created. Subsequently, the network will be visualized using the Cytoscape web plugin 
(http://cytoscapeweb.cytoscape.org/). Strongly connected terms have thick edges 
(high R-scaled score), which immediately shows important relations (Figure 3). For large 
networks (>500 nodes), the network can be downloaded and visualized in a
standalone Cytoscape environment. 
Add additional terms. 
At any time an uploaded set can be extended with additional terms. These additional 
terms can be provided by the user (via ‘add additional terms’), by searching for co-
occurrences between the set and categories in the database (via ‘Grow set with co-
occurrences’) or by adding a specific term via the ‘term search’ mode, from which it can 
be added to the set using the ‘Add term to set’ button.
Hidden relations
From the ‘term search’ mode and the ‘pair search’ mode in the website, it is possible to 
search for hidden relations using the CoPub Discovery technology [9]. CoPub Discovery 
uses an ‘open discovery’ and ‘closed discovery’ process to search for new hidden 
relations. Both processes follow an ABC principle in which, in case of ‘open discovery’, 
the user provides a term A (e.g. disease) and searches the literature for hidden relations 
with a category (C) via intermediates (B) and in case of ‘closed discovery’, the user tests 
the hypothesis that, for instance, a gene (A) is related to a disease (C) and searches the 
literature for shared intermediates (B) which support this hypothesis. This technology 
Figure 3 Network of a group of mixed terms using the Cytoscape plugin. In the network the 
gene IL4 has strong connections to the genes IL2 and CCL11 and is also strongly connected to 
the biological process ‘isotype switching’ and ‘cytokine biosynthesis’. This is indicated by the thick 
edges between these nodes. Clicking on an edge will show the abstracts in which both terms occur 
allowing for more detailed analysis of the biological context in which the terms are related.
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can be useful to find different roles of genes in new pathways or to get more insight into 
mechanisms behind diseases.
CoPub Web Service
The operations from the CoPub Web Service allows to embed CoPub functionality into 
work flows and to use it in an automatic fashion. For this, we provide to use these 
operations either via SOAP or via JSON. The description of these operations can be found 
in the help files of the CoPub 5.0 website and an example script, showing how operations 
can be used, is accessible via the CoPub portal http://www.copub.org.
Discussion and conclusion
CoPub 5.0 can be used to answer a wide variety of biological questions and bridges the 
gap between indexed searching of PubMed and dedicated manually curated pathway 
databases such as Wikipathways [12], Ingenuity Pathway Analysis (http://www.ingenuity.
com) and Metacore (GeneGo) (http://www.genego.com/metacore.php). There are a 
number of tools that provide part of the technology offered by CoPub. For example, 
Chilibot [13] is an NLP based tool that retrieves abstracts for user defined pairs of terms, 
but has no curated dictionaries, meaning that only relations between user defined terms 
are found, thus limiting the possibility to discover new relations. FACTA [14] offers curated 
dictionaries but does not provide indirect relation searching or network possibilities. 
Arrowsmith [15] is a tool for the discovery of hidden relations but does not contain 
curated ontologies nor does it provide networking possibilities or term mode options. 
Furthermore, options for analyzing enrichment in terms lists are not provided by these 
tools, limiting their use for the analysis of approximately omics sets. The advantage of 
CoPub is that it integrates the approaches offered by the above methods and combines 
this with advanced graphical output, web service ability and multiple options for analyzing 
lists of terms and creating networks. The statistical frame work of CoPub 5.0, together 
with the cloud view functionality is very suitable for the analysis of large ‘omics’ data sets. 
First, by running a broad scan using enrichment to get a general overview of the data and 
subsequently by zooming in on relevant pathways, focusing on strong connections (by 
means of R-scaled score) in the data. Together with the hidden relations technology, this 
can be used to generate new hypotheses. Future steps could include a better interface to 
Gene Set Enrichment Analysis (GSEA) software [16] and to incorporate Natural Language 
Processing (NLP) to be able to even better filter on biological relevant information.
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Abstract
Background
Glucocorticoids are potent anti-inflammatory agents used for the treatment of diseases 
such as rheumatoid arthritis, asthma, inflammatory bowel disease and psoriasis. 
Unfortunately, usage is limited because of metabolic side-effects, e.g. insulin resistance, 
glucose intolerance and diabetes. To gain more insight into the mechanisms behind 
glucocorticoid induced insulin resistance, it is important to understand which genes 
play a role in the development of insulin resistance and which genes are affected by 
glucocorticoids. 
Medline abstracts contain many studies about insulin resistance and the molecular 
effects of glucocorticoids and thus are a good resource to study these effects. 
Results
We developed CoPubGene a method to automatically identify gene-disease associations 
in Medline abstracts. We used this method to create a literature network of genes related 
to insulin resistance and to evaluate the importance of the genes in this network for 
glucocorticoid induced metabolic side effects and anti-inflammatory processes. 
With this approach we found several genes that already are considered markers of 
GC induced IR,  such as phosphoenolpyruvate carboxykinase (PCK) and glucose-6-
phosphatase, catalytic subunit (G6PC). In addition, we found genes involved in steroid 
synthesis that have not yet been recognized as mediators of GC induced IR. 
Conclusions
With this approach we are able to construct a robust informative literature network 
of insulin resistance related genes that gave new insights to better understand the 
mechanisms behind GC induced IR. The method has been set up in a generic way so it 
can be applied to a wide variety of disease networks.
Keywords: literature mining, insulin resistance, glucocorticoids, gene networks.
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Background
Glucocorticoids (GCs) are often prescribed for the treatment of inflammatory diseases 
such as rheumatoid arthritis, asthma, inflammatory bowel disease and psoriasis [1-3]. 
Despite their excellent efficacy, usage is limited because of side-effects such as insulin 
resistance, glucose intolerance, diabetes, central adiposity, dyslipidemia, skeletal muscle 
wasting and osteoporosis [4-8]. 
GCs bind to the glucocorticoid receptor (GR), which then dimerizes and translocates 
to the nucleus where it influences gene transcription. Positive regulation of genes 
(transactivation) is mainly mediated by direct binding of the GR-GC complex to 
glucocorti¬coid response elements located in the regulatory region of a target gene. The 
GR-GC complex may also bind to negative gluco¬corticoid response elements, which leads 
to a negative regulation of genes (transrepression). It is believed that transrepression, in 
which proinflammatory genes are downregulated, is mainly responsible for the efficacy 
of GCs as anti-inflammatory drugs [5, 7], while transactivation might be responsible for 
the GC-induced adverse effects [9].
An important side effect is the development of insulin resistance (IR), because it is the 
onset of many metabolic diseases and conditions such as obesity, diabetes mellitus and 
hypertension. IR is a physiological condition in which a given concentration of insulin 
produces a less-than-expected biological effect. These biological effects are different 
depending on the tissue in which they occur. For instance, under IR conditions, fat and 
muscle cells fail to adequately respond to circulating insulin, which results in reduced 
glucose uptake, and subsequently higher glucose levels in blood [10, 11]. In liver cells 
the IR- effects can be seen in reduced glycogen synthesis and storage, and a failure to 
suppress glucose production and release into the blood.
One way by which GCs induce IR is by inhibition of the recruitment of GLUT4 glucose 
transporter, which results in reduced insulin-stimulated glucose transport in skeletal 
muscle [12]. However, not all mechanisms involved in GC-induced side effects are not 
completely understood. To gain more insight into mechanisms behind GC induced IR, it is 
important to understand which genes play a role in the development of insulin resistance 
and which genes are affected by GCs. 
It has been widely recognized that a system approach in which networks of genes in their 
functional context are studied, contributes to a better understanding of the mechanisms 
and pathways related to the disease and the drug effects [13-17].  To study a gene 
network related to a disease such as IR, a list of disease related genes as well as a notion 
of the interactions between these genes is needed. 
Literature databases such as Medline contain many studies about IR and the molecular 
effects of synthetic glucocorticoids and thus are a good resource that can be used to 
create and study disease related gene networks. 
The retrieval of relevant gene-disease associations out of the millions of abstracts in 
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Medline is very labor intensive and thus a text mining system is needed to this in an 
automated fashion.
In previous work we reported about CoPub [18-20], a publicly available text mining 
system, which has successfully been used for the analysis of microarray data and in 
toxicogenomics studies [21-26]. CoPub calculates keyword co-occurrences in titles and 
abstracts from the entire Medline database, using thesauri for genes, diseases, drugs 
and pathways. We used this technology to develop CoPubGene, a rapid gene–disease 
network building tool. To evaluate the importance of genes in these networks we 
implemented a method to score the importance of genes in biological processes of 
interest by incorporating their functional neighborhood. 
We used CoPubGene to create a network of genes related to insulin resistance and to 
evaluate the importance of the genes in this network for glucocorticoid induced metabolic 
side effects and anti-inflammatory processes. 
By using this method, we identified several genes that already are considered markers 
of GC induced IR,  such as phosphoenolpyruvate carboxykinase (PCK) and glucose-6-
phosphatase, catalytic subunit (G6PC) [27, 28]. Even more importantly, we were able 
to identify genes involved in steroid synthesis that have not yet been recognized as 
mediators of GC induced IR.
Methods
CoPubGene
We constructed CoPubGene as a SOAP based web service (Table 1). This CoPub Web 
Service WSDL is created in Eclipse using the so-called Document Literal Wrapped style. 
The web service provider code is written in Perl using the SOAP::WSDL module and is 
available via the CoPub portal http://www.copub.org.
Retrieval of Gene-Disease associations
To create disease related gene networks, we used CoPubGene to retrieve gene-disease 
and gene-gene associations from Medline abstracts. Disease terms which had significant 
gene associations based on the R-scaled score (rs > 35) and literature count (lc > 5) in 
Medline abstracts, were extracted from the CoPub thesaurus. 
Disease clustering
Disease clustering was done in R (http://www.r-project.org) using the pvclust R package 
with “complete” setting for hierarchical clustering, based on correlation distance of 
R-scaled scores between genes and diseases, with 100 bootstrap replications. The 
hierarchical cluster was visualized using Denroscope [29]. Additional gene set enrichment 
analysis against the GENETIC_ASSOCIATION_DB_DISEASE was done with the annotation 
server DAVID [30, 31].
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Creation of IR gene network
CoPubGene was used to create a set of genes related to IR, by searching for associations 
between genes and IR in Medline abstracts using default values (rs> 30 and lc > 5). 
Subsequently the IR-gene network was created by connecting genes that had significant 
co-occurrences with each other.
Keyword enrichment analysis of IR related genes
Keyword enrichment analysis on the list of IR related genes was done against disease and 
drug terms from the CoPub database. Threshold values were chosen using default values.
Analysis of the IR gene network and calculation of neighbor score for genes
The IR gene network was analyzed by mapping specific occurrences of the IR related 
genes with ‘inflammation’ and ‘dexamethasone’ in Medline abstracts onto the network. 
For the evaluation of the involvement of a gene, calculation of the literature score for a 
given gene and a given disease term, also the effects of dexamethasone and inflammation 
on the connecting genes are included. The literature score for gene g with term d is 
calculated in the following way:
In which g1 is the R-scaled score of gene g with term d, and Ns is the literature score of 
its neighboring genes with term d. This latter score Ns is calculated using the R-scaled 
score of each neighboring gene of gene g with term d (g2, g3,..,gn) relative to its relation 
(R-scaled score) with gene g (rg2, rg3,..,rgn).
Results
We developed CoPubGene by creating a number of web service operations that can be 
used to construct networks of genes based on their co-occurrences in Medline abstracts. 
These web service operations can be combined to answer a variety of biological questions 
(Table 1).  For example, the question “to what biological processes is this gene related?” 
can be answered by running the “get genes” and “get literature neighbours” functions. 
Using subsequently the “get references” function will return all the relevant pubmed 
entries in which the gene and keywords co-occur. By applying the “get keywords” and 
“get literature neighbours” functions one can retrieve all disease terms that are linked to 
a given drug term in the Medline abstract, or vice versa, retrieve all drug terms that are 
linked to a given disease term in abstracts. The networks that are created can be written 
to Cytoscape for downstream applications and visualizations. Also more advanced 
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questions such as the construction of disease related gene networks, and subsequent 
calculation of keyword enrichment in this network can be addressed in an automatic way. 
In Table 1 the available web service operations are shown.
Name Operation name Input Output Description
Get genes Get_genes Gene name, 
gene identifier
Biological identifier(s), 
with gene specific 
information
Each gene in CoPub 
belongs to an internal 
identifier (biological 
identifier). Get_genes 
converts the input gene 
to such a Biological 
identifier. This biological 
identifier serves as an 
input for subsequent 
operations.
Get Keywords Get_keywords Keyword Biological identifier(s), 
with keyword specific 
information
Retrieves for a set of 
keywords, the Biological 
identifiers to which these 
keywords belong in 
CoPub. These biological 
identifiers serve as an 
input for subsequent 
operations.
Get references Get_references Biological
identifier(s)
Literature references Given a Biological 
identifier, retrieves all 
abstracts in which the 
term occurs.
Get literature 
neighbours
Get_literature_
neighbours
Biological 
identifier(s)
Literature neighbors Given a Biological 
identifier, retrieves a 
list of keywords which 
are mentioned in the 
literature together with 
the input term.
Get enriched 
keywords
Get_enriched_
keywords
List of gene 
identifiers
List of enriched 
keywords
For a list of genes, 
this operation 
calculates a keyword 
overrepresentation.
Get literature 
network
Get_literature_
network
Biological 
identifier(s)
SVG / Cytoscape 
network
For a set of genes, the 
operation creates a 
network of genes.
Get categories Get_Categories - List of categories Returns a list of 
categories of terms in 
CoPub
Get chips Get_chips - List of microarrays Returns a list of available 
Affymetrix chip names in 
CoPub.
Version Version - Version of code and 
literature
Returns the version of the 
code and literature.
Selftest Selftest - Diagnostic information -
Table 1 List of available operations of the CoPub Web Service. Biological identifiers are used by 
CoPub to identify biological concepts in the system. Each biological concept has a unique identifier.
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Retrieval of gene-disease associations
Our aim was to get insight into the pathways and genes that are involved in insulin 
resistance, and the effect of glucocorticoids on this network. As a first step we created a 
list of genes associated with insulin resistance using CoPubGene. This yielded a list of 384 
genes each of them connected to IR with an R scaled score (in Table 2A the top scoring 
genes with IR are shown, the full list is available in supplementary table 2). To evaluate 
the quality of this list and to investigate whether this gene list is unique for IR or whether 
this list contains a large number of genes that are associated with multiple diseases we 
constructed a gene association list for all diseases in the disease thesaurus of CoPub, 
using similar parameter settings as used for construction of the IR gene list. This yielded a 
list of disease profiles with for each disease, a number of genes connected to that disease 
with an R scaled score. (Table 2 shows the results for a few selected diseases, the full 
Figure 1 Hierarchical cluster of disease terms from the CoPub database. The top 80 disease 
terms with the most gene associations are shown. Disease terms are clustered together based on 
having the same gene associations. Red numbers at the nodes represent approximately unbiased 
bootstrap values (%).
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A
Gene 
Symbol
Gene Name IR Diabetes 
mellitus, 
type 2
Obesity Rheumatoid 
arthritis
Psoriasis IBD
RBP4 retinol binding protein 4,plasma 53 47 46 0 0 0
GPR83 G protein coupled receptor 83 51 48 39 0 0 0
BSCL2 Bernardinelli Seip congenital 
lipodystrophy 2
51 0 0 0 0 0
RETN resistin 51 46 47 0 0 37
AGPAT2 1 acylglycerol 3 phosphate O 
acyltransferase 2
50 0 0 0 0 0
SERPINA12 serpin peptidase inhibitor,clade 
A,member 12
50 0 47 0 0 0
IRS1 insulin receptor substrate 1 50 43 40 0 0 0
ADIPOR2 adiponectin receptor 2 50 0 45 0 0 0
STEAP4 STEAP family member 4 50 0 46 0 0 0
ADIPOQ adiponectin,C1Q and collagen 
domain containing
50 44 46 0 0 0
B
Gene 
Symbol
Gene Name IR Diabetes 
mellitus, 
type 2
Obesity Rheumatoid 
arthritis
Psoriasis IBD
PADI4 peptidyl arginine 
deiminase,type IV
0 0 0 48 41 0
FCRL3 Fc receptor like 3 0 0 0 48 0 0
NCOA5 nuclear receptor 
coactivator 5
0 0 0 48 0 0
OLIG3 oligodendrocyte 
transcription factor 3
0 0 0 47 0 0
TNFAIP3 tumor necrosis factor,alpha 
induced protein 3
0 0 0 46 45 0
PTPN22 protein tyrosine 
phosphatase,non receptor 
type 22
0 0 0 46 41 39
HLADRB4 major histocompatibility 
complex,class II,DR beta 4
0 0 0 45 0 36
HLADRB5 major histocompatibility 
complex,class II,DR beta 5
0 0 0 45 0 36
CHI3L1 chitinase 3 like 1 37 0 0 44 0 43
HLADRB1 major histocompatibility 
complex,class II,DR beta 1
0 0 0 44 0 36
Table 2 Part of the disease matrix, which has been used for the clustering. A link between 
a gene and a disease term is given by the R-scaled score. Top scoring genes with insulin resistance 
(IR) are related to other metabolic disease terms (indicated in green) and not to inflammatory 
disease terms (indicated in red) (A). Top scoring genes with rheumatoid arthritis are related to 
other inflammatory disease terms (shown in green) and not to metabolic disease terms (show in 
red) (B). IBD: inflammatory bowel disease.
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table is available in supplementary table 3).
These disease profiles were clustered using hierarchical clustering with multiscale 
bootstrap resampling, grouping together disease terms which have a similar profile, i.e. 
co-occur with the same genes (Figure 1). It appeared that a number of clusters of similar 
disease terms i.e. disease terms for which it is known that they have similar symptoms or 
have a similar mode of action, could be identified. For instance cancer related terms, such 
as ‘cancer of breast’, ‘cancer of prostate’ and ‘colon cancer’ are clustered together  and 
inflammatory related disease terms such as ‘psoriasis’, ‘inflammatory bowel disease’ and 
‘asthma’ are clustered together. These clusters also have high unbiased (AU) bootstrap 
values, indicating strong evidence for these clusters. To further confirm that the found 
gene-disease associations by CoPub are indeed biologically relevant, for each sub-cluster 
in Figure 1, we collected the union of all genes for that sub-cluster, and used these genes 
to perform a functional annotation analysis against the genetic association disease 
database using DAVID. The results of this analysis indicated that indeed similar disease 
terms to CoPub were found by DAVID (for the results of this analysis see supplementary 
tables). These analyses showed that with CoPubGene we are able to construct a relevant 
list of specific IR related genes that can be used for further analysis and that CoPubGene 
can be used to create a variety of disease related genes lists.
Network of insulin resistance related genes.
To create the IR gene network, we used the 384 genes from the IR gene list and connected 
the genes based on their co-occurrences with each other in Medline abstracts. The 
resulting network is shown in Figure 2A. We found that 381 genes of the IR gene list 
were connected to at least one other gene. We identified a number of hubs such as 
peroxisome proliferator-activated receptor gamma (PPARG), insulin receptor substrate 1 
(IRS1), v-akt murine thymoma viral oncogene homolog 1 (AKT1), insulin receptor (INSR), 
solute carrier family 2 (facilitated glucose transporter), member 4 (SLC2A4) and insulin 
(INS) which were connected to more than 100 other genes. The resulting network is a 
scale free network, as indicated by the distribution of connectivity that follows a power 
law distribution which is indicative for a scale free network (supplementary Figure 1) 
[32]. Although the above network has the characteristics of a biological network, and 
contains the expected genes as central hubs, without additional annotations this network 
representation is still largely uninformative and contains too little substructure to draw 
biological conclusions.
Annotation of the network with drugs and diseases terms
As a first step towards annotating the network and identification of sub networks with 
a shared biological function, we investigated which drugs and diseases in the literature 
are specifically linked to this network using a keyword enrichment analysis on the list of 
IR related genes (For details about the enrichment method see Table 1). This enrichment 
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yielded a number of drugs  that are known drugs for the treatment of diabetes such as 
‘rosiglitazone’, ‘metformin’ , ‘pioglitazone’, and also ‘glucagon’ and ‘insulin’ which are 
frequently used for the treatment of hypoglycemia and hypoinsulinemia (Table3A. For 
the full list see supplementary table 4A). Notably, among these top scoring drugs we 
found dexamethasone, a well known synthetic glucocorticoid. High scoring genes with 
dexamethasone are for instance CEBPA, SERPINA6, PCK2 and GPD1 (for a full list of genes 
per enriched drug term, see supplementary Table 4A.2), which also have been mentioned 
in the development of several metabolic diseases [33-37].
There are several top scoring over-represented terms that are related to metabolic diseases, 
e.g. ‘diabetes mellitus’, ‘obesity’, ‘diabetes  mellitus, type 2’ and ‘hyperinsulinemia’ (Table 
3B ). The fact that these terms are high scoring is expected since we constructed the gene 
network based on the keyword insulin resistance. However we also found diseases that 
share a common origin with insulin resistance such as cardiovascular disease (Table 3B). 
The most interesting high scoring term for our particular research question was the non-
metabolic term ‘inflammation’, which was represented in the network by genes such as IL6, 
IL18, IL1RA, SOCS1, SOCS3, CCL2 and CCR2. Several of these genes have been mentioned 
A
Term Number of genes
insulin 358
dexamethasone 195
nitric oxide 193
estrogen 169
adenosine 151
estradiol 145
rosiglitazone 125
actinomycin 124
actinomycin d 121
glucagon 120
thrombin 108
progesterone 97
trypsin 86
nicotinamide 85
metformin 84
pioglitazone 82
B
Term Number of genes
insulin resistance 381
obesity 263
inflammation 219
diabetes mellitus 190
cardiovascular disease 181
Diabetes mellitus,type 2 173
Oxygen deficiency 164
fibrosis 138
hyperinsulinemia 137
Cancer of breast 131
Adiposity 130
cancer 128
starvation 120
Table 3 Over-represented drug and disease terms (P-value < 0.05). The top scoring drug terms in 
the IR network from the CoPub database (A). Top scoring disease terms from the CoPub database 
in the IR network (B).
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in studies to be involved in the development of metabolic diseases. For instance, elevated 
levels of IL6 in subjects with obesity and diabetes showed an association between insulin 
resistance and IL6 [38]. Studies in mice showed that CCR2 deficiency or antagonism of 
this receptor resulted in attenuation of systemic insulin resistance and development of 
obesity, hence suggesting a modulating role of CCR2 in this [39, 40]. 
These results show that even with an unbiased data driven construction of a gene 
network, the relation between IR, dexamethasone and inflammation is discovered based 
on the genes that play a role in these effects. We subsequently highlighted the genes in 
the IR network that are related to inflammation and dexamethasone (Figure 2).
Genes linked to inflammation and glucocorticoids in the context of insulin resistance
From a drug development perspective it is interesting to separate the desired effect of 
GCs on inflammatory processes from the undesired effect on metabolic processes. To 
Figure 2 Literature network of insulin resistance related genes (A). Genes, represented by nodes 
are linked, based on co-occurrences in Medline abstracts. The thickness of the edge indicates the 
strength of the link between two genes (R-scaled score). Genes in blue have a co-occurrence with 
dexamethasone in Medline abstracts (R-scaled score). The strength of the link with dexamethasone 
is given by the color shading, ranging from no link (white) to a strong link (dark blue). The strength 
of the link with inflammation (R-scaled score) is given by the size of the node of the gene, ranging 
from no link (normal size of the node) to a strong link with inflammation (large size of the node). 
Sub-network for gene PPARG (B). Sub-network of Cytochrome P450s (C).
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rank each gene with respect to the relation with GC and inflammation, we calculated for 
each gene a literature score with dexamethasone and inflammation. Subsequently we 
focused on genes that score low on inflammation and high on dexamethasone (Figure 
3). These genes are thought to be more exclusively related to GC induced IR.  For these 
genes we calculated a literature neighbor score as well, by also including the relations 
of dexamethasone and inflammation with genes to which the gene is connected in the 
network. In Figure 3 it is shown that many genes which are not directly connected to 
inflammation (grey dots) are definitely influenced by inflammation via their connecting 
genes (black dots). The majority of the genes in Figure 3 are directly involved in important 
metabolic processes such as gluconeogenesis (PCK2, G6PC, PC and GCG), glycolysis 
(GCK, GCG), glucose uptake, lipid metabolism (ACACA, CHPT1, GPD1) and carbohydrate 
metabolism (GPD1). Other ones are directly involved in insulin signaling (GIP, IGF2, IPF1, 
IAPP).
Figure 3 Influence of dexamethasone and inflammation on IR genes that have a high score with 
dexamethasone (> 25) and a low score with inflammation (<25). The direct score of these genes 
with dexamethasone and inflammation are shown in grey. The literature neighbor score for these 
genes, by also including the relations of dexamethasone and inflammation with genes to which the 
gene is connected in the network, are shown in black. The grey arrows indicate the migration of the 
gene from a direct score to a literature neighbor score.
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Sex steroid physiology in relation to insulin resistance
Interestingly in Figure 3 we also see three cytochrome P450s, i.e. CYP17A1, CYP19A1 and 
CYP21A2, which are key regulator enzymes in the steroid synthesis (Figure 4). The sub-
network in Figure 2C shows the three cytocromes P450s and their direct gene neighbors. 
Analysis of this sub-network showed that many of the genes in the network are mentioned 
in studies from women suffering of the Polycystic ovary syndrome (PCOS), in which there 
is an imbalance of a woman's female sex hormones. PCOS is characterized by insulin 
resistance, possibly because of hyperandrogenism and low levels of SHBG. The latter 
effect has also been observed in men suffering from the metabolic syndrome [41]. Also 
a study by Macut et al. suggested that alterations of a cross-talk between glucocorticoid 
signaling and metabolic parameters, is related to PCOS pathophysiology [42]. 
Additional topological analysis of the sub-network using cytohubba [58] revealed that 
IGF1R, HSD11B2, IGF2 and SHBG have a high betweenness centrality, i.e. they have many 
shortest paths going through them, analogous to major bridges and tunnels on a high 
map. Studies show that such a bottle necks play important roles in biological networks 
[43, 44]. 
Figure 4 Steroid synthesis. Enzymes indicated with a red box have been found in our analysis. 
CYP17A1 encodes for an enzyme which has both a 17α-hydroxylase and a 17,20 lyase function. 
CYP21A2 encodes for a steroid 21-hydroxylase and CYP19A1 encodes for an aromatase. Figure 
derived from the image Steroidogenesis.png in Wikipedia, by David Richfield and Mikael Häggström, 
licensed under Creative Commons CC BY-SA 3.0 and GFDL.
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CYP19A1 encodes for an aromatase which is responsible for the aromatization of 
androgens into estrogens, thus influencing the androgen to estrogen balance. Several 
studies showed that an imbalance between androgen and estrogen balance because of 
aromatase deficiency resulted in the development of symptoms related to the metabolic 
syndrome [45-48]. The fact that dexamethasone can regulate aromatase activity [49-51], 
suggests a role of aromatase in GC induced IR.
CYP17A1 is a key regulator of androgen synthesis and catalyzes the reactions in which 
pregnenolone and progesterone are converted into their 17-alpha-hydroxylated products 
and subsequently into Dehydroepiandrosterone (DHEA). A decline in DHEA and also its 
sulfated ester (DHEA-S) has been suggested to be causally linked to insulin resistance and 
obesity [52-55]. The possible inhibitory effects of dexamethasone on Cyp17a1 [56, 57] 
suggests a role in GC induced IR by this gene.
CYP21A2 is a cytochrome P450 enzyme coding for the 21-hydroxylase that is involved 
in the biosynthesis of the steroid hormones aldosterone and cortisol. A defect in this 
gene leads to Congenital adrenal hyperplasia (CAH) in which there is a disbalance in 
cortisol and aldosterone secretion. CAH patients are characterized by insulin resistance, 
lower insulin sensitivity and hyperinsulinemia [58-61]. Some studies indicate that the 
development of IR is because of GC treatment in this patient group [62-64]. Whether 
these patients develop IR because of CAH and deficiency of 21-hydroxylase, or because 
of the fact that they are often treated with synthetic GCs need to be elucidated.
Genes involved in osteoporosis
Another side effect of GC treatment is the development of glucocorticoid induced 
osteoporosis (GIOP) [65]. GIOP is characterized by reduced bone mineral density 
(BMD), decreased bone mass and disturbance of the bone matrix, leading to increased 
susceptibility to fractures. We  applied CoPubGene to deduce important genes involved in 
GIOP by analyzing top scoring genes with OP (in total 131 genes associated with OP were 
found, see supplementary table 5;  the  network of these top scoring genes with relations 
to dexamethasone and inflammation is shown in supplementary figure 3. The majority 
of the genes are involved in bone remodeling and resorption (TNFRSF11A, TNFRSF11B, 
TNFSF11, SP7, CTSK), in bone mineralization (PTH, Klotho, VDR, Calca, BGLAP) or are 
part of the wnt signaling pathway that is involved in the regulation of bone formation 
(SOST, DKK1, LRP5, LRP6) [66]. Among these genes are known biomarkers of GIOP such 
as osteoprotegerin (encoded by TNFRSF11B) and the ligand RANK-L (encoded by TNFS11) 
[67]. Here we also searched for genes with a low score with inflammation. Several of 
these genes in the set, such as BGLAP, COL1A1 and SP7 are affected by GCs [68-72], have 
low associations with inflammation and therefore are interesting biomarker candidates 
for GIOP. 
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Discussion
In the work presented here we used Medline abstracts to study mechanisms and genes 
involved in glucocorticoid induced insulin resistance. We created CoPubGene, a number 
of web service operations that can be used to retrieve relevant gene-disease, gene-drug 
and gene-gene associations out of Medline abstracts, using the CoPub technology. 
The clustering of disease terms based on their associations with genes in Medline 
abstracts showed that CoPubGene is able to generate a list of specific IR genes that 
can be used for further analysis, and that this method also can be used to generate a 
variety of other gene disease associations. We used this clustering to evaluate the quality 
of disease related gene lists, generated using a text mining approach, because to our 
knowledge there is no real gold standard data set that covers a sufficient range of gene-
disease associations that can be used. Databases such as OMIM and the KEGG disease 
database [73] only cover a sub range of diseases which makes these datasets difficult to 
use in this type of evaluation.
Next, we studied the IR genes in their functional context, by including genes with which 
they co-occur in Medline abstracts. In this gene network we focused on genes that 
are strongly linked to dexamethasone and less strongly to inflammation. These genes 
are thought to be more exclusively related to GC induced IR and therefore might be 
interesting markers for this effect. 
However, all of them are to a certain extent related to inflammation, either directly 
or indirectly by their neighbors, which suggests that these genes cannot be used as 
an exclusive marker for GC induced IR. This might have consequences for the search 
of dissociating compounds, i.e. compounds which only have the immune suppressive 
properties and not the unwanted side effects. Instead the search should focus on 
compounds that show a reduced effect on the expression of these IR genes.  
The majority of the IR genes that have a low literature neighbor score for inflammation (< 
25) and a high score for dexamethasone (literature neighbor score > 25) code for enzymes 
and hormones directly involved in important metabolic processes, such as glycolysis, 
gluconeogenesis, glucose uptake and lipid metabolism. All these processes are tightly 
regulated by insulin. This suggests that at a first instance, the search for mechanisms of 
GC induced IR should be focused on these processes.  
Additionally, we also identified a sub network of genes involved in sex steroid synthesis 
that to our knowledge, not have been recognized yet as mediators of GC induced side 
effects. Key enzymes involved in steroid synthesis, i.e. CYP17A1, CYP21A2 and CYP19A1 
keep the balance between several steroids, and an impairment of this balance could 
possibly result in metabolic disturbances such as IR. Additional topological analyses could 
further prioritize this sub-network for follow-up studies to determine the influence of 
GCs on sex steroid synthesis and the relation to IR. In such a study one could look at the 
influence of GCs on the balance between the steroids in combination with their influence 
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on insulin stimulated glucose uptake in glucose sensitive tissues such as adipose and 
muscle tissue. 
Conclusions
Using CoPubGene we are able to construct an informative literature network of IR related 
genes by only using information from Medline abstracts. Our approach revealed genes, 
that on a first glance were not considered to be involved in GC induced IR and thus gave 
new insights that might lead to a better understanding of the mechanisms behind GC 
induced IR.
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Abstract
Background
Prednisolone and other glucocorticoids (GCs) are potent anti-inflammatory and 
immunosuppressive drugs. However, prolonged use at a medium or high dose is hampered 
by side effects of which the metabolic side effects are most evident. Relatively little is 
known about their effect on gene-expression in vivo, the effect on cell subpopulations 
and the relation to the efficacy and side effects of GCs. 
Aim
To identify and compare prednisolone-induced gene signatures in CD4+ T lymphocytes 
and CD14+ monocytes derived from healthy volunteers and to link these signatures to 
underlying biological pathways involved in metabolic adverse effects. 
Materials & methods
Whole-genome expression profiling was performed on CD4+ T lymphocytes and CD14+ 
monocytes derived from healthy volunteers treated with prednisolone. Text-mining 
analyses was used to link genes to pathways involved in metabolic adverse events. 
Results
Induction of gene-expression was much stronger in CD4+ T lymphocytes than in CD14+ 
monocytes with respect to fold changes, but the number of truly cell-specific genes 
where a strong prednisolone effect in one cell type was accompanied by a total lack of 
prednisolone effect in the other cell type, was relatively low. Subsequently, a large set 
of genes was identified with a strong link to metabolic processes, for some of which the 
association with GCs is novel. 
Conclusion
The identified gene signatures provide new starting points for further study into GC-
induced transcriptional regulation in vivo and the mechanisms underlying GC-mediated 
metabolic side effects.
Keywords: gene signature, glucocorticoids, metabolic side effects,  prednisolone, whole-
genome expression profiling.
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Introduction
Glucocorticoids (GCs) display strong anti-inflammatory effects and are therefore among
the most prescribed agents for the treatment of numerous inflammatory conditions [1].
Exogenous GCs are used in daily clinical practice to treat inflammatory, autoimmune and
allergic disorders, to attenuate organ rejection after transplantation, to treat brain edema,
shock and various blood cancers [2]. Most of the effects of GCs are mediated through 
binding to the intracellular GC receptor (GR). This receptor can be found in almost all 
tissues of the human body. Upon entering the cell, GCs bind to the GR, which then 
dimerizes and translocates to the nucleus where it influences gene transcription. Positive 
regulation of genes (transactivation) is mainly mediated by direct binding of the GR 
homodimer to glucocorticoid response elements located in the regulatory region of a 
target gene. Ligand-activated GR homodimers may also bind to negative glucocorticoid 
response elements, which leads to a negative regulation of genes (transrepression). 
Transrepression is also achieved by interaction of GR monomers or homodimers with 
other transcription factors via protein–protein interactions [1,3]. It is believed that the 
transrepression pathway, in which proinflammatory genes are downregulated, is mainly 
responsible for the efficacy of GCs as anti-inflammatory drugs [1,3]. However, in spite of 
excellent efficacy, the clinical use of GCs is hampered by a wide range of dose-dependent 
side effects. Persistent exposure to elevated levels of circulating GCs is related to insulin 
resistance, glucose intolerance, diabetes, adiposity, dyslipidemia, skeletal muscle wasting
and osteoporosis [1,2,4]. The mechanisms of action behind these adverse events are 
largely unknown. It is thought that the transactivation pathway might be responsible for 
these GC-induced adverse effects[5].
A number of synthetic analogs of the natural human GC cortisol have been developed, 
and one of the most widely used GCs in the daily clinic is prednisolone [6]. For example, 
prednisolone is used for the treatment of rheumatoid arthritis, inflammatory bowel 
disease, psoriasis and asthma [7–9]. As seen for all GCs, treatment with prednisolone 
also induces, besides the desired effects, a large number of (metabolic) adverse events. 
Therefore, there is a high medical need for improved anti-inflammatory drugs that are as 
effective as classical GCs but have a better safety profile. Since the precise mechanisms
involved in prednisolone-induced side effects remain unclear, it is of importance to 
elucidate genes or gene pathways that contribute to these side effects. 
In recent years, genome-wide gene-expression analysis using microarrays has become 
a key component to unraveling the underlying transcriptional regulation of various 
complex mechanisms and diseases [10,11]. Indeed, a large number of experiments 
detailing the effects of GC-induced transcriptional regulation have been described [12–
14]. However, most of these experiments have been performed in cell lines or cultured 
primary cells or whole blood. Relatively little is known regarding the effects of GCs in an 
in vivo setting and the effect on the individual cell types that are present in blood. To 
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address these issues and to monitor the acute effects of GCs in an in vivo setting in which 
GC-induced transcriptional regulation is measured in the context of all other relevant 
signals, we performed gene-expression profiling on CD4+ and CD14+ cells isolated from 
healthy volunteers that were treated with prednisolone. These cell types were chosen 
since T cells and monocytic cells are the two most important immune cells involved in 
inflammation and are also accessible. 
The healthy volunteers that participated in the trial demonstrated metabolic adverse 
events after prednisolone treatment such as a decrease in the C-peptide:glucose ratio 
and impaired glucose sensitivity [15]. The aim of the present study was to identify and 
compare acute prednisolone-induced gene signatures in CD4+ T lymphocytes and CD14+ 
monocytes. In addition, we aimed to link these signatures to underlying biological 
pathways involved in previously described metabolic adverse effects [15]. 
The results demonstrate that prednisolone induces significant changes in the 
transcriptional activity of T cells and monocytes, with a large overlap in the gene sets 
that are affected in both cell types and a relatively low number of genes regulated by 
prednisolone exclusively in one cell type. Several genes were identified that play crucial 
roles in metabolic pathways and that might be good candidates for further studies 
aimed at identifying biomarkers for GC-induced adverse events and the development of 
improved GCs.
Materials & methods
Study design
The study was a single-centre, double blind, randomized, placebo-controlled study, 
consisting of two distinct parts which were performed in parallel. In the first part of 
the study the acute effects of prednisolone treatment were assessed (acute protocol). 
Subjects were treated for 1 day with either two doses of 5 mg prednisolone (30 mg
group; n = 6) or one dose of 75 mg prednisolone (n = 6). Prednisolone and cortisol levels 
were monitored at several time points (from 7:55 AM to 8:00 AM the next day) at day 0 
and day 1 (predose) and day 2 (24 h or 12 h after the last dosing). Blood was sampled at 
day 1 (predose) and day 2 (24 h or 12 h after the last dosing) and used for whole-genome 
expression profiling. In the second part of the study, subjects were treated for 15 days 
with a placebo (n = 11) or 30 mg/day prednisolone (n = 12) and blood was sampled for 
expression analysis at day 0 (predose) and day 15 (predose) (24 h after the last dose on 
day 14) (2-week protocol). In this study, we focused on the results from the acute protocol 
and used results from the 2-week cohort for validation. In both parts, medication was 
taken in the morning (8:00 AM) and for the 2 ×15 mg prednisolone group also at 8.00 
PM. Prednisolone tablets were obtained from Pfizer AB (Sollentuna, Sweden), placebo 
tablets were provided by MSD (Oss, The Netherlands). Tablets were encapsulated in 
order to allow the treatment to be blinded. Blood prednisolone and cortisol levels were 
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determined by using the normal-phase HPLC procedure as described previously [16].
After sampling, the blood was separated into CD4+ T lymphocytes and CD14+ monocytes.
Subsequently, RNA was isolated and used for whole-genome expression analysis. 
All participants provided written informed consent. The study was approved by an 
independent ethics committee and the study was conducted in accordance with the 
Declaration of Helsinki, using good clinical practice.
Study population
Both the acute and 2-week protocols enrolled healthy male volunteers (age range 
between 20 and 45 years; BMI 22–30 kg/m2). Health status was confirmed by medical 
history, physical and laboratory examination, ECG and vital signs recordings. Participants 
were excluded if they had a clinically relevant history or presence of a medical disorder 
known to influence the investigational parameters.
Isolation of CD4+ & CD14+ cells
Human peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll density 
gradient centrifugation. Next, CD4+ T cells were isolated from PBMCs by the use of a 
MACS® CD4+ T-Cell Isolation Kit II according to protocol (Miltenyi Biotec, Utrecht, The 
Netherlands). In short, T cells are isolated by depletion of non-T cells (negative selection). 
Non-T cells are indirectly magnetically labeled with a cocktail of biotin-conjugated 
monoclonal antibodies, as primary labeling reagent, and antibiotin monoclonal 
antibodies conjugated to Microbeads® (MicroBeads, Cateno, AS, Norway), as secondary 
labeling reagent. The magnetically labeled non-T cells are depleted by retaining them on
a MACS Column in the magnetic field of a MACS Separator, while the unlabeled T cells
pass through the column. CD14+ monocytes were isolated from PBMCs by using the 
MACS Monocyte Isolation Kit II, which uses a positive selection procedure. 
RNA isolation
RNA was isolated using the RNeasy® midi kit according to the manufacturer’s protocol 
(Qiagen Benelux BV, Venlo, The Netherlands). To remove residual traces of genomic DNA, 
the RNA was treated with DNase I (Invitrogen, Leek, The Netherlands) while bound to the
RNeasy column. Quality and quantity of the purified RNA was controlled using a 
NanoDrop® spectrophotometer (Nanodrop technologies, DE, USA). RNA integrity was 
investigated by using the 2100 Bioanalyzer (Agilent technologies, PA, USA). 
Expression analysis using Affymetrix GeneChip Human Genome U133 Plus 2.0 
Amplification of 20 ng total RNA was performed with the Two-Cycle Eukaryotic Target 
Labeling kit (Affymetrix, CA, USA). Briefly, after the first round of cDNA synthesis, an 
unlabeled ribonucleotide mix (MEGAscript® T7 kit, Ambion, TX, USA) was used to generate 
unlabeled cRNA according to the protocol of Affymetrix. After clean up of the cRNA with 
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a GeneChip® Sample Cleanup Module IVT Column (Affymetrix, CA, USA), the unlabeled 
cRNA concentration was determined and 150 ng was reverse transcribed using random 
primers. Subsequently, the T7-Oligo(dT) Promoter Primer was used in the second-strand 
cDNA synthesis to generate double-stranded cDNA containing T7 promoter sequences. 
The resulting double-stranded cDNA was then amplified and biotin labeled using the IVT 
Labeling kit (Affymetrix). Biotin-labeled cRNA was fragmented at 1 μg/μl following the 
manufacturer’s protocol. After fragmentation, cRNA (10 μg) was hybridized at 45°C for 
16 h to the Human Genome U133 2.0 Plus array (Affymetrix). Following hybridization, 
the arrays were washed, stained with phycoerythrin–streptavidin conjugate (Molecular 
Probes, OR, USA), and the signals were amplified by staining the array with biotin-labeled 
antistreptavidin antibody (Vector Laboratories, CA, USA) followed by phycoerythrin–
streptavidin. The arrays were laser scanned with a GeneChip Scanner 3000 7G (Affymetrix) 
according to the manufacturer’s instructions. Data was saved as a raw image file and 
quantified using AGCC version 1.0 (Affymetrix). Raw data files are available on request.
Synthesis of cDNA & quantitative PCR
Total RNA (1 μg) was reverse transcribed using a commercially available cDNA synthesis 
kit (iScript®, BioRad Laboratories, CA, USA). Quantitative PCR was performed by SYBR® 
Green-based quantification according to the manufacturer’s protocol (Applied Biosystems, 
CA, USA). Primers were developed for FKBP5, DDIT4, KLF9, ZBTB16, FLT3 and ABCA1 
using Primer3 (Supplementary Table 1; www.futuremedicine.com/doi/suppl/10.2217/
pgs.11.34) [17]. All primer pairs were exon-spanning. The genes HUWE1 and FXBO9 were 
chosen as endogenous controls since the expression arrays did not demonstrate any 
differences in expression of these genes between the experimental groups. PCR products 
were selected to be between 80 and 120 bp long. Samples were run on the 7900 HT Real-
Time PCR System (Applied Biosystems) using the following protocol: 10 min denaturation 
at 95°C, and 40 cycles of 15 s denaturation at 95°C, 1 min, annealing and extension at 
60°C. All primer pairs were validated in triplicate using serial cDNA dilutions that resulted 
in a final concentration of the equivalent of 800, 400, 200, 100 and 50 pg/μl input of total 
RNA in the first strand synthesis. Primer pairs that were 100 ± 10% efficient, which implies 
a doubling of PCR product in each cycle, were used to quantify mRNA levels. Threshold 
cycle numbers (referred to as Ct) were obtained using the 7900 HT SDS software version 
2.3 (Applied Biosystems). All samples were measured twice and duplicate samples with a 
standard deviation larger than 0.5 were excluded from the analysis. The relative quantity 
of the gene-specific mRNA was calculated from the average value of the ΔCt (target gene 
Ct endogenous control gene Ct) for each sample. Differences in expression between two 
samples were calculated by the 2ΔCt method [18,19].
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Statistical analysis
Raw data were analyzed in R using packages from the BioConductor library [101]. 
Expression data were normalized using guanine cytosine robust multiarray analysis. 
Identification of regulated genes was carried out using the limma package from 
Bioconductor. For identifying differentially expressed genes after treatment with 
prednisolone, the following selection criteria were used: fold change >2 and p-value 
<0.05 after correction for multiple testing using the Benjamini–Hochberg correction.
Results
Comparison between subjects of both study protocols
Subjects of the acute and the 2-week protocol were matched regarding age, BMI and 
physical activity at baseline. No physical complaints were reported in both protocols 
when compared with the placebo group. The completion rate of the study was 100%, 
none of the healthy volunteers withdrew owing to prednisolone-induced adverse events 
[15].
Changes in lymphocyte & monocyte cell counts after treatment with prednisolone in 
the acute protocol
Glucocorticoid treatment will affect the number of immune cells in the blood. Leukocyte 
count (109/l) changed from 6.37 (± 2.21) at baseline to 8.77 (± 2.06) after treatment with 
2 × 15 mg prednisolone at day one and from 5.62 (± 0.85) at baseline to 8.67 (± 0.66) after 
treatment with 1 × 75 mg prednisolone at day one. Lymphocyte count (109/l) changed 
from 2.63 (± 0.93) to 2.18 (± 0.63) in the prednisolone 2 × 15 group and from 2.23 (± 0.34) 
to 2.67 (± 0.10) in the prednisolone 1 × 75 group after treatment. Monocyte count (109/l) 
changed from 0.47 (± 0.197) to 0.52 (± 0.172) in the prednisolone 2 × 15 group and from 
0.45 (± 0.084) to 0.53 (± 0.052) in the prednisolone 1 × 75 group after treatment. 
Identification of prednisolone induced gene-expression profiles in CD4+ T lymphocytes 
& CD14+ monocytes
In order to study GC effects on distinct subpopulations in human blood, CD4+ and CD14+
cells were isolated from PBMCs as described in the methods section from the samples 
obtained from the acute protocol. These purification steps yielded >98% purified CD4+ 
T cells and >90% CD14+ cells. In total, 892 probe sets were found to be significantly 
regulated by prednisolone (in CD4+ and/or CD14+ cells). Figure 1 shows the distribution 
of fold changes for the differentially expressed probe sets under each condition. The 
maximum fold changes that are observed are between four- and eight-fold, the majority 
of the genes being upregulated. It appeared that the fold changes of the regulation were 
much larger in the CD4+ T cells compared with CD14+ monocytes. Surprisingly, the classical 
GC target genes such as FKBP5, ZBTB16, DDIT4, KLF9 and FLT3 were downregulated in this 
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study (FKBP5: 2.1-fold; ZBTB16: 2.9-fold; DDIT4: threefold; KLF9: 3.8-fold) whereas most 
studies reported an upregulation of these genes after GC treatment [12–14,20–22]. These 
observed downregulations were also found by microarray analysis in the independent
validation cohort (2-weeks protocol) and by quantitative PCR validation. It is known that
expression of these genes is not only induced by GCs, which are administered as a drug,
but also by the endogenous GC cortisol. We observed that in the acute protocol, cortisol 
levels decreased after treatment with prednisolone. Even after 24 h of prednisolone 
intake, cortisol levels are still reduced when compared with baseline despite that 
prednisolone levels are decreased to zero after a few hours (Figure 2). These reduced 
cortisol levels after 24 h may provide an explanation for the observed downregulation of 
FKBP5, ZBTB16, DDIT4, KLF9 and FLT3. 
In order to identify probe sets that are specifically regulated in CD4+ or CD14+ cells, we 
followed two approaches. The first approach consisted of identifying probe sets that 
demonstrated the largest difference in prednisolone effects between both cell types. It 
appeared that a large number of the probe sets that were identified using this criteria 
demonstrated a regulation in both cell types, but differed only in the strength of the 
regulation. GAS7 is an example of such a gene (Figure 3, left panel). This indicates that 
the difference between the cell types is caused more by a difference in magnitude of 
the prednsiolone effect rather than an on–off effect in which a prednisolone effect in 
one of the cell types is completely absent. To identify the latter category, which we 
regard as a better representation of cell-specific probe sets, we selected probe sets 
that demonstrated regulation in one cell type (using the criteria stated earlier) and an 
absence of regulation in the other (defined as a log2 ratio of <0.1). This analysis yielded 
62 CD4+ specific probe sets and 14 CD14+ specific probe sets (Table 1, Supplementary 
Tables 2 & 3). Both cell-specific probe sets included many genes related to inflammation 
and immune regulation. However, a link between gene function and cell specificity could 
be made for a number of genes. For example, FCER1G and IFNGR1, regulated in CD4+ cells 
but not in CD14+ cells, are involved in T-helper cell signaling and differentiation [23–25], 
Figure 1 Distribution of ratios of 
differentially expressed probe sets 
in CD4+ and CD14+ subsets under 
both conditions (30 mg and 75 mg 
prednisolone). The ordered gene index
shown on the x-axis presents all the 
probe sets that were differentially 
regulated on day 2 compared
with day 1. These probe sets were 
ordered on the basis of the fold 
change between day 2 and day 1.
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Figure 2 Cortisol and prednisolone levels in acute protocol. The solid lines show the 
prednisolone levels during the course of the trial. Prednisolone was administered at 8 am on 
day 1 at two doses: 2 × 15 mg (second dose at 8 pm; lighter colored line) and 75 mg (darker 
colored line) as indicated by the arrows. Cortisol levels (dashed lines) were suppressed for 
almost 20 h by these doses of prednisolone compared with the levels at day 0 after placebo 
administration. Samples for gene-expression analysis were taken predose at day 1 and after 24 h. 
Figure 3 Examples of genes which show differences in prednisolone effects concering magnitude or 
cell specificity. (A) Example of a gene which is regulated by prednisolone in both CD4+ and CD14+ cells 
but shows a difference in the magnitude of expression after treatment. (B) Example of a gene which 
demonstrates expression in both cell types (cut-off: intensity >20) but is regulated by prednisolone 
only in CD4+ cells (CD4+ specific). (C) Example of a gene which demonstrates expression in both cell 
types (cut-off: intensity >20) but is regulated by prednisolone only in CD14+ cells (CD14+ specific).
Cells in which specific 
regulation occurs
Total number of 
regulated genes
Genes expressed in 
other cell type
Genes not expressed 
in other cell type
CD4+ 62 33 29
CD14+ 15 1 14
Table 1 Number of cell-specific regulated probe sets. Cut-off for determining whether a probe 
set was expressed or not was set at an average intensity of 20. Numbers denote probe sets that 
demonstrated a log ratio of <0.1 in the other cell type (corresponding to a fold change of <1.07)
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processes that are predominantly mediated by CD4+ T lymphocytes. The genes PECAM1 
and CXCL9, regulated in CD14+ cells but not in CD4+ cells, are known to have a role in 
antigen presentation and phagocytosis, which are functions mainly performed by CD14+ 
cells [26,27]. 
The relatively small sets of cell-type specific regulated genes indicate that only a 
minority of the genes demonstrate true cell specific behavior and that the majority of 
prednisolone-regulated genes are regulated in both cell types.
Pathways affected by prednisolone treatment
In order to investigate which biological pathways were mostly affected by prednisolone,
we used Ingenuity Pathway Analysis software version 8.8 (Ingenuity systems, CA, USA) 
and CoPub ([28,102]) to map the regulated probe sets to canonical pathways. The top 
five over-represented pathways as identified by Ingenuity Pathway Analysis and CoPub 
analysis is outlined in Table 2, the total list is outlined in Supplementary Table 4. The 
top scoring terms appeared to have a strong immunological component, exemplified 
by pathways such as Toll-like receptor signaling, acute phase response, T-cell and B-cell 
signaling. Also a link to autoimmune diseases such as systemic lupus erythematosus 
and rheumatoid arthritis was observed. In addition, a link to specific signaling pathways 
Pathway P-value
Ingenuity Pathway Analysis
TREM1 Signaling 2.45E-09
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses 7.41E-08
B Cell Receptor Signaling 2.00E-07
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages 5.75E-07
Toll-like Receptor Signaling 2.51E-06
CoPub Analysis
cell adhesion 0.00E+00
neutrophil activation 0.00E+00
respiratory burst 0.00E+00
t-cell proliferation, t-cell homeostatic proliferation 9.79E-11
cell development 9.79E-11
Table 2 Top five over-represented pathways as identified by Ingenuity Pathway Analysis and 
CoPub Analysis. The enrichment was calculated for 892 probe sets that were differentially 
regulated in CD4+ or C14+ samples. The total list of over-represented pathways is outlined in 
Supplementary Table 4.
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via NF-kB, IL-8, IL-6 and GM-CSF was observed, all of which are signaling pathways that 
play an important role in inflammatory processes. This indicates that the main effects 
that are induced by prednisolone in CD4+ and CD14+ are related to the pharmacological, 
anti-inflammatory properties of prednisolone. Interestingly, these effects can thus be 
observed in healthy, unchallenged volunteers.
Text-mining analysis to identify  genes that are involved in prednisolone-induced 
metabolic side effects
The above mentioned results demonstrated that we can clearly identify GC signatures 
in both CD4+ and CD14+ cell types and that these signatures have a strong link to 
immunological processes. The above analysis is, however, an enrichment analysis in 
which only the most affected pathways are identified. In the case that only a small, 
but possibly crucial, number of genes in a pathway are regulated, this pathway will not 
receive a high enrichment score and might therefore easily be missed when the results 
are interpreted. 
To make a link to possible prednisoloneinduced metabolic side effects, we set out to 
identify genes that are regulated by prednisolone and are involved in metabolic pathways 
and processes. To perform this in an unbiased way we used CoPub to identify from the set 
of regulated genes, all genes with a strong literature link to keywords describing glucose 
and fatty-acid metabolism. Since we were also interested in the interplay between 
immunological and metabolic processes and the possible relation with GC regulation, 
we also examined for each of the genes whether there was a strong known link with 
keywords describing GR-mediated processes and immunological pathways. The keywords 
that were used are presented in Supplementary Table 5.
We identified 253 genes with a link to one or more of the metabolic keywords that were 
used for searching. The top scoring metabolic genes (34 genes) are shown in Figure 4, 
together with their literature scores. A short description regarding the function of ten of 
these 34 genes is outlined in Table 3; in Supplementary Table 6 the function of all 34 genes 
is summarized. It appeared that a large number of these genes had not only a strong link 
to metabolic processes but were also connected to inflammatory  processes. For example, 
MAPK14 (p38 MAP kinase) is involved in signal transduction of inflammatory stimuli, but 
has also been reported to play a role in insulininduced glucose transport in muscle [29]. 
Other genes with a strong link to both metabolic and inflammatory processes are MAPK1 
and IL-1B. However, for a number of genes an immunological function is less obvious, and 
these may represent a set of genes that have a predominantly metabolic function and 
are less important for the anti-inflammatory action of prednisolone. Examples of such 
genes are genes related to fatty acid transport and metabolism: ABCA1, ACOX1, PDK4, 
ACSL1 and EPHX2 [30–36], and genes related to (regulation of) glucose and glycogen 
metabolism: PYGL, GYG1, SLC16A3, PFKFB3, PFKFB2, AQP9, GK and SLC2A3 (also known 
as GLUT3) (Figure 4) [32,35,37–42]. These results clearly indicate that the glucose and 
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lipid metabolic signaling pathways, in which these genes play a role, are affected by GC 
treatment. 
Some of the above mentioned genes, for example PYGL, GYG1 and AQP9 display a weak 
literature link with GC. A detailed search in PubMed confirms that these genes indeed 
have not been reported to be under control of GCs. Interestingly, in promoter regions 
of human and pig AQP9, putative GC response elements have been identified [43,44] 
indicating that this gene might be under the direct control of GCs. A metabolic role for 
GYG1 and PYG1 in PBMCs is supported by the fact that these genes were also strongly 
Figure 4 Text-mining analysis to identify genes involved in prednisolone-induced metabolic side 
effects. Genes depicted in this list are sorted according to high literature co-occurrence score for 
keywords involved in metabolism
(cut-off ≥0.5).
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Gene 
symbol
Gene 
name
Function Role in metabolism
PYGL Phospho-
rylase, 
glycogen, 
liver
Encodes a homodimeric 
protein that catalyses the 
cleavage of alpha-1,4-
glucosidic bonds to release 
glucose-1-phosphate from 
liver glycogen stores
Humans have three glycogen phosphorylase 
isozymes that are primarily expressed in liver, 
brain and muscle, respectively. The liver isozyme 
serves the glycemic demands of the body in 
general while the brain and muscle isozymes 
supply just those tissues. In glycogen storage dis-
ease type VI, or Hers disease, mutations in liver 
glycogen phosphorylase inhibit the conversion 
of glycogen to glucose and results in moderate 
hypoglycemia, mild ketosis, growth retardation 
and hepatomegaly
GYG1 Glycogenin 
1
Encodes a member of the 
glycogenin family. Glycogenin 
is a glycosyltransferase that 
catalyzes the formation of a 
short glucose polymer from 
uridine diphosphate glucose 
in an autoglucosylation 
reaction
This gene is expressed in muscle and other tis-
sues and has a key role in glycogen formation.  
Mutations in this gene result in glycogen storage 
disease XV
AQP9 Auaporin 9 The aquaporins are a family 
of water-selective membrane 
channels. The protein 
encoded by this gene allows 
passage of a wide variety of 
noncharged solutes
AQP9 stimulates urea transport and osmotic wa-
ter permeability; there are contradicting reports 
about its role in providing glycerol permeability. 
It may also play a role in specialized leukocyte 
functions such as immunological response and 
bactericidal activity
PDK4 Pyruvate 
dehydro-
genase 
kinase, iso-
zyme 4
PDK4 is located in the 
matrix of the mitrochondria 
and inhibits the pyruvate 
dehydrogenase complex by 
phosphorylating one of its 
subunits
By inhibiting the pyruvate dehydrogenase com-
plex it is contributing to the regulation of glucose 
metabolism. Expression of this gene is regulated 
by glucocorticoids, retinoic acid and insulin
GLUL Glutama-
te-ammo-
nia ligase
The protein catalyzes the 
synthesis of glutamine from 
glutamate and ammonia
Glutamine is a main source of energy and is 
involved in cell proliferation, inhibition of apop-
tosis, and cell signaling
ACSL1 Acyl-CoA 
synthetase 
long-chain 
family 
member 1
Isozyme of the long-chain 
fatty-acid-coenzyme A ligase 
family. All isozymes of this 
family convert free long-chain 
fatty acids into fatty acyl-CoA 
esters
Plays a key role in lipid biosynthesis and fatty 
acid degradation
Table 3 Function of ten of 34 genes that were identified by text mining. Information was ob-
tained from two sources. Information on the general function of the gene was obtained from 
the EntrezGene database from the NCBI (http://www.ncbi.nlm.nih.gov/gene). The link be-
tween the gene and metabolic processes was obtained from manual inspection of the Pubmed 
abstracts returned by the CoPub text mining strategy, i.e., those abstracts in which the genes 
and metabolic keywords co-occur which is the underlying evidence for the literature scores 
depicted in figure 4. The total gene list of 34 genes is outlined in supplementary table 6.
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Gene 
symbol
Gene 
name
Function Role in metabolism
CEBPB CCAAT/
enhancer 
binding 
protein (C/
EBP), beta
The protein encoded by this 
intronless gene is a bZIP 
transcription factor which can 
bind as a homodimer to cer-
tain DNA regulatory regions
Polymorphisms in CEBPB are associated with 
abdominal obesity and related metabolic abnor-
malities like type 2 diabetes
IL1B Interleukin 
1, beta
This cytokine is an important 
mediator of the inflammatory 
response, and is involved in 
a variety of cellular activities, 
including cell proliferation, 
differentiation, and apoptosis
Inflammation is associated with obesity, the 
metabolic syndrome, and diabetes.  Weight 
reduction results in a decrease in the mRNA ex-
pression of IL-1beta (IL1B), IL-1 receptor antago-
nist, and tumor necrosis factor alpha.  Decrease 
in IL1B expression is correlated with an increase 
in insulin sensitivity index. The strong correlation 
between the decrease in IL1B expression and 
the increase in insulin sensitivity suggest a con-
tribution of IL1B to insulin-resistant states found 
in obesity and the metabolic syndrome.
MAPK14 Mitogen-
activated 
protein 
kinase 14
Member of the MAP kinase 
family. MAP kinases act as an 
integration point for multiple 
biochemical signals, and are 
involved in a wide variety of 
cellular processes such as 
proliferation, differentiation, 
transcription regulation and 
development
Regulates the activities of many transcription 
factors and proteins/enzymes and thus has a 
wide-spectrum of biological effects. Patients 
with insulin resistance and/or type 2 diabetes 
have high levels of plasma free fatty acids, 
inflammatory cytokines, and/or glucose, and 
over-activation of the cardiovascular renin-
angiotensin system, all are capable of activat-
ing MAPK14. MAPK14 plays a central role in 
hepatic glucose and lipid metabolism, leading 
to increased hepatic glucose production and de-
creased hepatic lipogenesis. The role of MAPK14 
in insulin-mediated glucose uptake in skeletal 
muscle and adipose tissue remain controversial
MAPK1 Mitogen-
activated 
protein 
kinase 1
Member of the MAP kinase 
family. MAP kinases act as an 
integration point for multiple 
biochemical signals, and are 
involved in a wide variety of 
cellular processes such as 
proliferation, differentiation, 
transcription regulation and 
development
Recent evidence suggests that common stress-
activated signaling pathways such as nuclear 
factor-kappaB, MAPK1, and NH2-terminal Jun 
kinases/stress-activated protein kinases underlie 
the development of diabetic complications. In 
type 2 diabetes, there is evidence that the acti-
vation of these same stress pathways by glucose 
and possibly FFA leads to both insulin resistance 
and impaired insulin secretion
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regulated in PBMCs of healthy volunteers after a high calorie breakfast [45].
Discussion
It is well known that GCs are very efficacious drugs in humans and that prolonged use of
GCs induces metabolic side effects in humans. However, knowledge of the effects of 
GCs on immune-related and metabolic pathways in an in vivo setting is relatively scarce. 
Therefore, we conducted genome-wide profiling of gene-expression in human healthy 
volunteers that were treated with prednisolone as a typical, broadly used GC. To our 
knowledge this is the first study in which gene-expression profiles in prednisolone-treated 
healthy volunteers is described. As a first aim of this study, we identified prednisolone-
induced gene signatures in CD4+ T lymphocytes and CD14+ monocytes, cells which are 
known to be peripheral immune target cells for GC action. These expression signatures 
will provide insight into the effects of GCs in an in vivo setting. We observed a much 
stronger induction of gene-expression in CD4+ T lymphocytes than in CD14+ monocytes 
with respect to fold changes, but the number of truly cell-specific genes regulated by 
prednisolone was relatively low. Tissue-specific regulation is known for GCs and large 
differences between expression profiles of liver, muscle and kidney can be observed 
[46–48]. Genes such as TAT, G6PC and PCK1 are specifically regulated in the liver, and 
the interplay between GR- and tissue-specific cofactors have been studied in detail 
[49–51]. However, to the best of our knowledge, no literature studies exist in which in 
vivo GC regulation in monocytes and T cells have been compared. Apparently, the tissue 
specificity of GC is less pronounced between cells from the same organ and lineage. 
It should, however, be noted that, although we found a strong prednisolone effect on 
immune-related pathways, these cells were derived from healthy volunteers;  in diseased 
people the effect of GCs might well be larger and more cell specific than observed in our 
study. 
We found that classical GC target genes FKBP5 and ZBTB16 were downregulated. The 
product of FKBP5 functions as a co-chaperone molecule of the GR that affects the 
transport of GR into the nucleus. ZBTB16 encodes a zinc finger transcription factor that 
contains nine Kruppel-type zinc finger domains at the carboxyl terminus. This protein is 
located in the nucleus and is involved in cell cycle progression. Expression of both genes 
have previously been reported as being strongly induced shortly after GC administration 
in both cell lines and primary patient cells [12,52–55]. The main difference between those 
studies and our study is that we studied  prednisolone-induced gene-expression in a 
complex in vivo setting in contrast to other studies in which most often cell lines, animals 
or cultured primary cells, were investigated [12–14,20–22]. Interestingly, other known 
target genes of GR (for example GLUL) demonstrated an upregulation by prednisolone 
after 24 h, whereas other known GC target genes such as DUSP1 and GILZ were not 
regulated by prednisolone in this study. The exact interplay between exogenous and 
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endogenous cortisol levels (which were strongly reduced after 24 h), kinetics of induction 
of gene-expression and mRNA stability determines the effect of GC on its target genes in 
a complex (in vivo) setting and can only partly be replicated in isolated in vitro studies. 
This demonstrates that when using the expression of GR target genes as biomarkers 
for GR-induced processes, either time resolved measurements are needed or markers 
should be chosen that are relatively independent of the time window at which sampling 
is taking place. 
In our study, we used purified CD4+ and CD14+ cells to study the effect of prednisolone. 
For large scale clinical trials, gene-expression studies with whole-blood samples are 
preferred because of ease of handling and reproducibility of the results [56]. A potential 
problem in measuring prednisolone-induced changes in gene expression in whole blood 
is that direct effects of prednisolone on gene transcription may be confounded by the 
shifts in T cell and monocyte subsets that can be induced by prednisolone. In the case that 
prednisolone would act on largely distinct gene sets for each cell type, changes in whole-
blood gene expression could be unambiguously assigned to a specific cell type. However, 
the fact that we observed a large overlap in gene sets regulated by prednisolone in CD4+ 
and CD14+ cells indicates that when measuring prednisolone-induced gene-expression in 
whole blood, cell counts of leukocyte subsets populations or gene-expression markers in 
these subsets need to be measured to account for shifts in cell populations [57]. 
Clinical measurements that were carried out during this trial demonstrated that both 
acute and short-term exposure to different prednisolone impaired aspects of pancreatic 
β-cell function, such as glucose sensitivity and fasting insulin secretion, contribute to a 
diabetic phenotype [15]. Therefore, we used the expression profiles obtained from CD4+ 
and CD14+ cells to study whether we could find a link to pathways and mechanisms that 
might be involved in prednisolone-induced metabolic adverse events. Although blood 
cells are not the tissues most relevant for metabolic side effects (these are most likely 
liver, pancreas, muscle and adipose tissue), there is growing evidence that blood cells 
can act as sentinels of disease [58–61]. The permanent interactions between blood cells 
and every tissue in the body make it plausible that subtle changes occurring in relation 
to disease within cells or tissues of the body trigger specific changes in gene-expression 
in blood cells, thereby reflecting the disease state of affected cells and tissues. Indeed, 
Liew and colleagues demonstrated that over 80% of the genes expressed in other tissues 
overlapped with the genes expressed in peripheral blood [58]. These findings suggest 
that peripheral bloodexpression profiles can provide information concerning the health 
or disease state of any particular tissue in the body and may serve as a tool for diagnostic 
purposes. 
Text-mining analysis identified 253 prednisolone- regulated genes with a metabolic link. 
Among the top scoring genes were a number of genes that play a crucial role in the 
regulation of glucose and lipid metabolism (Figure 4). From these genes, PDK4 and ACSL1 
are particularly interesting. PDK4 is a crucial regulator of glucose and lipid metabolism. 
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In the well-fed state, the pyruvate dehydrogenase complex reduces blood glucose 
levels by converting it to acetyl-coenzyme A which will enter the citric acid cycle. In the 
fasting state, inactivation of the pyruvate dehydrogenase complex is mainly achieved by 
PDK4, thereby maintaining blood glucose levels [62]. Increased PDK4 activity has been 
implicated in the pathogenesis of insulin resistance, diabetes and obesity [62,63]. Our 
results demonstrate an upregulation of PDK4 in CD4+ and CD14+ cells after prednisolone 
treatment. These results imply that prednisolone-induced insulin resistance might partly 
be mediated through PDK4 regulation. ACSL1 encodes an isozyme of the long-chain fatty 
acid-CoA ligase family that converts free fatty acids into fatty acyl-CoA esters that can 
be used for lipid biosynthesis and oxidation. In adipose tissue, insulin signaling leads 
to the translocation of ACSL1 to the membrane, together with other enzymes involved 
in fatty acid binding and  translocation. SNPs in this gene have been demonstrated to 
be associated with metabolic syndrome [32]. It was observed that ACSL1 expression 
in subcutaneous  adipose tissue was negatively correlated with insulin resistance [64]. 
Whereas the regulation of PDK4 and ACSL1 in metabolic tissues such as the muscle, 
adipose tissue and the liver, and the effect of GC on this regulation, has been well 
studied [65], relatively little is known regarding the regulation of these genes in T cells or 
monocytes. 
The results obtained by text-mining analyses identify interesting genes that might 
be involved in GC-induced metabolic adverse events. Expression-profiling studies 
demonstrated that several of the genes identified in this study are also regulated in the 
muscle of collagen-induced arthritic mice after treatment with prednisolone [Van Lierop 
et al., Unpublished Data]. Genes that were regulated after prednisolone treatment are 
AQP9, PDK4, GLUL, CEBPB and CD14. 
Taken together, these results indeed demonstrate that prednisolone has a major impact 
on metabolic processes in blood cells. Whether this is caused by a direct effect of 
prednisolone on these cells or whether this is a reaction of the blood cells to a changed 
metabolic state of the primary metabolic organs such as the liver, remains to be studied.
A number of genes that were identified via text mining also revealed prednisolone-
induced genes with a metabolic function that had not yet been linked to GCs in the 
literature. These genes might be interesting new candidate genes for further investigation 
of GC-induced metabolic side effects. This demonstrates that a combined transcriptomics 
and text-mining approach may reveal new genes and pathways involved in GC-induced 
metabolic side effects and provide new hypotheses for follow-up research. 
Conclusion
By using whole-genome expression profiling, we generated expression signatures in 
blood CD4+ and CD14+ cells that reflect anti-inflammatory effects but also metabolic 
side effects. Our findings demonstrate that prednisolone induces a very specific profile 
75Prednisolone-induced changes in healthy volunteers
 
Ch
ap
te
r 
4
in both cell types, consisting of a large number of primary GC-responsive genes that 
are regulated in both cell types, as well as a set of cell-type-specific genes. Combined 
with the fact that prednisolone-induced pancreatic b-cell failure was observed in these 
volunteers, these findings suggest that peripheral blood-expression profiles can provide
information on the prednisolone-induced metabolic state. The identified genes may 
be useful as biomarkers for GC-induced side effects or provide a starting point for the 
development of improved GCs that demonstrate the same anti-inf lammatory effect but 
have a better safety profile.
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Abstract
Synthetic glucocorticoids are potent anti-inflammatory drugs but show dose dependent 
metabolic side effects such as the development of insulin resistance and obesity. The 
precise mechanisms involved in these glucocorticoid-induced side effects, and especially 
the participation of adipose tissue in this are not completely understood.
We used a combination of transcriptomics, antibody arrays and bioinformatics approaches 
to characterize prednisolone-induced alterations in gene expression and adipokine 
secretion, which could underlie metabolic dysfunction in 3T3-L1 adipocytes. 
Several pathways, including cytokine signaling, Akt signaling, and Wnt signaling were 
found to be regulated at multiple levels, showing that these processes are targeted by 
prednisolone. 
These results suggest that mechanisms by which prednisolone induce insulin resistance 
include dysregulation of wnt signaling and immune response processes. These pathways 
may provide interesting targets for the development of improved glucocorticoids.
Keywords: glucocorticoids, metabolic dysfunction, gene profiling
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Introduction
Synthetic glucocorticoids (GCs) such as prednisolone and dexamethasone are widely 
used for the treatment of inflammatory diseases such as rheumatoid arthritis, asthma, 
inflammatory bowel disease and psoriasis [1-3]. Despite their excellent efficacy, GC usage 
is hampered because of  adverse (metabolic) side effects, such as insulin resistance, 
glucose intolerance, diabetes, central adiposity, dyslipidemia, skeletal muscle wasting and 
osteoporosis [4-8]. The precise mechanisms involved in these GC-induced side effects are 
not completely understood and are tissue specific [9-12]. One of the key tissues thought 
to be involved in metabolic side effects is the adipose tissue. Several studies have shown 
that the side-effects of  GCs in adipose tissue include the development of central adiposity 
[7], dyslipidaemia [13, 14] and the inhibition of insulin-stimulated glucose uptake [15-18].
It is now well established that adipose tissue is not only involved in energy storage, but 
also functions as an endocrine organ that secretes hundreds of bioactive substances 
known as adipokines [19-21]. Previously, GCs have been found to affect the secretion 
of several adipokines, including TNF-α, IL-6, Resistin, Adiponectin and Leptin in 
rodents [22]. Because recent proteomic approaches have led to the characterization of 
numerous novel adipokines, we applied a combination of genomics, antibody arrays and 
bioinformatics approaches to identify prednisolone-induced alterations in (adipokine) 
gene expression and secretion which could potentially underlie prednisolone-induced 
metabolic dysfunction of 3T3-L1 adipocytes. 
Materials and Methods
Set up of the study
In this study, differentiated 3T3-L1 adipocytes were treated with prednisolone or 
DMSO for 0, 1, 6, 24 and 48 hours and the effects of prednisolone were studied at gene 
expression and protein secretion level.
Cell culture
3T3-L1 pre-adipocytes obtained from ATCC were cultured and differentiated in 
adipocytes as previously described [23]. Cells were used seven days after completion 
of the differentiation process.  Only cultures in which >95% of cells displayed adipocyte 
morphology were used. Prior to use, adipocytes were serum starved for 16 hours with 
DMEM supplemented with 0.5% fetal bovine serum.
Analysis of insulin signaling
Differentiated 3T3-L1 adipocytes, grown in 12-well plates, were incubated with 
prednisolone (1 μM) or DMSO at day 8 for 48 hours. After incubation with prednisolone 
or DMSO, cells were serum-starved for 2 hours, and then stimulated with insulin (100 
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nM) for 10 minutes. Following insulin stimulation, cells were washed twice with ice-cold 
PBS, and lysed as described previously [24]. Protein expression and phosphorylation 
were determined by Western blotting as described [24] using the following antibodies: 
phospho-insulin receptor substrate 1-Tyr1222, phospho-Akt-Thr308, phospho-Akt-Ser473 
(all from Cell Signalling Technology, Danvers, MA, USA), total Akt, phospho-Akt substrate 
of 160-kDa (AS160), total AS160 (all from Millipore, MA, USA), glucose transporter 4 
(GLUT4), and β-actin (both from Abcam, Cambridge, UK).
Assay of 2-deoxy-D-glucose (2DOG) uptake
Differentiated 3T3-L1 adipocytes, grown in 12-wells plates, were incubated with 
prednisolone (1 µM) or DMSO at day 8 for 6, 24 and 48 hours. After incubation with 
prednisolone or DMSO for the indicated times, the cells were washed once with HEPES 
buffer, consisting of  50 mM HEPES, 0.14 M NaCl, 1.85 mM CaCl
2
, 1.3 mM MgSO
4
, and 
4.8 mM KCl [pH 7.4]), and then incubated in this buffer for an additional hour at 37oC. 
Then, cells were stimulated with insulin (100 nM) or kept untreated. After 15 min, 2DOG 
uptake was initiated by the addition of 2-deoxy-D-[14C]glucose (0.075  µCi per well) in 3 
mM 2DOG. After 10 min, the assay was terminated by three quick washes with ice-cold 
PBS. Cells were lysed in 0.1 M NaOH, 0.2% SDS, whereafter incorporated 2-deoxy-D-[14C]
glucose was determined by liquid scintillation counting. 
RNA isolation
Differentiated 3T3-L1 adipocytes grown in 6-well plates were incubated with prednisolone 
(1µM) for 1, 6, 24 and 48 hours and used for RNA isolation and whole-genome expression 
profiling. RNA was isolated using Tripure (Roche), and subsequently purified using the 
RNeasy mini kit according to the manufacturer’s protocol (Qiagen Benelux B.V. Venlo, 
The Netherlands). To remove residual traces of genomic DNA, the RNA was treated with 
DNase I (Invitrogen, Leek, The Netherlands) while bound to the RNeasy column. Quality 
and quantity of the purified RNA was controlled using a NanoDrop spectrophotometer 
(Nanodrop technologies, Montchanin, DE, USA). RNA integrity was investigated by using 
the 2100 Bioanalyser (Agilent technologies, Philadelphia, PA, USA).
Whole-genome expression analysis using Affymetrix GeneChip Mouse Genome 430 2.0 
Array 
Amplification of 20 ng total RNA was performed with the Two-Cycle Eukaryotic Target 
Labeling kit (Affymetrix, Santa Clara, CA). Briefly, after the first round of cDNA synthesis, 
an unlabeled ribonucleotide mix (MEGAscript T7 kit, Ambion) was used to generate 
unlabeled cRNA according to the protocol of Affymetrix. After cleanup of the cRNA 
with a GeneChip Sample Cleanup Module IVT Column (Affymetrix, Santa Clara, CA), 
the unlabeled cRNA concentration was determined and 150 ng was reverse transcribed 
using random primers. Subsequently, the T7-Oligo(dT) Promoter Primer was used in 
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the second-strand cDNA synthesis to generate double-stranded cDNA containing T7 
promoter sequences. The resulting double-stranded cDNA was then amplified and biotin 
labeled using the IVT Labeling kit (Affymetrix, Santa Clara, CA). Biotin-labeled cRNA 
was fragmented at 1 μg/μl following the manufacturer’s protocol. After fragmentation, 
cRNA (10 μg) was hybridized at 45°C for 16 hours to the Human Genome U133 2.0 Plus 
array (Affymetrix, Santa Clara, CA). Following hybridization, the arrays were washed, 
stained with phycoerythrin-streptavidin conjugate (Molecular Probes, Eugene, OR), and 
the signals were amplified by staining the array with biotin-labeled anti-streptavidin 
antibody (Vector Laboratories, Burlingame, CA) followed by phycoerythrin-streptavidin. 
The arrays were laser scanned with a GeneChip Scanner 3000 7G (Affymetrix, Santa Clara, 
CA) according to the manufacturer's instructions. Data was saved as raw image file and 
quantified using AGCC v 1.0 (Affymetrix, Santa Clara, CA).
Murine adipokine antibody arrays
This array allows simultaneous detection of 308 secreted mouse proteins in cell culture 
supernatants (AAM-BLM, L-series, Raybiotech, Inc, Norcross GA, USA). Differentiated 
3T3-L1 adipocytes were subjected to 4 hours pred/dmso, followed by two rinsing steps 
and culture medium containing 0.2% FBS and Prednisolone or vehicle (1 • M) for 44 
hours. To prepare samples for the antibody array, samples were subjected to centricon 
tubes (Millipore amicon ultra-15 ultracel 3K) and washed 3 times with PBS, pH 8.0. 
Finally proteins were recovered in 2 ml PBS. Samples were biotin-labelled according 
to manufacturer’s protocol. Then, membranes were blocked and incubated with the 
biotinylated samples overnight at 4ºC, and finally incubated with HRP conjugated 
streptavidin. Signals were detected using enhanced chemiluminescence and quantified 
on a LumiIMager system using LumiAnalyst software version 3.1 (Roche Diagnostics, 
Mannheim, Germany).
Gene expression data
Microarray data were analyzed with packages from the BioConductor library[25]. Gene 
expression data was normalized using gcrma. Identification of regulated probes was done 
using limma package from Bioconductor. For identifying differentially expressed probes 
after incubation with prednisolone, the following selection criteria were used: fold 
change >2, intensity > 20, and p-value<0.05 after correction for multiple testing using the 
Benjamini-Hochberg correction. All statistical analysis was performed in R. Significance of 
regulation of the Wnt pathway has been calculated using globaltest.
Secreted protein data obtained from murine adipokine antibody arrays
Regulated proteins as a result of prednisolone treatment have been selected using a 
P-value < 0.05 (calculated using a standard Student's t-Test).
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Keyword enrichment analysis
Keyword enrichment analysis on the microarray data was performed using CoPub, a text 
mining algorithm that detects co-occurring biomedical concepts in abstracts from the 
MedLine literature database  [26], using the following settings for the threshold values: 
p-value <0.05, R-scaled score > 35 and abstract count > 3. A heatmap of the pathway 
terms was been generated using a transformation of the p-value in the following way:
Additional gene annotation enrichment analysis was done using the functional annotation 
module of Database for Annotation, Visualization and Integrated Discovery (DAVID) tool 
[27, 28] with default settings against the KEGG pathway database.
Results
Effect of prednisolone on insulin action in 3T3-L1 adipocytes 
Exposure of differentiated 3T3-L1 adipocytes to 1 µM prednisolone had no effect on the 
expression of key signaling molecules, like the insulin receptor β-subunit, Akt, AS160 and 
GLUT4. Prednisolone significantly impaired the phosphorylation of Akt-Thr308 and Akt-
Ser473 in response to insulin, whereas no effects were observed on IRS1-Tyr1222 (Figure 
1). Intriguingly, but in line with a study on the effects of dexamethasone on insulin action in 
3T3-L1 adipocytes [29], prednisolone did not impact on insulin-induced phosphorylation 
of AS160-Thr642 (Figure 1). The mechanism(s) underlying this discordance in signaling 
from Akt to AS160 is not understood. Nevertheless, prednisolone was found to impair 
insulin-stimulated glucose uptake already after 6 hours of incubation, and this inhibition 
was still present at 48 hours after incubation (Figure 1). These findings are in line with 
earlier observations using dexamethasone in 3T3-L1 adipocytes [15, 29] and confirm the 
induction of insulin resistance by prednisolone in our experimental conditions.
Whole genome expression profiling
We next studied prednisolone-induced changes in gene expression following exposure of 
3T3-L1 adipocytes to prednisolone or DMSO for 1, 6, 24 and 48 hours. Principle Component 
Analysis (PCA) showed a separation between prednisolone- and DMSO-treated samples 
after 6, 24 and 48 hours (Supplementary Figure 1). At each time-point, the significantly 
differentially expressed probes were identified between cells treated with prednisolone 
and DMSO (Supplementary Table 2). Comparison of probes significantly affected by 
prednisolone at 6 hours with probes significantly affected by prednisolone at 48 hours 
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showed that probes with a high fold change are found to be regulated at both time points 
(Figure 2). Probes which are only regulated at 6 hours or at 48 hours have a lower fold 
change.
The same trend was observed when comparing prednisolone induced probes at 6 hours 
with prednisolone induced probes at 24 hours (Figure 2B). At all time points, 25 genes 
represented by 34 probes (in fact 26 genes were found, but for probe 1434025_at we 
could not find annotation), were found to be significantly regulated by prednisolone 
Figure 1 Effect of prednisolone on insulin action in 3T3-L1 adipocyte cells. Effects on protein 
expression of the insulin receptor (IR) β-subunit, Akt, AS160, and GLUT4, as well as the 
phosphorylation of insulin receptor substrate 1 (IRS1-Tyr1222), Akt-Thr308, Akt-Ser473, and 
AS160-Thr642 were determined by Western blotting in cells exposed to 1 μM prednisolone for 48 
hours prior to stimulation with insulin (10 min, 100 nM). Data are presented as mean ± standard 
error of the mean of  >4 independent experiments  (A-D), and representative Western blots (F). E. 
Effect of prednisolone on 2-deoxyglucose uptake in in 3T3-L1 adipocytes  after 6, 24 and 48 hours 
of incubation with prednisolone. Data are mean ± standard error of the mean of >4 independent 
experiments. In all bar graphs, open columns represent the basal condition, and filled bars depict 
insulin-stimulated cells. The effects of prednisolone on insulin action were analyzed using a two-
way ANOVA followed by Bonferonni analysis for multiple comparisons. *** indicates a P<0.001; 
**, P<0.01. Effects of insulin versus basal were analyzed using a student’s t-test. ###, P<0.001, ##, 
P<0.01, #, P<0.05.
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(Table 1). Most of these genes were upregulated and showed a sustained response to 
prednisolone at all time points, starting after one hour of incubation, with the highest 
response after 6 hours, and still present after 48 hours of incubation.
Biological pathways targeted by prednisolone
To identify biological pathways that were affected by prednisolone, we mapped the 
regulated genes to biological pathway terms using the text mining algorithm CoPub [26] 
(Figure 3). It appeared that the most significant pathway terms could be divided into 
three categories: immune system/inflammation (eicosanoid metabolism, prostaglandin 
metabolism, cytokine receptors, cytokine network, immune system, platelet activation), 
general metabolism (fatty acid metabolism, glucose metabolism, gluconeogenesis, lipid 
metabolism, fatty acid metabolism, glycolysis) and signaling (insulin signaling, TGF-β 
signaling, Akt signaling, Wnt signaling, MAPK signaling). Additional functional analysis of 
these regulated genes using DAVID, an annotation server based on GeneOntology and 
KEGG pathways [27], gave similar results (results not shown).
We are interested in mechanisms and pathways that could underlie prednisolone-induced 
metabolic dysfunction and more specific prednisolone-induced insulin resistance in 
adipocytes. Therefore for the remainder of the paper, we focused on pathways that are 
known to play a role in the disturbance of insulin signaling that eventually could lead to 
insulin resistance, i.e. Akt/ insulin signaling, cytokine signaling, TGF-β signaling and MAPK 
signaling. Furthermore, we also focused on pathways that play a role in the disturbance of 
adipocyte differentiation that could lead to dyslipidaemia and obesity, i.e. Wnt signaling 
and cytokine signaling. In Figure 4 the prednisolone-induced genes have been categorized 
according to these pathways. Genes that have an effect on insulin signaling, e.g. growth-
Figure 2 Regulated probes by prednisolone at 6 hours versus at respectively 48 hours (A) 
and 24 hours (B). Probes represented by red dots are regulated at both time points. Probes 
represented by blue dots are only regulated by prednisolone at 6 hours. Probes represented by 
green dots are only regulated by prednisolone at 48 hours. In B the regulation of the probes by 
prednisolone after 6 hours versus 24 hours is shown. The scale on both axes is log 2 fold change.
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Table 1 Regulated probes (genes) by prednisolone after 1, 6, 24 and 48 hours of incubation. 
For each probe the log fold change at each time point is shown. Probes that are up-regulated are 
indicated with a red color and probes that are down-regulation are indicated with a green color. 
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factor insulin-like growth factor I (Igf1), insulin receptor substrate 1 (Irs1) and platelet 
derived growth factor receptor, beta polypeptide (Pdgfrb) and genes from the TGF-β 
pathway such as MAD homolog 3 (Drosophila) (Smad3), gremlin 1 (Grem1), transforming 
growth factor, beta 2 (Tgfb2) and transforming growth factor, beta induced (Tgfbi) were 
down-regulated. Phosphatase and tensin homolog (Pten) an important regulator of the 
Akt pathway was up-regulated.
The majority of the genes coding for cytokines, such as Interleukin-6 (Il-6), chemokine 
(C-X-C motif) ligand 5 (Cxcl5), chemokine (C-X-C motif) ligand 10 (Cxcl10) and chemokine 
(C-C motif) ligand 7 (Ccl7), were down regulated by prednisolone. Other cytokines such as 
interleukin 1 receptor, type I (IL1r1) and interleukin 1 receptor accessory protein (IL1rap) 
were up regulated. 
Many Wnt signaling pathway members were significant down regulated by prednisolone 
in our study. We observed down regulation of frizzled receptors Fzd1, Fzd2, Fzd4, Fzd5 
together with ligand wingless-related MMTV integration site 5A (Wnt5A) and antagonist 
secreted frizzled-related protein 2 (Sfrp2). Also several down-stream molecules such as 
Wisp1, Wisp2, Id2 were down regulated (Figure 4). 
Figure 3 Heatmap representation of biological pathways identified using CoPub analysis of 
regulated genes. The colors shading indicates the significance of the over-represented pathways 
(based on pval
_transformed
), from the lowest value shown in red, to the highest value shown in white. 
Columns represent the time points at which the pathways have been found after incubation with 
Prednisolone: 1 hour (T1), 6 hours (T6), 24 hours (T24) and 48 hours (T48).
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Regulation of adipokines measured after 48 hours of incubation with prednisolone
The microarray data showed several transcripts that encode hormones secreted by 
Figure 4 Prednisolone induced genes after 1 hour (T1), 6 hours (T6), 24 hours (T24) 
and 48 hours (T48). Prednisolone-induced up-regulated genes are shown in red, prednisolone 
induced down-regulated genes are shown in green. For clarity genes have been assigned to 
major pathways. However, one should keep in mind that genes can belong to multiple pathways 
depending on the definition of a pathway.
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adipocytes, like cytokines, and regulators of the Wnt, Akt and TGF-β pathway. We therefore 
decided to study to what extend the altered levels of gene expression would lead to 
changes in protein expression, by analyzing the effects of prednisolone on adipokine 
secretion by 3T3-L1 adipocytes treated with DMSO or prednisolone for 48 hours. For this 
purpose, the supernatants of the 3T3-L1 adipocytes that were used in the gene expression 
study were analyzed. Out of the 308 proteins on the array, 25 proteins were significant 
regulated by prednisolone (Table 2, p-value < 0.05. For all proteins, see supplementary 
table 1). The majority of these proteins are cytokines involved in inflammatory and 
immune response related processes (indicated with a purple background in Table 2). 
Cytokines such as CXCL2, CCL3, CCL9, IL31 were down regulated by prednisolone while 
CCR6, IL12B, TNFSF8, TNFRSF7 and TNFRSF17 showed an up regulation.
Also several components of the Wnt signaling pathway were significantly regulated at 
protein level (Table 2, indicated with a blue background). DKK4 an inhibitor of the Wnt 
signaling pathways was up-regulated. Furthermore downstream regulators of the Wnt 
signaling pahthway, LRP6 and WISP1 are down regulated. Additionally, initiation of insulin 
signaling is represented by the down regulation of IGFBP5, IGFBP3 and Resistin.
These results indicate that the regulation of the Akt/ insulin signaling, cytokine signaling 
and Wnt signaling pathways by prednisolone is not only found on the transcriptome level, 
but is also translated into altered proteins levels in these pathways.
Regulation of the Wnt signaling pathway by prednisolone
Individual Wnt signaling components were found to be significantly regulated by 
prednisolone at both gene and protein levels. Therefore, we next investigated whether 
the entire Wnt signaling pathway was affected by prednisolone. The KEGG database was 
used to select genes upstream in the canonical Wnt signaling pathway that are more 
exclusively linked to the Wnt signaling in comparison with down-stream genes like 
Smad3, Lef, Tak1 and Pparδ, which are also linked to TGF-β signaling, MAPK signaling 
and Cell cycle (Supplementary Table 3). We used the expression profiles of these 51 Wnt 
signaling genes to test whether there is a difference in expression for the entire Wnt 
signaling pathway between prednisolone and DMSO treated samples. In this method, 
genes that do not meet the FC>2-fold and Pval <0.05 cut offs but may have nevertheless 
a changed expression level were taken into consideration. A significant difference in 
expression for the entire Wnt signaling pathway was observed after 6 hours (p-value = 
0.031). In Figure 5, the genes that had the most influence on this difference are shown. 
In this figure, the gene expression ratios (open dots) and protein ratios (black dots) as 
a result of prednisolone treatment are also shown. Genes that had an influence on 
the difference between DMSO and prednisolone treated samples and that showed a 
higher expression in DMSO treated samples (red bars) were down-regulated because of 
prednisolone treatment (open dots). The same effect on the Wnt signaling pathway was 
also seen after 48 hours (p-value = 0.064) of treatment (Supplementary Figure 3). This 
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Table 2 Regulated proteins after 48 hours of incubation with prednisolone. Inflammatory related 
proteins are indicated with a purple background, wnt signaling related proteins with a blue 
background and insulin signaling related proteins with a green background. Up-regulated proteins 
are indicated with a red color. Down-regulated proteins are indicated with a green color.
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analysis indicates that in 3T3-L1 adipocytes, the entire Wnt signaling pathway is down-
regulated by prednisolone.
N
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Protein Sym
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Discussion and conclusions
The prolonged use of glucocorticoids is hampered by metabolic side-effects such as 
insulin resistance, which eventually leads to diabetes and obesity. Adipose tissue is 
thought to play an important role in GC-induced development of metabolic side effects. 
The mechanisms behind these side-effects are not completely understood. Key findings 
of our study indicate that prednisolone reduces insulin stimulated glucose uptake in 3T3-
L1 cells, which is reflected by changes in expression of genes and proteins from the Akt/
insulin, cytokine and Wnt signaling pathways. To our knowledge, this is the first work 
that uses a combination of gene expression and antibody arrays to study effects of 
prednisolone in adipocyte cells.
The set of 25 genes that showed regulation by prednisolone at all time points includes 
known target genes of the glucocorticoid receptor, such as Ddit4, Dusp1 and Cebpd 
[30, 31], and genes such as Fam107a  and PDK4, that were also found to be regulated 
by prednisolone in in vivo studies of mouse and human [30, 32]. This indicates that 
prednisolone acts via its target genes and initiates a GC specific response in these 3T3-L1 
Figure 5 Wnt signaling genes that have an influence on the difference between prednisolone 
and DMSO, after 6 hours of incubation. Genes that are upregulated in DMSO treated samples are 
shown in red and genes that are upregulated in prednisolone treated samples are shown in green. 
Ratios of prednisolone-induced genes are indicated with open dots. Prednisolone-induced ratios of 
the proteins are indicated with black dots. Ratio are indicated in log2 fold change.
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cells.
Multiple cytokine molecules were regulated by prednisolone. Increasing evidence 
suggests that a chronic low-grade state of inflammation in adipose tissue contributes 
to the development of systemic insulin resistance and diabetes [33-35]. In the absence 
of IL1, mice are protected against high fat diet induced insulin resistance which is 
accompanied with a reduction in local adipose tissue inflammation [36, 37]. Our results 
showed up-regulation of IL1 signaling by means of IL1r1 and IL1rap. This suggests a role 
of IL-1 signaling in GC induced development of insulin resistance in 3T3-L1 cells.
Also other studies reported about the up-regulation of cytokines such as Il6, Cxcl5, Ccl2 
and Cxcl10 in insulin resistance and obesity (Figure 6) [35, 38-42]. In contrast to these 
studies, we observed a down regulation of expression of these genes by prednisolone. 
Based on these results it is difficult to deduce whether prednisolone-induced regulation 
of cytokines in adipocytes contribute to the development of insulin resistance or are the 
result of the immune suppressing properties of prednisolone or a combination of both.
Furthermore our results indicated that the reduction in insulin stimulated glucose uptake 
by prednisolone acts partly via the down regulation of insulin signaling. This regulation 
might be mediated by Pten, a known suppressor of insulin signaling that acts via the 
PI3K/ Akt signaling pathway [43]. Additional studies confirm this observation and suggest 
an important role of Pten in the development of insulin resistance and diabetes [44-46]. 
Again an apparent contrasting effect of prednisolone is the down regulation of proteins 
like Igfb3 and resistin that reduce glucose uptake in adipose tissue [47, 48].
Inhibition of TGF-β/ Smad3 signaling results in diminished adiposity, improved glucose 
tolerance and insulin sensitivity and in the protection from insulin resistance, diabetes 
and obesity [49-51]. The observed down regulation of Smad3 suggests that disturbance 
of glucose uptake and adiposity by prednisolone in 3T3-L1 cells acts via additional 
mechanisms.
Activation of the Wnt signaling pathway has been linked to inhibition of adipogenesis [52-
55]. Recent studies toward the characterization of the adipocyte secretome have shown 
that multiple regulators of the activity the Wnt signaling are secreted by adipocytes, such 
as WISP2 and SFRP5 [54, 56]. Interestingly, expression and circulating levels of these 
factors are altered in insulin resistance and obesity [54, 57-59], underlying the suggestion 
that a dysregulated secretion of Wnt regulators could lead to metabolic disturbances 
and eventually into the development of obesity and diabetes [54, 60-63]. Yet, in the 
context of our study, it remains to be investigated to what extent the factors affected by 
prednisolone interfere with insulin action in adipocytes.
Prednisolone induced Pten, Smad3 and Lef1 which are able to mediate cross-talk 
between the signaling pathways [64]. Via the alteration of the Pten function, TGF-β is 
able to influence the Akt activity, and via Smad3 the Akt pathway is able to restrict the 
TGF-β pathway. Also Smad activity is involved in the cross-talk between Wnt signaling and 
TGF-β signaling, as part of the Smad/β-catenin/Lef protein complex in the nucleus. These 
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genes could play a central role in the development of prednisolone induced metabolic 
effects because of their ability to connect multiple pathways (Figure 6). The sometimes 
opposing effects of prednisolone on individual pathway members of Smad3  and Akt in 
comparison with earlier work, requires additional in vivo studies in which the systemic 
effect of prednisolone on these pathways could be determined. 
To our knowledge, for the first time it is shown that prednisolone affects the expression 
and secretion of Wnt regulators in adipocytes. The fact that Wnt signaling also 
participates in the development of metabolic disturbances in other tissues [65, 66] may 
direct future work towards a dedicated study of the Wnt signaling pathway in GC-induced 
metabolic effects. In an in vivo setting the Wnt signaling mediated GC effects in multiple 
glucose responsive tissues such as muscle tissue, liver tissue and adipose tissue could 
be determined. Hence new GC compounds with an improved efficacy/ side effects ratio 
should have a reduced effect on components in the Wnt signaling pathway.
Figure 6 Overview of pathway members of insulin/ Akt signaling, TGF-β, wnt signaling and 
inflammatory pathways that were regulated by prednisolone in 3T3-L1 cells. For these pathway 
members the literature links to metabolic disorders and other pathways are shown. The numbers 
at the arrows indicate the references in the literature, in which the association between pathway 
member and pathways/disease phenotype is mentioned.  1 [59], 2  [44], 3 [43], 4 [42], 5 [62], 6 
[48], 7 [47], 8 [63], 9 [58], 10 [52], 11 [64], 12 [51], 13 [50], 14 [36], 15 [34], 16 [35], 17 [37], 18 [38], 
19 [33], 20 [65], 21 [66], 22 [39], 23 [67], 24 [68]  , 25 [69], 26 [70], 27 [71], 28 [72], 29 [73], 30 [74], 
31 [75], 32 [76], 33 [77], 34 [78], 35 [79].
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Abstract
Background
Glucocorticoids (GCs) control expression of a large number of genes via binding to the 
GC receptor (GR). Transcription may be regulated either by binding of the GR dimer 
to DNA regulatory elements or by protein-protein interactions of GR monomers with 
other transcription factors. Although the type of regulation for a number of individual 
target genes is known, the relative contribution of both mechanisms to the regulation 
of the entire transcriptional program remains elusive. To study the importance of GR 
dimerization in the regulation of gene expression, we performed gene expression 
profiling of livers of prednisolone-treated wild type (WT) and mice that have lost the 
ability to form GR dimers (GRdim). 
Results
The GR target genes identified in WT mice were predominantly related to glucose 
metabolism, the cell cycle, apoptosis and inflammation. In GRdim mice, the level of 
prednisolone-induced gene expression was significantly reduced compared to WT, 
but not completely absent. Interestingly, for a set of genes, involved in cell cycle and 
apoptosis processes and strongly related to Foxo3a and p53, induction by prednisolone 
was completely abolished in GRdim mice. In contrast, glucose metabolism-related genes 
were still modestly upregulated in GRdim mice upon prednisolone treatment. Finally, we 
identified several novel GC-inducible genes from which Fam107a, a putative histone 
acetyltransferase complex interacting protein, was most strongly dependent on GR 
dimerization. 
Conclusions
This study on prednisolone-induced effects in livers of WT and GRdim mice identified a 
number of interesting candidate genes and pathways regulated by GR dimers and sheds 
new light onto the complex transcriptional regulation of liver function by GCs.
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Background
Naturally occurring glucocorticoids (GCs), such as cortisol, play an important role in the 
regulation of cardiovascular, metabolic and immunological processes. GCs are potent 
suppressors of inflammatory indices and are widely used to treat chronic inflammatory 
diseases such as rheumatoid arthritis and asthma [1-3]. However, chronic use of GCs 
induces side effects, such as diabetes mellitus, fat redistribution, osteoporosis, muscle 
atrophy, glaucoma and skin thinning [4].
One of the aspects influencing the balance between the desired anti-inflammatory 
effects and the side effects of GCs is the activation and repression of gene expression. 
After binding of GCs to the cytosolic GC receptor (GR), the receptor-ligand complex 
translocates to the nucleus where it alters gene expression. Ligand-bound GR can 
influence the expression of target genes, either by binding as a dimer to palindromic GC 
response elements (GRE) or tethering to other DNA-bound transcription factors [5, 6]. 
It is generally assumed that the anti-inflammatory actions of GCs are mainly driven by 
transrepression, in which ligand-bound GR binds to the pro-inflammatory transcription 
factors NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells), AP-1 
(Activator protein 1), IRF-3 (Interferon regulatory factor 3) or other factors, forming 
an inactive transcription machinery complex, which prevents expression of pro-
inflammatory genes [7-16]. However, recent studies demonstrated that under some 
inflammatory conditions DNA dimer-dependent gene expression could also contribute to 
the anti-inflammatory activities of the GR [17]. The occurrence of side effects has been 
linked mainly to transactivation of gene transcription. The well-documented example of 
GC-induced upregulation of Pck1 (Phosphoenolpyruvate carboxykinase 1; also known as 
Pepck) and G6pc (Glucose-6-phosphatase), two genes encoding key enzymes that control 
gluconeogenesis, is one example linking transactivation to metabolic side effects [18-20].
One of the mechanisms by which GR activates gene transcription is by binding as a 
homodimer to a GRE in the promoter region of a target gene. GR dimerization involves 
the D loop located in the DNA-binding domain of the GR, in which several amino acids 
interact to facilitate receptor dimer formation. It was shown that an A458T point mutation, 
introduced in the D loop of the GR (GRdim), impairs homodimerization and ablates DNA 
binding [21]. Mice carrying this GRdim mutation are almost as effective as wild type (WT) 
mice in repressing AP-1 and NF-κB-modulated gene transcription, whereas GR-mediated 
Tat (Tyrosine aminotransferase) mRNA induction is largely abolished [21, 22].
The mechanism of dimer-dependent transactivation by the GR has been studied in detail 
for a limited number of GR target genes, including Fkbp5 (FK506 binding protein 5), 
Tat, Pck1 and Dusp1 (Dual specificity phosphatase 1) [23-26], and tethering-facilitated 
transrepression of Mmp1/Mmp13 (Matrix metallopeptidase 1/13), IL-8 (Interleukin 8) 
and others [27-29]. In order to perform a comprehensive study of the genes and cellular 
processes that are affected by GC-treatment and influenced by GR dimerization, we have 
performed genome wide gene expression profiling in liver of prednisolone-treated WT 
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and GRdim mice. 
We found that prednisolone predominantly influenced expression of genes involved in 
glucose metabolism, inflammation, the cell cycle and apoptosis. In general, activation of 
transcription, including transactivation of known GR marker genes such as Fkbp5 and Tat, 
was significantly reduced, but not totally absent in the GRdim mutant. However, a total 
absence of transcriptional transactivation upon GC-treatment was observed in GRdim 
mice for a subset of genes, all related to regulation of the cell cycle. In contrast, a small 
subset of genes was found exclusively regulated by GCs in GRdim mice. Furthermore, we 
identified Fam107a (Family with sequence similarity 107, member a; also known as Tu3a 
and Drr1) as a novel GC-inducible gene that completely relies on GR dimerization for 
transactivation. 
Results
Clustering of individual samples
In order to chart the gene expression profile induced by prednisolone in WT and GRdim 
mice, 6 mice per group were treated with prednisolone or vehicle. A principal component 
analysis (PCA) on the normalized intensity data showed that the samples clustered into 
four distinct groups (Figure 1). The largest separation, represented by PC1, was observed 
between samples derived from male versus female mice. The genes with the highest 
gender specificity belong to the family of cytochrome P450 proteins, such as Cyp3a41, 
Cyp3a44 and Cyp4a12, which are known for their gender-specific expression [30, 31]. 
In addition to the gender-based separation, a clear separation was observed between 
prednisolone-treated and vehicle-treated WT mice, whereas prednisolone-treated GRdim 
mice clustered closely together with vehicle-treated GRdim and WT mice (PC2). These 
Figure 1 Principal component analysis on 
gene expression intensity data. 
A principal component analysis (PCA) was 
performed on normalized gene expression 
intensity data from 12 wild type (WT) mice 
(vehicle and prednisolone treatment) and 
12 GRdim mice (vehicle and prednisolone 
treatment). Bullets: WT mice; Triangles: GRdim 
mice. White symbols: vehicle-treated mice; 
Black symbols: prednisolone-treated mice. 
The largest separation was seen between 
samples derived from male versus female 
mice (PC1).
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results indicate that there is a significant prednisolone effect in WT mice, which is strongly 
reduced in prednisolone-treated GRdim mice. Genes with high loading scores on PC2 
include Tat and Fkbp5, which are known GR-regulated genes in liver [32, 33] (Figure 2). 
These results show that the transcriptional program that is induced by prednisolone in WT 
mice is strongly reduced in mice carrying the GRdim mutation. This supports the hypothesis 
that the loss of GR dimerization leads to a reduction in transcriptional transactivation 
by the GR and underscores the importance of GR dimerization in induction of gene 
expression. The effect of prednisolone on up and downregulated genes and pathways 
will be discussed in more detail below.
Prednisolone-induced changes in gene expression
To quantify the differences that were seen in the multivariate analysis, differentially 
expressed probe sets were identified for several treatment comparisons (e.g. prednisolone 
versus vehicle-treated WT mice and prednisolone vs. vehicle-treated GRdim mice). Probe 
sets were marked as differentially regulated when the p-value, corrected for multiple 
testing, was below the 0.01 cutoff value.
Prednisolone treatment resulted in a significant differential regulation of 518 probe 
sets in WT mice (347 upregulated and 171 downregulated), whereas in prednisolone-
treated GRdim mice only 34 probe sets were differentially regulated (29 upregulated and 
5 downregulated). Notably, no differentially regulated probe sets were found in the 
comparison between vehicle-treated GRdim and vehicle-treated WT mice, suggesting that 
Figure 2 Intensity profiles of Tat and Fkbp5 in vehicle and prednisolone-treated wild type versus 
GRdim mice. The expression intensities of Tat (Tyrosine aminotransferase) and Fkbp5 (FK506 binding 
protein 5) in vehicle-treated (white bars) and prednisolone-treated (grey bars) wild type (WT) and 
GRdim mice are plotted. Symbols: Bullets: male mice; Triangles: female mice. Both Tat and Fkbp5 are 
known GR marker genes and show strong differential regulation in prednisolone-treated WT mice.
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the GRdim mutation itself does not cause differential gene regulation and that the effects 
between WT and GRdim mice only become apparent after treatment with prednisolone. 
The observation that only 34 probe sets are differentially regulated in GRdim mice 
upon prednisolone treatment, suggests that there is almost no regulation of gene 
expression by prednisolone in GRdim mice. However, a large number of the probe sets 
that are differentially regulated in WT mice showed the same direction of regulation by 
prednisolone in GRdim mice, but did not meet the cutoff value of 0.01 for the p-value. 
This indicates that induction of gene expression by prednisolone in GRdim mice is strongly 
reduced but not completely absent (see below).   
Taken together these data are in line with the hypothesis that transactivation of gene 
expression through the GR is significantly reduced in mice carrying the GRdim mutation.
Biological processes targeted by prednisolone in WT mice
In order to identify cellular processes on which prednisolone has a prominent effect, 
a gene set enrichment analysis was conducted using the 518 probe sets that were 
differentially regulated in WT mice by prednisolone. For this analysis we used CoPub, a 
text mining tool that calculates which biological processes are significantly associated to 
a set of genes [34]. It appeared that the differentially regulated genes are predominantly 
involved in three major processes: (glucose) metabolism, cell cycle/apoptosis and 
immune/inflammatory response (Table 1). 
In order to gain insight into the relationships between genes and cellular processes a 
network representation was created, in which differentially regulated genes are plotted 
together with enriched keywords. In this representation, cellular processes that are 
affected by prednisolone can be appreciated as separate areas in the network, such as 
cell cycle and apoptosis, acute-phase response, and metabolism-related processes such 
as amino acid metabolism, gluconeogenesis and lipid metabolism. The most influential 
genes appear as highly connected hubs (Figure 3). Important factors that seem to connect 
the gluconeogenesis and the cell cycle and apoptosis subnetworks are the transcription 
factors Foxo1 and Foxo3a (Forkhead box O1 and Forkhead box O3a; see below).
Strong effects of prednisolone treatment on gluconeogenesis, the cell cycle and 
apoptosis are in line with the anticipated effect of the GR in the liver. The fact that 
many inflammation and acute phase response-related genes, such as IL6r (Interleukin 
6 receptor) and Cxcl12 (Chemokine (C-X-C motif) ligand 12) were regulated (Figure 3) 
is interesting, given that we analyzed livers from healthy mice, not challenged with 
inflammatory stimuli. The direction and magnitude of prednisolone-induced differential 
regulation of genes involved in gluconeogenesis and the cell cycle was studied in more 
detail to get more insight into these prednisolone-affected processes.
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Gluconeogenesis
Table 2 shows the prednisolone-regulated genes in WT mice identified by CoPub as being 
associated with gluconeogenesis. Among the upregulated genes are Pck1, encoding 
the rate limiting enzyme in gluconeogenesis [35], Ppargc1a (Peroxisome proliferative 
activated receptor, gamma, coactivator 1 alpha), a transcriptional coactivator that 
coordinates the expression of genes involved in gluconeogensis and ketogenesis [36], 
and Sds (Serine dehydratase) and Aass (Aminoadipate-semialdehyde synthase), two 
genes encoding enzymes involved in amino acid catabolism and amino acid utilization for 
gluconeogenesis [37, 38].
The set of downregulated genes includes Irs1 (Insulin receptor substrate 1), a downstream 
mediator of the growth factor/insulin signaling pathway that negatively regulates 
gluconeogenesis [39] and Pklr (Pyruvate kinase), which encodes a glycolysis associated 
Biological process # of associated genes
Metabolism
Glucose metabolism / transport 22
Gluconeogenesis 21
Lipid metabolism / glycosylation 21
Glycolysis 14
Carbohydrate metabolism / transport 14
Amino acid metabolism / transport 13
Cell cycle and apoptosis
Apoptosis 77
Cell proliferation 72
Cell cycle 65
Cell growth and–or maintenance, cell growth 63
Homeostasis 58
Cell differentiation 49
Cell cycle arrest 37
Immune / inflammatroy response
Inflammatory response 31
Acute-phase response 20
Table 1 CoPub keyword enrichment analysis on prednisolone-regulated genes. CoPub was used 
to calculate keyword enrichment in the set of prednisolone-regulated probe sets in wild type mice. 
The analysis revealed that the differential regulated genes (non-redundant set) are predominantly 
involved in three main processes: metabolism, cell cycle and apoptosis, and immune/inflammatory 
response. The right column shows the number of differential regulated genes associated with a 
specific enriched keyword.
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enzyme known to catalyze the production of pyruvate from phosphoenolpyruvate [40].
The direction of regulation and the function of these genes, suggests that in the liver 
of prednisolone-treated WT, glucose metabolism is balanced towards gluconeogenesis, 
which is in line with the reported gluconeogenic effect of glucocorticoids [41, 42]. 
Biological process - Gluconeogenesis
Gene name Symbol Fc WT Fc GRdim*
Insulin-like growth factor binding protein 1 Igfbp1 9.7 3.6
Tyrosine aminotransferase Tat 4.1 1.6
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 Pfkfb3 3.9 2.3
Peroxisome proliferative activated receptor, gamma, 
coactivator 1 alpha
Ppargc1a 3.2 3.2
CCAAT/enhancer binding protein (C/EBP), beta Cebpb 3.1 1.6
Protein-tyrosine sulfotransferase 2  Tpst2 2.7 1.5
Solute carrier family 2 (facilitated glucose transporter), 
member 1   
Slc2a1 2.6 1.9
Forkhead box O1 Foxo1 2.2 1.7
Serine dehydratase Sds 2.1 1.5
Aminoadipate-semialdehyde synthase  Aass 2.1 1.3
Phosphoenolpyruvate carboxykinase 1, cytosolic Pck1 1.9 1.3
Tryptophan 2,3-dioxygenase Tdo2 1.5 1.2
Aconitase 2, mitochondrial Aco2 1.4 1.3
Transketolase   Tkt -1.2 -1.1
Protein kinase, AMP-activated, beta 1 non-catalytic 
subunit 
Prkab1 -1.5 1.0
Adiponectin receptor 2 Adipor2 -1.6 -1.3
Purinergic receptor P2Y, G-protein coupled, 5 P2ry5 -1.6 -1.3
Pyruvate kinase liver and red blood cell Pklr -2.1 -1.4
CCAAT/enhancer binding protein (C/EBP), alpha Cebpa -2.3 -1.2
Sterol regulatory element binding factor 1 Srebf1 -3.0 -1.6
Insulin receptor substrate 1   Irs1 -4.0 -1.5
Table 2 Prednisolone-regulated genes associated with ‘gluconeogenesis’ in literature. CoPub 
identified 21 prednisolone-regulated genes in wild type (WT) mice that are associated in literature 
with gluconeogenesis. The identified genes share at least 3 publications and have an R-scaled score 
[34] of at least 35 with keyword ‘gluconeogenesis’ in Medline abstracts. For each gene, the fold 
change (Fc) in prednisolone versus vehicle-treated WT mice (Fc WT) is given. Additionally, for each 
gene also the Fc in prednisolone versus vehicle-treated GRdim mice (Fc GRdim) is shown. *It should be 
noted that in GRdim mice these genes did not meet the p-value cutoff of 0.01 for significance after 
correction for multiple testing, and are mentioned to illustrate a small effect of prednisolone on 
gene expression in GRdim mice.
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The reduced fold changes in GRdim mice compared to WT mice (Table 2) indicate that 
glucocorticoid-induced gluconeogenesis is reduced in GRdim mice. 
Cell cycle
Table 3 shows the prednisolone-regulated genes in WT mice that CoPub identified as 
being associated with the cell cycle. Upregulated genes include Gadd45b, Gadd45g 
(Growth arrest and DNA-damage-inducible 45 beta and gamma), Cdkn1a (Cyclin-
dependent kinase inhibitor 1a; also known as p21) and Plk3 (Polo-like kinase 3), which 
Biological process - Cell cycle
Gene name Symbol Fc WT Fc GRdim*
Growth arrest and DNA-damage-inducible 45 gamma Gadd45g 17.8 2.9
Dual specificity phosphatase 1 Dusp1 8.2 1.0
Cyclin-dependent kinase inhibitor 1A (P21) Cdkn1a 8.1 1.0
Growth arrest and DNA-damage-inducible 45 beta Gadd45b 5.1 1.0
Polo-like kinase 3 Plk3 4.5 1.0
Retinoblastoma binding protein 8 Rbbp8 4.5 1.3
Bcl2-like 1 Bcl2l1 3.0 1.1
Tensin 1 Tns1 2.6 1.2
Protein tyrosine phosphatase 4a1 Ptp4a1 2.3 1.1
Forkhead box O1 Foxo1 2.2 1.7
PAX interacting protein 1 Paxip1 1.9 1.0
Forkhead box O3a Foxo3a 1.9 -1.1
E1A binding protein p300 Ep300 1.8 1.0
NIMA (never in mitosis gene a)-related expressed kinase 7 Nek7 1.8 1.1
Cell division cycle 2-like 6 (CDK8-like) Cdc2l6 1.8 1.2
Cell division cycle 40 homolog Cdc40 1.4 1.0
Cyclin D2 Ccnd2 -1.5 -1.2
NIMA (never in mitosis gene a)-related expressed kinase 6 Nek6 -1.7 -1.2
CDC28 protein kinase regulatory subunit 2 Cks2 -2.3 -1.3
TSC22 domain family, member 1 Tsc22d1 -4.0 -2.3
Table 3 Prednisolone-regulated genes associated with ‘cell cycle’ in literature. CoPub identified 
65 prednisolone-regulated genes in wild type (WT) mice that are associated in literature with the 
cell cycle (top 20 shown). The identified genes share at least 3 publications and have an R-scaled 
score [34] of at least 35 with keyword ‘cell cycle’ in Medline abstracts. For each gene, the fold 
change (Fc) in prednisolone versus vehicle-treated WT mice (Fc WT) is given. Additionally, for each 
gene also the Fc in prednisolone versus vehicle-treated GRdim mice (Fc GRdim) is shown. *It should be 
noted that in GRdim mice these genes did not meet the p-value cutoff of 0.01 for significance after 
correction for multiple testing, and are mentioned to illustrate a small effect of prednisolone on 
gene expression in GRdim mice.
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are stress sensors involved in cell cycle arrest, DNA repair and apoptosis [43-45]. Other 
upregulated genes are Bcl2l1 (also known as Bcl2-like1 and Bcl-xl), an anti-apoptotic 
protein that is enhanced by binding to the Gadd45 family [46, 47], and Dusp1, a p53 
target gene involved in cell cycle regulation [48]. 
Amongst the downregulated genes are Ccnd2 (Cyclin D2) and Cks2 (Cdc28 protein 
kinase regulatory subunit 2), both involved in cell cycle progression [49, 50]. Overall, the 
direction of the prednisolone-induced differential regulation of genes associated with the 
cell cycle suggests that prednisolone induces a cytostatic response in liver of WT mice.
Foxo transcription 
From the literature-based network, the two transcription factors Foxo1 and Foxo3a 
appear to be intermediates between the gluconeogenesis and cell cycle and apoptosis 
subnetworks (Figure 3). Foxo transcription factors are key mediators of cell cycle 
progression, apoptosis, glucose metabolism, reactive oxygen species detoxification and 
DNA damage repair [51-54]. Their activity is tightly controlled by the insulin and growth 
factor-inducible Pi3k/Akt pathway. Akt-mediated phosphorylation of Foxo transcription 
factors promotes their translocation from the nucleus to the cytosol and thereby their 
inactivation through binding of 14-3-3 proteins [54-56].
Foxo transcription factors regulate gene expression of enzymes that are important 
regulators of gluconeogenesis, such as Pck1 and G6p [57, 58]. In addition, they suppress 
genes that are involved in glycolysis, the pentose shunt and lipogenesis [59]. Analysis 
of Foxo1-overexpressing mice revealed an increased expression of Igfbp1 (Insulin-like 
growth factor binding protein 1), Pck1, Tat and Tdo (Tryptophan 2,3-dioxygenase) and 
downregulation of Srebf1 (Sterol regulatory element binding factor 1) and Adipor2 
(Adiponectin receptor 2) in liver [59]. Interestingly, these genes are similarly regulated in 
prednisolone-treated WT mice (Figure 3 and Table 2).
Finally, Foxo transcription factors are regulators of cell cycle progression and were shown 
to induce Cdkn1a and Gadd45b [60] and to suppress Ccnd2 [54]. Also these genes show 
the same direction of regulation in prednisolone-treated WT mice (Figure 3 and Table 3). 
These observations suggest that GCs in WT mice induce Foxo transcription factors, which 
in turn may synergize with the GR to modulate the expression of their respective target 
genes. 
Prednisolone-induced differential gene expression in WT versus GRdim mice
Table 2 and 3 list a number of genes that are significantly regulated by prednisolone in 
WT mice. In the GRdim mice these genes do not meet the significance cutoff for differential 
regulation (p<0.01), but for most of them a small effect of prednisolone on the expression 
level can be observed in GRdim mice. To analyze these differences quantitatively, we 
plotted the log2 ratios of gene expression after prednisolone treatment in WT versus 
GRdim mice (Figure 4). This figure shows that on average, genes in WT mice are more 
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Figure 3 Literature-based network of glucocorticoid-induced effects. A network representation of 
the enrichment results was generated, in which differentially expressed genes together with enriched 
keywords are plotted. Genes are shown as circles (Red: upregulated; Green: downregulated), 
whereas enriched keywords are shown as squares. Connections between genes and keywords 
represent co-publications in Medline abstracts. To avoid an over-complex network, thresholds 
were set to simplify the interpretation of the results. Only keywords and genes that share at least 
5 publications and have an R-scaled score of at least 45 are plotted in the network [34]. Several 
higher-order biological processes that are affected by prednisolone can be appreciated: cell cycle 
and apoptosis, acute-phase response, stress response, amino acid metabolism, gluconeogenesis 
and lipid metabolism.
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strongly regulated than in GRdim mice after prednisolone treatment and confirms that 
induction of gene expression by prednisolone is not abrogated in GRdim mice but reduced 
to on average 33% of the level in WT mice, as indicated by the slope of the dotted line in 
Figure 4. 
Identification of genes that differentially respond to prednisolone in GRdim mice as 
compared to WT mice
In Figure 4, several genes are highlighted that show a different response upon prednisolone 
treatment in WT mice than in GRdim mice. 
Unexpectedly, a small subset of these genes shows stronger upregulation by prednisolone 
in GRdim mice compared to WT mice. These genes include Car8 (Carbonic anhydrase 8), a 
protein associated with proliferation and invasiveness of colon cancer cells [61], Zdhhc23 
(Zinc finger, DHHC-type containing 23), a Nitric oxide synthase-binding and activation 
protein [62], Flvcr2 (Feline leukemia virus subgroup C cellular receptor family, member 2), 
Figure 4 Log2 ratio plot of prednisolone-induced differential gene expression in wild type versus 
GRdim mice. Genes on the solid black line show an equal induction of differential gene expression by 
prednisolone in wild type (WT) versus GRdim mice. The black-dotted line indicates the average slope 
of the data and shows that the level of gene regulation in prednisolone-treated GRdim mice is 33% 
of that observed in WT mice. A subset of genes that show obvious differences in the magnitude of 
regulation by prednisolone in WT versus GRdim mice is highlighted, as well as genes that show equal 
magnitude of regulation in WT versus GRdim mice.
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a calcium-chelate transporter [63], and Amy2 (Amylase 2), an amylase that catalyzes the 
endohydrolysis of 1,4-alpha-D-glucosidic linkages in oligosaccharides.
Genes that appear to strictly rely on GR dimerization include Dusp1, Gadd45b, Cdkn1a, 
Foxo3a, Plk3 and Fam107a (Figure 4 and 5). As discussed above, Foxo3a, Dusp1, 
Gadd45b, Cdkn1a and Plk3 all participate in cell cycle regulation, apoptosis and DNA 
damage repair [43-45, 52]. The most striking difference in the level of regulation by 
prednisolone between WT and GRdim mice was observed for Fam107a (also known as 
Tu3a and Drr1) (Figure 4, 5 and 6). The expression profile suggests that transcription 
of Fam107a is under direct control of the GR and strictly depends on its dimerization. 
Fam107a encodes a ubiquitously expressed protein that was first described in the 
context of renal cell carcinoma, in which Fam107a expression is reduced or absent due to 
promotor hypermethylation [64-66]. Overexpression of Fam107a in Fam107a-negative 
cell lines leads to growth retardation and apoptosis, indicating that Fam107a might act as 
a tumor suppressor [65, 67]
We also identified a subset of genes that showed an equal induction of gene expression 
by prednisolone in WT and GRdim mice (located on the diagonal black line in Figure 4); 
Dst (Dystonin), a cytoskeletan-interacting protein postulated to cross-link cytoskeletal 
filaments and thereby maintain cellular integrity [68], Gtf2a2 (General transcription factor 
II A, 2), a subunit of the transcription initiation factor TFIIA [69], Agpat6 (1-acylglycerol-3-
phosphate O-acyltransferase 6), an enzyme involved in triglyceride synthesis [70], Marcks 
(Myristoylated alanine rich protein kinase C substrate), cytoskeletal protein involved in 
cell adhesion and cell motility [71], Obfc2a (Oligonucleotide/oligosaccharide-binding fold 
containing 2A), a single stranded nucleic-acid-binding protein [72], and Ppargc1a.
Prednisolone-induced changes in gene expression in WT and GRdim mice were validated 
by Q-PCR for Fam107a, Dusp1, Cdkn1a and Car8. Figure 6 shows the fold-changes of the 
selected genes in prednisolone versus vehicle-treated WT and GRdim mice. For all four 
genes, the regulation by prednisolone in WT and GRdim mice was qualitatively similar to 
what was found by microarray analysis.  
Discussion and conclusion
In this study we performed liver gene expression profiling of WT and GRdim mice after 
prednisolone administration. Our aim was to chart the biological processes in the liver 
that are affected by GCs and to study their dependence on DNA-binding and dimerization 
of the GR. CoPub keyword enrichment analysis with prednisolone-regulated genes in 
WT mice showed enrichment of keywords associated with glucose, lipid and amino acid 
metabolism, the cell cycle and apoptosis (Table 1 and Figure 3). This is in agreement 
with cellular processes known to be affected by GCs [73, 74]. Interestingly, the forkhead 
transcription factors Foxo1 and Foxo3a are regulators of these cellular processes and 
induced by prednisolone in WT mice. Together with the observation that a subset of 
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Figure 5 Intensity profiles of Plk3, Dusp1, Gadd45b, Cdkn1a, Foxo3a and Fam107a in vehicle 
and prednisolone-treated wild type and GRdim mice. Several genes were identified that showed 
differences between prednisolone-treatment in wild type (WT) and GRdim mice. Amongst those 
genes are Plk3, Dusp1, Gadd45b, Cdkn1a, Foxo3a and Fam107a were differential regulated in 
prednisolone-treated WT mice, but not in GRdim mice. White bars represent vehicle-treated mice, 
whereas grey bars represent prednisolone-treated mice. Symbols; Triangles: female mice, Bullets: 
male mice.
Figure 6 Validation of microarray-obtained gene expression by Q-PCR. The relative expression 
of Fam107a, Dusp1, Cdkn1a and Car8 in prednisolone-treated versus vehicle-treated wild type 
(WT) and GRdim mice was validated by Q-PCR. Differences in expression between two samples were 
calculated by the 2ΔΔCt method [103, 104]. Mean differences in gene expression between WT 
and GRdim mice were analyzed using the Student’s t-test. No expression was observed for Fam107a 
and Cdkn1a in vehicle and prednisolone-treated GRdim mice (Ct>30). Asterisks denote p-values as 
follows: *p < 0.05, **p < 0.01 and ***p < 0.001.
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the prednisolone-induced genes are Foxo1 and Foxo3a target genes and are similarly 
regulated in Foxo1 and Foxo3a expression profiling experiments [54, 59, 60], this suggests 
that the GR synergizes with these transcription factors in mouse liver to control lipid and 
glucose metabolism and the cell cycle. This concept is further supported by the recent 
finding that the MurF1 (Muscle RING finger 1) promoter contains adjacent binding sites 
for the GR and Foxo transcription factors and is synergistically activated when both are 
co-expressed [75]. However, it is likely that a subset of the prednisolone-induced genes 
is under direct control of Foxo1 and Foxo3a without the need for synergy with the GR. 
Other studies, addressing small gene sets or individual genes, had also identified a role 
for Foxo1 and Foxo3a in GR-induced gene expression [58, 75-77].
The list of differentially regulated genes by prednisolone in WT mice overlaps with that 
of an earlier study by Phuc Le et al., which combined chromatin immunoprecipitation 
(ChIP) data with gene expression data to identify direct GR target genes in mouse liver 
[78]. Most of the genes found in our study displayed the same up and downregulation 
of gene expression, such as Tat, Foxo1 and Fkbp5 that are upregulated and Adipor2, 
CCAAT/enhancer binding protein alpha (C/EBPα) and Tkt that are downregulated. From a 
candidate gene set of 302 genes, Phuc Le et al. identified metabolism, cell proliferation 
and programmed cell death as important processes in their GO-term analysis, which is in 
agreement with our findings. 
Interestingly, in contrast to our study, Phuc Le et al. did not observe upregulation of bona 
fide GR target genes, such as Pck and Igfpb in fed CD1 mice and explain this by lack of 
response due to a potential inhibition by insulin signaling in the fed state [79]. The fact 
that we observed upregulation of these genes indicates that in our experimental setup, 
which differs in several aspects from the setup used by Phuc Le et al, such as mouse strain 
used for the study, GC dosage and the fed state of the mice, the inhibitory effects of fed-
induced insulin signaling do not play a role.
The overall induction of gene expression was strongly reduced in prednisolone-treated 
GRdim mice compared to WT mice (Figure 4). Nevertheless, in many cases residual gene 
induction by prednisolone was still observed. This indicates that GR dimerization is indeed 
an important mechanism for activation of these genes, although some regulation can 
take place even in the absence of GR homodimers. In fact, GR monomers are in principle 
capable of binding to GC response elements (GREs) and evoking a basal induction of gene 
expression. However, due to the lack of cooperative binding they are less potent than GR 
homodimers. This is in line with the regulation reported for Pnmt (Phenylethanolamine-
N-methyltransferase) and Amy2 in which binding of GR monomers to GREs or a GRE 
half-site (i.e. only one-half of the classical palindrome) was sufficient to confer induction 
by GCs [80, 81]. In case of the Pnmt gene, multiple GRE half-site have been identified 
in the promoter region allowing receptor clustering and thereby stable binding of GR 
monomers independent of the DNA-binding domain (DBD) interface [80]. This also 
explains why expression of the Pnmt gene is not compromised in GRdim mice despite the 
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lack of GR dimer formation [21]. Another explanation for the residual gene induction by 
prednisolone in GRdim mice is that the mutant GR still forms homodimers but that these 
are far less stable than in WT mice. 
A recent study showed that the specific sequence of a GRE differently affects the 
conformation of the GR and thereby its activity towards specific target genes [82]. 
Mutation analysis of overexpressed GR domains that are involved in transcriptional 
activation, namely the dimerization region in the DBD (Dim) as well as AF1 and AF2 
(activation function 1 and 2), showed that the dependency on each of them was specific 
for the sequence of the GR binding site and that genes differed in their dependence on 
dimerization [82]. The fold induction of Tat and Fkbp5 by dexamethasone in the Dim 
mutant was around 30% for Tat and 50% for Fkbp5 of that for WT GR, which is in gross 
agreement with our own observations in vivo (Figure 4).
The effect of the GRdim mutation was found in all major pathways that were induced by 
prednisolone, i.e. for genes in inflammatory pathways, gluconeogenesis and cell cycle. 
Moreover, the attenuating effect of the GRdim mutation was found for genes that were 
upregulated as well as for genes that were downregulated by prednisolone. This suggests 
that genes, which fail to be repressed by prednisolone in GRdim mice, are either regulated 
through GR binding to negative GRE elements (nGREs) or indirectly regulated via other GR 
target genes. Interestingly, analysis of the magnitude of gene regulation by prednisolone 
in WT mice compared to GRdim mice showed that the cell cycle-related genes are more 
dependent on the dim interface than genes related to gluconeogenesis (Table 2 and 3). 
This can also be appreciated in Figure 4; several genes that are on the x-axis (i.e. show no 
differential gene expression upon prednisolone treatment in GRdim mice), are cell cycle-
related.
We identified several genes that showed strong upregulation by prednisolone in GRdim 
mice compared to WT mice, such as Amy2, Car8 and Zdhhc23, and several genes that 
showed equal induction of gene expression by prednisolone in WT and GRdim mice, 
amongst them are Dst and Ppargc1a (Figure 4). These genes are potential candidates 
for having GRE half-sites in their promotor regions, which could explain why these genes 
show equal or even higher induction of gene expression by prednisolone compared to 
WT mice. As mentioned earlier, the presence of GR half-sites in the promotor region 
for Amy2 was indeed experimentally confirmed [81]. For the other genes however, 
we did not find literature evidence for the presence of GR half-sites in their promotor 
regions. Therefore, follow-up studies on these genes to determine the functional GRE 
sites in their regulatory region would be of interest to study the significance of dimer-
interface independent GRE binding. Genes that showed equal or stronger upregulation 
by prednisolone in GRdim mice compared to WT mice can also be secondary response 
genes; under transcriptional control of transcription factors other than the GR. Keyword 
enrichment analysis performed with this set of genes did not identify enrichment for a 
particular cellular process.
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We identified several genes that are absolutely dependent on GR dimerization for the 
induction of gene expression by prednisolone, such as Cdkn1a, Gadd45b, Dusp1, Plk3 and 
Foxo3a (Figure 4). Interestingly, all of these have a strong relationship with p53: some are 
under direct transcriptional control of p53 (Cdkn1a [83], Gadd45b [84] and Dusp1 [48]) 
or physically interact with p53 (Foxo3a [85, 86] and Plk3 [87]). The cellular responses 
mediated by Foxo3a and p53 are highly similar, share some of their target genes (e.g. 
Cdkn1a and Gadd45b) and use similar mechanisms to regulate post-translational 
modification [51, 88]. Therefore, Foxo3a and p53 can be regarded as partners that 
positively as well as negatively regulate each other, depending on the context [51]. This 
observation might indicate that GC-induced activation of Foxo3a and/or p53 is hampered 
in GRdim mice. In line with this hypothesis Foxo3a was recently shown to be required for 
GC-induced apoptosis in lymphocytes [89]. Interestingly, this process is defective in GRdim 
mice highlighting a possible link between the GR, Foxo3a and induction of lymphocyte 
apoptosis [21].
Fam107a showed the largest induction of gene expression by prednisolone in WT mice 
(Figure 4 and 5). Analysis of protein-protein interactions revealed that Fam107a interacts 
with Tada2a [90, 91], a protein that together with binding partner Tada3a (Transcriptional 
adaptor 2 and 3 alpha) are core proteins of the histone acetyltransferase (HAT) complex 
[92]. HAT complexes are involved in chromatin structure modification for initiation of 
gene transcription, but can also acetylate non-histone proteins to modify their activity 
and stability [92, 93]. Interestingly, Fam107b a paralog of Fam107a with 84% protein 
similarity (not regulated in mouse liver by prednisolone) was shown to interact with 
Tada3a [94]. 
The observation that Fam107a inhibits cell proliferation and induces apoptosis when 
overexpressed [65, 67], suggests that Fam107a, like Foxo3a, Dusp1, Gadd45b, Cdkn1a 
and Plk3 play a role in regulating the cell cycle. Furthermore, the association of Fam107a 
with a core protein of the HAT complex might indicate that Fam107a may serve as a 
cofactor in the transcription machinery complex.
The activity and function of Foxo3a and p53 are strongly modulated by acetylation [51, 88, 
95]. Hence, Fam107a is an interesting candidate gene for follow up experiments to study 
whether it modulates GR-induced gene expression and/or acetylation of GR-associated 
transcription factors such as Foxo3a, p53, C/EBPα and C/EBPβ (CCAAT/enhancer binding 
protein, beta).
For a more comprehensive view on GC regulated process in the liver, experiments with 
multiple time points, different doses of GCs and using one or more inflammatory stimuli, 
could be considered.
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Methods
Animals
All mice (WT and GRdim; Balb/c) were bred at the Institute of Virology and Immunobiology 
at the University of Würzburg. In total 24 mice (8 male WT, 4 female WT, 8 male GRdim 
and 4 female GRdim) were included in the study. Mice were treated subcutaneously 
with 1 mg/kg prednisolone (5% DMSO and 5% Chremophor in manitol, 10 ml/kg) once 
and sacrificed 150 minutes later by cervical dislocation, which was approved by the 
responsible authorities in Bavaria (Regierung von Unterfranken). All experiments were 
performed in the morning between 9 and 10 AM. The mice were exposed to a regular 
dark-light-cycle (lights on between 6 AM and 6 PM) and had access to water and food ad 
libitum at any time.
RNA isolation 
Liver biopsy specimens were collected into aluminum containers, snap freezed in liqN
2 
and stored at -80°C before use. RNA isolation was done using Trizol, followed by RNeasy 
clean-up to enhance the A
260
/A
230 
ratio. RNA quantity and quality was determined using 
the NanoDrop Spectrophotometer and Agilent Bioanalyzer. For all samples subjected to 
microarray hybridization, the RIN (RNA integrity number) was 9.0 - 10.
Microarray data processing
Processed RNA samples were hybridized on GeneChip Mouse Genome 430 2.0 arrays 
(MOE430-2) from Affymetrix [96]. Processing and downstream statistical analysis of the 
microarray data was done using the R-Statistics package [97]. Data were normalized using 
the gcrma algorithm, pair-wise ratios between treatments were built using the limma 
package and annotation for the probe sets was derived from the mouse430-2 library, 
all as provided in BioConductor [98]. In all contrast matrices, a correction for gender 
type was applied. Data were deposited in the NCBI Gene Expression Omnibus (GEO), 
accession number GSE21048.
Keyword enrichment analysis
Keyword enrichment analysis on the microarray data was performed using CoPub [34] 
with default settings as provided by the web server [99]. The literature-network between 
enriched keywords and genes (nodes) and their co-publications (edges) were visualized 
using Cytoscape software [100, 101].
Validation of microarray results with Q-PCR
Total RNA (1 µg) was reverse transcribed using a commercially available cDNA synthesis kit 
(iScript, BioRad Laboratories, Hercules, CA, USA). Q-PCR was performed by SYBR Green-
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based quantification according to the manufacturer’s protocol (Applied Biosystems, Foster 
City, CA, USA). Primers were developed for Fam107a (Family with sequence similarity 
107, member a; Fw:TCATCAAACCCAAGAAGCTG; Rev: CTCAGGCTTGCTGTCCATAC), Car8 
(Carbonic anhydrase 8; Fw: CACACCATTCAAGTCATCCTG; Rev: ACCACGCTGGTTTTCTCTTC), 
Cdkn1a (Cyclin-dependent kinase inhibitor 1a; Fw: TCTTGCACTCTGGTGTCTGAG; 
Rev: ATCTGCGCTTGGAGTGATAG) and Dusp1 (Dual specificity phosphatase 1; Fw: 
GTGCCTGACAGTGCAGAATC; Rev: CCAGGTACAGGAAGGACAGG) using Primer3 [102]. 
All primer pairs were exon-spanning. The gene Azgp1 (alpha-2-glycoprotein 1, zinc-
binding; Fw: AAGGAAAGCCAGCTTCAGAG; Rev: ACCAAACATTCCCTGAAAGG) was chosen 
as endogenous control since the expression arrays did not show any differences in 
expression of this gene between the two experimental groups (WT vs GRdim). PCR 
products were selected to be between 80 and 120 bp long. Samples were run on the 
7500 Fast Real-Time PCR System (Applied Biosystems) using the following protocol: 
10 min. denaturation at 95°C, and 40 cycles of 15 sec. denaturation at 95°C, 60 sec. 
annealing and extension at 60°C. All primer pairs were validated in triplicate using serial 
cDNA dilutions. Primer pairs that were 100+/-10% efficient, which implies a doubling of 
PCR product in each cycle, were used to quantify mRNA levels. Threshold cycle numbers 
(referred to as C
t
) were obtained using the 7900 HT System SDS software version 2.3 
(Applied Biosystems). All samples were measured for three times and samples with a 
standard deviation (SD) larger than 0.5 were excluded from the analysis. The relative 
quantity (RQ) of the gene-specific mRNA was calculated from the average value of the 
ΔCt (target gene Ct – endogenous control gene Ct) for each of the 24 analyzed samples. 
Differences in expression between two samples were calculated by the 2ΔΔCt method 
[103, 104]. For Q-PCR, mean differences in expression between groups were analyzed 
using the Student’s t-test. A p-value of <0.05 was considered statistically significant in 
each situation.
Protein – protein interaction data
Protein-protein interaction data were retrieved from the Biological General Repository 
for Interaction Datasets (BioGRID) database [105, 106].
Abbreviations
GR: Glucocorticoid receptor, WT: Wild type, GRdim: GR with the A458T point mutation 
in the dimerization region of the DNA-binding domain, GCs: Glucocorticoids, GRE: 
Glucocorticoid response element.
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Abstract
Background: T lymphocytes are orchestrators of adaptive immunity. Naïve T cells may 
differentiate into Th1, Th2, Th17 or iTreg phenotypes, depending on environmental co-
stimulatory signals. To identify genes and pathways involved in differentiation of Jurkat 
T cells towards Th1 and Th2 subtypes we performed comprehensive transcriptome 
analyses of Jurkat T cells stimulated with various stimuli and pathway inhibitors. Results 
from these experiments were validated in a human experimental setting using whole 
blood and purified CD4+ Tcells.
Results: Calcium-dependent activation of T cells using CD3/CD28 and PMA/CD3 
stimulation induced a Th1 expression profile reflected by increased expression of T-bet, 
RUNX3, IL-2, and IFNγ, whereas calcium-independent activation via PMA/CD28 induced a 
Th2 expression profile which included GATA3, RXRA, CCL1 and Itk. Knock down with siRNA 
and gene expression profiling in the presence of selective kinase inhibitors showed that 
proximal kinases Lck and PKCϴ are crucial signaling hubs during T helper cell activation, 
revealing a clear role for Lck in Th1 development and for PKCϴ in both Th1 and Th2 
development. Medial signaling via MAPkinases appeared to be less important in these 
pathways, since specific inhibitors of these kinases displayed a minor effect on gene 
expression. Translation towards a primary, whole blood setting and purified human CD4+ 
T cells revealed that PMA/CD3 stimulation induced a more pronounced Th1 specific, Lck 
and PKCθ dependent IFNγ production, whereas PMA/CD28 induced Th2 specific IL-5 and 
IL-13 production, independent of Lck activation. PMA/CD3-mediated skewing towards a 
Th1 phenotype was also reflected in mRNA expression of the master transcription factor 
Tbet, whereas PMA/CD28-mediated stimulation enhanced GATA3 mRNA expression in 
primary human CD4+ Tcells.
Conclusions: This study identifies stimulatory pathways and gene expression profiles 
for in vitro skewing of T helper cell activation. PMA/CD3 stimulation enhances a Th1-
like response in an Lck and PKCϴ dependent fashion, whereas PMA/CD28 stimulation 
results in a Th2-like phenotype independent of the proximal TCR-tyrosine kinase Lck. 
This approach offers a robust and fast translational in vitro system for skewed T helper 
cell responses in Jurkat T cells, primary human CD4+ Tcells and in a more complex matrix 
such as human whole blood. 
Keywords: Signal transduction pathways, Gene expression profiling, T lymphocytes, Th1 
and Th2 development
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Background
Activation of T helper 0 (Th0) cells leads to differentiation into several lineages. These 
lineages include the Th1 and Th2 subsets as well as the more recently described subsets 
such as induced T regulatory cells and Th17 cells. The Th1 cells protect against intracel-
lular pathogens and are in general characterized by their ability to produce IFNγ, IL-2 and 
TNFα and express the Th1-specific transcription factor T-bet. The Th2 subset, which is in-
volved in the defense against extracellular pathogens, is characterized by the production 
of IL-4, IL-5 and IL-13 and is controlled by the master transcription factor GATA3 [1,2].
In a proper functioning immune system, these different T helper subsets are well-bal-
anced and co-operate to eliminate invading pathogens and to maintain homeostasis. Hy-
per activation of one T helper subset, however, can tip the balance from health towards 
disease, in which Th2-overshoot can lead to inappropriate immune responses leading to 
diseases like allergy and asthma. Alternatively, overshoot towards a Th1 or Th17-phe-
notype can cause autoimmune diseases, like rheumatoid arthritis and multiple sclerosis 
[3,4]. For effective CD4 T cell activation, the antigen presenting cell (APC) provides a key 
contact point to facilitate T cell activation and polarization towards different T helper 
subsets. A crucial event in this process is the interaction between the antigen presented 
via the MHCII receptor and the TCR receptor (signal 1). The nature of activation, defined 
by the strength of the TCR stimulation, can affect T helper cell polarization towards Th1 
or Th2, in which a high affinity interaction favors Th1 development and low affinity drives 
Th2 development [5-8]. Besides the TCR signal transduction, an additional signal is pro-
vided by the APC in the form of a co-stimulatory signal (signal 2). This signal is provided 
via CD28-B7 interaction and has been shown to be important for effective T cell activa-
tion [9]. Furthermore, CD28-mediated co-stimulation has been implicated in effective 
polarization of T cells towards a Th2 phenotype [10,11]. Also other co-stimulatory mol-
ecules, including ICOS and OX40, have been positively correlated with Th2 differentiation 
[12,13]. The results from these studies underline the importance of both signal 1 and 
signal 2, but also underline the complexity of these integrated signaling pathways.
The cascade of biochemical events, linking cell surface receptor engagement to cellular 
responses has been a focus of many studies. Detailed investigation of these signal trans-
duction events has led to identification and functional characterization of many kinases 
and phosphatases downstream of the TCR and CD28-receptor. TCR ligation results in the 
recruitment of p56Lck (Lck), a proximal TCR Src family kinase, which kick-starts the signal 
transduction cascade leading to phosphorylation of the ITAM motifs in the TCR, which 
recruits and activates ZAP70 [14]. This initial step leads to the activation of PLCγ that 
hydrolyzes PIP
2
 into IP
3
, which is the second messenger molecule responsible for the 
sustained intracellular calcium flux in T cells. CD28-ligation on T cells results in the re-
cruitment of PI
3
K, with PIP
2
 and PIP
3
, which serve as pleckstrin homology (PH) domain 
membrane anchors. Via this mechanism PDK1 and PKB/Akt are recruited and regulate 
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several pathways that increase cellular metabolism [15]. Additionally, CD28-signaling has 
been shown to initiate NFB signaling, via a mechanism that is functionally linked through 
recruitment of PKCθ to CD28 in the immunological synapse [16-18].
Members of the Mitogen-activated protein kinase family, which can be activated via TCR 
signaling, also play a role in the differentiation of Th1 and Th2 subsets. In a thorough re-
view by Dong et al., the role of p38, JNK and ERK in T helper cell differentiation has been 
outlined [19]. ERK is important for Th2 differentiation, whereas p38 and JNK2 appear to 
be involved in Th1 development. TCR/CD3 stimulation and CD28 stimulation alone are 
weak activators of T cell signaling. It is generally conceived that CD28 signaling merely 
acts as a signal potentiator on top of the initiator signal mediated via the TCR/CD3. Led-
better and June et al. described that CD28 stimulation in the absence of cross-linking on 
top of PMA stimulation can activate T cells, without increasing calcium flux [20,21]. This 
suggests that co-stimulatory pathways synergize with biochemical pathways induced via 
the TCR. Whether CD28 ligation, in the absence of TCR signaling, leads to activation and 
differentiation has not been fully explored.
These findings show that effective T cell activation and differentiation towards effector 
subsets is the result of precise integration of multiple signaling routes. To explore the 
pathways underlying these distinct routes towards T cell activation and differentiation we 
used comprehensive biochemical characterization and gene expression profiling of Jurkat 
T cells that were activated with various co-stimulatory signals in the presence of various 
inhibitors of specific signaling routes. With this approach we identified specific PMA/
CD3 and PMA/CD28 signal transduction and genomic fingerprints. PMA/CD3 stimulation 
induced a Th1 phenotype, dependent on both Lck and PKCϴ, whereas PMA/CD28 stimu-
lation, which is independent of TCR-mediated activation of Lck, resulted in a profound 
activation of T cells, skewing towards a Th2 phenotype.
Results and discussion
Activation of Jurkat T cells by various stimuli leads to differential signaling fingerprints
Jurkat T cells were activated by anti-CD3, anti-CD28, PMA, or ionomycin or combina-
tions of these single stimuli, in order to map the contribution of these stimuli towards 
the activation of proximal, medial and distal signal transduction pathways. As shown in 
Figure 1A, CD3-stimulation and ionomycin/PMA were able to increase intracellular lev-
els of Ca2+. Interestingly, neither CD28 nor PMA stimulation alone, affected intracellular 
Ca2+ levels. As expected, CD3-signaling resulted in an Lck-dependent phosphorylation of 
ZAP70 (Figure 1B). Stimuli containing PMA directly activated the MAPK pathway, which 
is reflected by the phosphorylation of ERK, P38 and JNK (Figure 1B). Furthermore, PMA 
addition directly activated PKC which was not reflected in the autophosphorylation of 
PKCθ, but was clearly detectable on the phosphorylation of the PKC substrate MARCKS 
(Figure 1B). CD3-mediated stimulations and PMA-induced stimulations resulted both in 
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the activation of AP1 family transcription factors c-Jun and ATF2 (Figure 1B). Analysis of 
nuclear translocation of NFATc1 and c-Jun (AP1)/NFκB p65, as part of the distal signal-
ing events revealed that indeed CD3-mediated signaling induced both NFAT and c-Jun/
NFκB, of which the latter pathways were potentiated by CD28-mediated signaling (Figure 
1C). In line with the calcium release from the ER, PMA or PMA/CD28-mediated signal-
ing did not induce NFAT nuclear translocation but highly activated the CD28 responsive 
element transcription factors c-Jun and NFκB p65 (Figure 1C). These results indicate that 
two distinct co-stimulatory profiles can be identified. A CD3/28 and PMA/CD3 stimulus 
that signals via Lck, increasing intracellular Ca2+ and activating NFAT, and a PMA/CD28 
calcium independent (co)-stimulatory activation signaling via PKCθ and MARCKS. Next, 
the molecular mechanisms involved in these signaling pathways were further explored 
in genomics studies.
Differential regulation of genes after PMA/CD3 and CD3/28 Vs PMA/CD28 stimulation
In order to further characterize the different signal transduction events induced by dif-
ferent (co)-stimulatory signals, we performed a first gene expression experiment with 
Jurkat T cells that were stimulated for 1 or 8 hours with PMA/CD3, CD3/28 and PMA/
CD28. It appeared that after 1 hour a limited response on transcription level was seen, 
whereas after 8 hours of stimulation, several hundreds of genes were regulated. Further-
more, PMA/CD3 and PMA/CD28 regulate more genes compared to CD3/28, reflecting 
the strength of the stimuli used (Figure 2). Multivariate analysis by principal component
analysis and hierarchical clustering showed that the 3 stimuli lead to clearly distinct gene 
expression profiles. At both time points the profile induced by PMA/CD28 is clearly dis-
tinct from the profiles induced by PMA/CD3 and CD3/28 (Figure 2).
Differentially regulated genes CCL1 and IL-2 are profilespecific secreted proteins
Gene profiles of the differential stimuli were ranked on the level of induction and evalu-
ated on whether or not the translated protein is secreted. This resulted in the identifica-
tion of the PMA/CD28-specific transcript CCL1 (Figure 3A), the CD3-specific transcripts 
IL-2 (Figure 3B) and XCL1/2 (data not shown). Small but significant inductions of these 
genes were observed after 1 hour of stimulation for both CCL1 and IL-2. However, both
genes were highly induced after 8 hours of stimulation. The secretion of the protein 24 
hours after stimulation reveals an identical profile compared to the mRNA (Figure 3A/B, 
right hand panel).
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Pathway profiling with multiple stimuli and inhibitors
To investigate the contribution of proximal, medial and distal signaling events on the 
CD3/28, PMA/CD3 and PMA/CD28 stimuli, we performed a second gene expression pro-
filing experiment with different selective inhibitors, including proximal kinase inhibitors 
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Figure 1 Signal transduction in Jurkat T cells. Jurkat T cells were stimulated with different 
combinations of stimuli in order to elucidate the different signal transduction pathways. A; Jurkat 
T cells were stimulated as indicated and intracellular Ca2+ release was monitored over/in time. 
B; Intracellular signal transduction routes were charted via phospho-analysis using western blot. 
Jurkat T cells were stimulated for 15 min using different stimulations. Proximal (Lck, ZAP70, PKCΘ 
and the PKC substrate MARCKs), medial (MAPK phosphorylation) and distal (c-Jun and ATF2) 
signaling was monitored based on the phosphorylation status of the described proteins. C; Nuclear 
translocation of the transcription factors NFAT, NFkB and c-Jun was evaluated 15 minutes after 
stimulation.
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Lck (A420983), PKCθ (AEB071), medial MAPK inhibitors PD98059 (MEK/ERK), SP600125 
(pan JNK), Org 48762-0 (P38) and the distal Calcineurin (Cn) inhibitor Cyclosporin A (CsA). 
Jurkat T cells were stimulated with PMA, CD28 and CD3 alone and combinations thereof 
in the presence of the above mentioned inhibitors. Based on the results of the first gene 
expression profiling experiment, we chose evaluated gene expression after 8 hours of 
stimulation.
A principal component analysis on the ratio data set is shown in Additional file 1: Figure 
S1. It appeared that the PMA/CD28, CD3/CD28 and PMA/CD3 co-stimuli induced several 
hundreds of genes, whereas the effect of a single stimulus was smaller, with the excep-
tion of the PMA single stimulus (Additional file 1: Figure S1, Additional file 2: Table S1). 
The gene set induced by a PMA stimulus showed a larger overlap with the genes induced
by the PMA/CD28 stimulus than with the CD3/PMA induced gene set. Whereas PMA and 
CD3 as a single stimulus induce a large number of genes, CD28 elicits only a minor effect. 
It can be observed that CsA, AEB071 and A420983 induce the largest effects on gene 
regulation, whereas the inhibitors of the MAPK pathway only have a minor effect on gene 
expression. This finding is corroborated by the number of regulated genes, showing that 
the MAPK inhibitors only regulate a small number of genes whereas A420983, CsA and 
AEB071 regulate many genes (Additional file 2: Table S1). A420983 and CsA only show a 
significant effect on the PMA/CD3 and CD3/CD28 pathways, in which the effect of CsA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PMA + CD28
PMA + CD3
CD3 + CD28
Overlap with
Number of
 probe sets CD3_PMA PMA_CD28 CD3_CD28
T= 1 hrs
CD3_PMA 338 1.00 0.53 0.83
PMA_CD28 194 0.92 1.00 0.89
CD3_CD28 319 0.88 0.54 1.00
T= 8 hrs
CD3_PMA 1567 1.00 0.72 0.42
PMA_CD28 1853 0.60 1.00 0.30
CD3_CD28 786 0.84 0.70 1.00
Figure 2 PMA/CD3 and CD3/28 stimulations differ from PMA/CD28 stimulation. The table shows 
the number of regulated probe sets and their overlap at 1 and 8 hrs following stimulation with CD3/
PMA, PMA/CD28 and CD3/CD28 (using a fold change cut off of 2 and a p-value cut off of <1.10-6. 
The right panel shows a hierarchical clustering of the data using the data for the regulated probe 
sets. Most of the variation is caused by the time difference (1hr vs 8 hrs). At both time points the 
PMA/CD28 stimulus was clearly different from the CD3/CD28 and CD3/PMA stimulus. Repeating 
this analysis with different values for the fold change and p–value cut off yielded essentially the 
same results for the multivariate analysis.
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is smaller than the effect of A420983. AEB071 is the only compound that shows also a 
significant effect on the PMA/CD28 induced pathway. These analyses were rerun with 
different settings for the thresholds used for gene selection. In all cases similar results 
were obtained indicating that the results were not critical dependent on the thresholds 
settings that were used. 
Inspection of the profiles of CCL1 and IL-2 revealed that CCL1 mRNA is highly induced 
via the PMA/CD28 pathway. This induction is depending on PKC signaling and negatively 
regulated via Lck signaling. Apparently this effect was upstream of Cn, since the inhibitor 
CsA did not increase CCL1 mRNA induction (Figure 4A). 
Figure 3 Differential regulation of IL-2 and CCL1. Jurkat T cells were activated for 1 and 8 hours 
using different stimuli (as indicated). Differentially regulated genes of which the proteins were 
secreted were identified and the highest ranking genes were selected. A; regulation of the CCL1 
mRNA is highly and differentially regulated after PMA/CD28 stimulation. Right panel shows the 
validation of the mRNA levels on protein level, secreted by activated Jurkat T cells. B; regulation of 
IL-2 mRNA is highly and differentially regulated after CD3/28 and PMA/CD3 stimulation. Right panel 
shows the validation of the mRNA levels on protein, secreted by activated Jurkat T cells.
 
 
 
A
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As expected, PMA/CD3 and CD3/28 stimuli and to a lesser extent PMA/CD28 resulted 
in a marked expression of IL-2, which is highly depending on the Lck/Cn signal transduc-
tion pathway, and the PKC pathway. Interestingly inhibition of MAPK signaling (with the 
Figure 4 Involvement of signal transduction pathways on differentially regulated genes. Jurkat T 
cells were stimulated as indicated previously and the involvement of different signaling pathways 
on gene regulation was elucidated using inhibitors of specific pathways, including Lck (1µM), PKC 
(10µM), Calcineurin (1 µM), and MAPKs p38, JNK, and MEK/ERK (all 10µM). A; Regulation of CCL1 
mRNA in Jurkat T cells after stimulation with PMA/CD28-, CD3/28- or PMA/CD3-and co-incubated 
and cultured for 8 hours in the presence or absence of signal transduction pathway inhibitors. B; 
Regulation of IL-2 mRNA in Jurkat T cells after stimulation with PMA/CD28-, CD3/28- and PMA/
CD3- and co-incubated and cultured for 8 hours in the presence or absence of signal transduction 
pathway inhibitors. The height of the bars represent the average intensity of 3 biological replicates, 
the error bars indicate the variation (min and max values). Significance of changes in expression 
level between the stimulated sample and the sample that was stimulated in the presence of the 
pathway inhibitor is indicated as follows; *** P value < 0.0001; ** 0.01 < P value >0.001
* 0.05 < P value >0.01.
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exception of the MEK/ERK pathway) does not affect IL-2 mRNA induction (Figure 4B). 
These effects on CCL1 and IL-2 production by inhibitors of the Lck/Cn and PKC pathway 
were further substantiated in a full dose-response experiment. Figure 5A shows that 
indeed AEB071 dose-dependently inhibited PMA/CD28-induced CCL1 production, which 
is slightly enhanced in the presence of an Lck inhibitor and which is not affected by Cn 
inhibition via CsA. IL-2 production can be blocked by inhibition of both the Lck/Cn and 
PKC pathway (Figure 5B). The involvement of Lck in the CD3-mediated pathway and PKC 
in the CD3 and CD28-mediated pathways was further confirmed by the knock-down of 
both kinases under the distinct stimuli. Knock-down of Lck did not affect PMA/ CD28-
induced CCL1 production, whereas knock-down of PKCθ resulted in significant inhibition 
of both IL-2 and CCL1 (Figure 5C). These results clearly show that PMA/CD28-induced 
gene profiles are highly depending on PKCθ signaling pathways but are independent of 
Lck/Cn and MAPK signaling pathways, whereas CD3-mediated signaling pathways are 
dependent on both Lck/Cn and PKCθ signal transduction and independent on MAPK sig-
naling events.
PMA/CD3, PMA/CD28 and CD3/CD28 induce distinct genomic fingerprints
The above analysis indicated that treating Jurkat T-cells with multiple combinations of 
stimuli and inhibitors highlights pathways that are regulated by specific combinations 
of stimulus and inhibitor, revealing the involvement of certain kinases as signaling hub 
under specific stimulatory conditions. In order to identify additional genes in the path-
ways that are exemplified by CCL1 and IL-2, we searched for genes with similar profiles 
to these pathway genes. Figure 6 shows genes related to CCL1, identified by a strong up 
regulation following PMA/CD28 stimulation only and a down regulation by AEB071. In-
terestingly, besides CCL1, which is a chemo attractant for Th2 cells, many Th2-associated 
genes co-clustered with CCL1, including GATA3, Itk, RXRA, c-FLIP (CFLAR), ICOS and the 
IL-31 receptor and also other genes that are associated with Th2 development (See Fig-
ure 6; CCL1 gene cluster). 
Likewise a very specific IL-2 profile can be constructed by selecting genes that are up 
regulated under all three conditions and down regulated by all three inhibitors, and by 
which CsA is the weakest inhibitor (see Figure 6; IL-2 cluster). In this gene cluster ap-
peared to be Th1- associated genes, including the Th1 master transcription factor Tbet 
(TBX21), Th1 chemokine XCL1/2, IFNγ, granzyme, RUNX3, FASL, OX40L (TNFRSF4), CD27, 
and the IL-21 receptor. Of note, inhibition of both Lck and Cn under PMA/CD3 stimula-
tion enhanced the expression of Th2 master transcription factors GATA3 and RXRA, but 
also peptidoglycan recognition protein 4 (PGLYRP4) and G protein-coupled receptor 84 
(GPR84). 
A third example is provided by genes clustering together with EGR1, which show an up 
regulation by all stimuli but are specifically regulated by AEB071 in all conditions and only 
by A420983 after CD3/CD28 stimulus. Although IL-2 and EGR1 show a similar regulation 
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by the stimuli used, the profiles can clearly be discriminated by the effects of the various 
inhibitors on their expression. The list of genes that are shown in Figure 7 together with 
their annotation and the correlation score to the CCL, IL-2 and EGR1 profiles are shown in 
Additional file 1: Figure S1, Additional file 2: Table S2, Additional file 3: Table S3. 
This analysis shows that by applying multiple stimuli and selective compound treatments, 
pathways can be unraveled at high resolution.
Figure 5 PMA/CD28-induced CCL1 production is not dependent on the Lck/Cn pathway. Jurkat T 
cells were stimulated using PMA/CD3 and PMA/CD28 in the presence of Lck (A420983), Cn (CsA) 
and PKC (AEB071) pathway inhibitors for 24 hours. Dose-response effects of the inhibitors were 
evaluated on the production of CCL1, after PMA/CD28 stimulation (A) and IL-2 after PMA/CD3 
stimulation (B) in supernatant of the cell cultures. The data are representative for 3 independent 
experiments. C; Knock down of Lck and PKCϴ resulted in a clear dose-dependent reduction of the 
protein (500, 100, 20 nM siRNA). 24 hour culture supernatants were collected after stimulation 
with PMA/CD28 and PMA/CD3 and the effect of knock down on respectively CCL1 and IL-2 was 
determined. Data of two independent experiments are presented as mean + SEM. Significance of 
differences are indicated by ** p<0.01, *p<0.05, # no difference using a one-way ANOVA with a 
Bonferroni's post-hoc test. N.b the values shown in this figure are log2 values no to be confused 
with the intensity values as shown in figure 3.
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Translation of PMA/CD3 and PMA/CD28 stimulations; differential modulation of 
primary T cell cytokine responses in human donor blood
In order to assess whether the stimulation profiles and signal transduction profiles 
identified in Jurkat T-cells were also relevant in a primary human setting, the stimulation
protocols were adapted and a primary assay was established using healthy human donor 
whole blood. The effect of differential stimulation was evaluated using IFNγ and IL-17 as 
Th1- and Th17-associated read-outs respectively and both IL-5 and IL-13 as Th2-associated 
read-outs. Stimulation of human whole blood cells with CD3/CD28 was unsuccessful: no 
cytokine release was detected. However, PMA/CD3 stimulation of human blood cells, 
resulted in a high production of IFNγ (Figure 7A). Interestingly, INFγ production levels 
were significantly lower after PMA/CD28 stimulation. A similar observation was seen 
Figure 6 Heatmap of stimulation dependent gene clusters. A: CCL1 cluster characterized by 
induction of genes exclusively following CD28/PMA stimulation and subsequent repression by 
AEB071. B: IL-2 cluster characterized by induction of genes by all stimulations, and down-regulated 
by A420983 and AEB071 and to a lesser extent by CsA. C: EGR1 cluster characterized by induction 
of genes by all stimulations, but down-regulated only by AEB071 when stimulated with PMA/CD28 
or PMA/CD3. A red color denotes an up-regulation, a green color a down-regulation. The MAPK 
inhibitors induced very little regulation and have been omitted from this figure for clarity. The gene 
lists shown in this figure, with extended annotation and their distance to the CCL1, IL-2 and EGR1 
profiles are provided in supplemental files 1,2 and 3.
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when analyzing IL-17 production. Thus, higher production levels of both IFNγ and IL-17 
were seen following PMA/CD3 stimulation when compared to PMA/CD28 stimulation. 
Furthermore, when analyzing Th2-associated IL-5 and IL-13 production, we found that 
PMA/CD28 stimulation was superior to PMA/CD3 stimulation in enhancing production of 
these cytokines (Figure 7B). Of note, CCL1 production could not be detected in this assay 
system (data not shown). In aggregate, the data suggests that PMA/CD28 stimulation 
favours Th2 responsiveness in this assay. Since PMA/CD28 signaling was shown to be 
independent of Lck, but mainly dependent on PKCθ whereas PMA/CD3 signaling was 
both Lck and PKCθ dependent we evaluated the effect of both proximal kinases in this 
human whole blood assay and evaluated IFNγ and IL-13 production since these cytokines 
were most readily produced. Figure 7C shows that indeed PMA/CD3-induced IFNγ 
production is depending on both Lck and PKCθ signaling, whereas PMA/CD28-induced 
IL-13 production is Lck-independent and PKCθ dependent. These results clearly show that 
the differential stimulations identified in the Jurkat assay can be translated towards a 
primary human cellular assay and are depending on the same proximal signaling hubs. 
Furthermore, also in this setting it can be observed that PMA/CD3 stimulation diverges 
more towards a Th1-like phenotype, whereas PMA/CD28 stimulation skews more towards 
a Th2-like response. 
PMA/CD3 stimulation of purified human CD4+ T cells enhances Th1 activation, whereas 
PMA/CD28 potentiates Th2 activation
Using purified human CD4+ T cells we validated the effects observed on Jurkat T cells and 
in a primary human whole blood assay setting. Of all stimuli used PMA/CD3 appeared 
to be the most powerful stimulus able to induce IFNγ production. Also in this setting 
inhibition of either Lck using A-420983, or PKC using AEB071 completely inhibited PMA/
CD3 induced IFNg production. CD3/CD28-mediated stimulation, which can be successfully
applied in this assay format induced IFNg production, which was dependent on both 
Lck and PKC mediated signal transduction pathways. Of interest and comparable to the 
effects observed on CCL1 production by Jurkat T cells, Lck inhibition under PMA/CD28 
stimulation did not inhibit IFNγ production and even appears to slightly enhance IFNγ 
production (Figure 8A). The observed effect on IFNγ production of the different stimuli is 
in line with the effects observed on the induction of the Th1 master transcription factor 
Tbet (Figure 8B). Both inhibition of Lck and PKC reduced CD3/28 and PMA/CD3 mediated
induction of Tbet, whereas Lck inhibition did not affect PMA/CD28-induced expression 
of Tbet. 
PMA/CD28 was the most profound inducer of IL-13 in CD4+ cells (Figure 8B). Interestingly 
IL-13 production under al stimulatory conditions used is dependent on PKC, whereas 
Lck inhibition does not affect IL-13 production under PMA/CD3 or PMA/CD28 culture 
conditions. Under all culture conditions inhibition of PKC reduced IL-13, which was 
paralleled with reduced GATA3 expression (Figure 8D), whereas inhibition of Lck appeared 
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to promote Th2 dvelopment under all stimuli used, which was reflected by enhanced 
expression of GATA3.
Figure 7 PMA/CD3 and PMA/CD28 stimulation differentially modulate primary T cell cytokine 
responses in human healthy donor blood. Healthy donor blood was stimulated with PMA/CD3 
and PMA/CD28 and cultured for 24 hours in the presence or absence of pathway inhibitors for 
Lck and PKC. Culture supernatants were analyzed on A; IFNγ, IL-17 (Th1/17 cytokines) and B; IL-13 
and IL-5 (Th2 cytokines).  Figure C shows the involvement of Lck (420983; 1µM) and PKC (AEB071; 
1µM) signal transduction on PMA/CD3-induced IFNγ production. Figure D shows the effect of Lck 
(A-420983; 1µM)) and PKC (AEB071; 1µM) signal transduction pathways on PMA/CD28-induced 
IL-13 production. Data are presented as results from 3 donors measured as biological duplicates. 
Significance of differences are presented as followed; * p<0.05, **p<0.01 using a one-way ANOVA 
with Dunnett’s post hoc testing.
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Text mining of IL-2 cluster genes and CCL1 cluster genes.
The gene expression study showed that PMA/CD3 induced an IL-2 gene profile which 
has been associated with a Th1 type of response. Similarly, PMA/CD28 induces a CCL1 
gene profile which is associated with a Th2 response. In order to find additional evidence 
for the Th1 cell specificity of IL-2 and the Th2 cell specificity of CCL1, we used CoPub to 
search in Medline abstracts for other studies which support these results. 
First we performed a keyword enrichment analysis of the genes that showed a similar 
gene expression profile to CCL1 (CCL1 cluster) and of the genes that showed an expression 
Figure 8 PMA/CD3 and PMA/CD28 effects on purified primary human CD4+ T cells. Purified 
CD4+ T cells were stimulated with anti-CD3/CD28, PMA/CD3 and PMA/CD28 and cultured for 24 
hours in the presence or absence of pathway inhibitors for Lck (A420983; 1µM) and PKC(AEB071; 
1µM). Culture supernatants were analyzed for  IFNγ, production (A),  mRNA expression of the Th1 
master transcription factor T-bet (B), the production of  the Th2 cytokine IL-13 (C) and expression 
of  the Th2 master transcription factor GATA3 (D). Message RNA expression was normalized against 
ribosomal house hold gene RPL19. Data are presented of three independent experiments using 
purified human CD4+ T cells from three different healthy donors. Data are presented as mean + 
SD. Significance of differences are indicated by ** p<0.01, * p<0.05, using a mann-withney U-test.
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Table 1 Gene set enrichment analysis of CCL1 cluster and IL2 cluster with cell terms from the 
CoPub database. P-value < 0.01.
CCL1 cluster IL2 cluster
Cell name Nr. of genes Cell name Nr. of genes
macrophage 16 Lymph cell 28
epithelial cell 15 Neoplastic cell 27
monocyte 14 Cancer cell 23
fibroblast 14 macrophage 23
Thymus derived lymphocyte 13 fibroblast 22
Lymph cell 13 Thymus derived lymphocyte 21
Neoplastic cell 13 epithelial cell 21
Cancer cell 12 endothelial cell 20
dendritic cell 12 dendritic cell 18
hepatocyte 11 monocyte 18
endothelial cell 11 Stem cell 18
Th2 cell 10 thymocyte 16
Keratinocyte 10 granulocyte 15
Bursa-equivalent lymphocyte 10 leukocyte 15
leukocyte 10 Leukemic cell 14
Peripheral blood mononuclear cell 9 Bursa-equivalent lymphocyte 12
Antigen-presenting cell 9 Neutrophilic leukocyte 12
mast cell 9 Hela cell 11
Neutrophilic leukocyte 9 Myeloid cell 11
granulocyte 9 T-lymphocyte,cytotoxic 11
eosinophil 8 natural killer cell 11
Effector cell 8 Peripheral blood mononuclear cell 11
Breast cancer cell 7 hepatocyte 11
Th1 cell 7 plasma cell 11
adipocyte 7 stromal cell 11
splenocyte 7 Breast cancer cell 10
thymocyte 7 splenocyte 10
T-lymphocyte,cytotoxic 7 Melanoma cell 10
natural killer cell 7 Squamous cell 10
Melanoma cell 6 hybridoma 10
Muscle cell 6 Muscle cell 10
stromal cell 6 neuron 10
Stem cell 6 Th2 cell 9
T4 lymphocyte 5 Th1 cell 9
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profile similar to IL-2 (IL-2 cluster) against a list of cell terms from the CoPub database. 
Both the enrichment analysis with the IL-2 cluster and the CCL1 cluster resulted in similar 
enriched terms such as ‘macrophage’, ‘lymph cell’, ‘Thymus derived lymphocyte’ and 
‘monocyte’ (Table 1). These results are not surprising since both clusters of genes were 
found to be expressed in Th1 and Th2 cells. Th1 and Th2 are T helper cells which play 
important roles in the immune system in recruiting other cells. This analysis confirms that 
these clusters of genes are involved in immune responses.
Both the CCL1 cluster and the IL-2 cluster are enriched with the terms ‘Th1 cell’ and ’Th2 
cell’. Therefore we studied into more detail the relation of each cluster with Th1 and Th2 
cell types. We created a literature network, searching for co-occurrences between the 
genes in each cluster and identifying the link of the genes in the network with Th1 and 
Th2 cells in Medline abstracts. In Figure 9A the network of the IL-2 cluster is shown. In the 
network we can identify 7 hub-genes, i.e. IL-2, IFNG, IL2RA, GZMB, FASLG, TNFRSF4 and 
TNFRSF7, which are connected to several other genes in the network. With the exception 
of GZMB, all these hub genes have connections to both Th1 and Th2. From the network 
it is also clear that Th1 has a slightly higher connectivity (9 connections) than Th2 (8 
connections). In Figure 9B the network of the CCL1 cluster is shown. Also in this network 
highly connected genes such as CCL1, CXCl10, CXCL9, GATA3 and ISG20 have connections 
to both Th1 and Th2. Hence from the literature network, the specificity of the genes for 
either Th1 or Th2 is not immediately clear. However, in the network (Figure 9B) Th2 has 
more connections (9 connections) than Th1 (7 connections).
Figure 9 Literature networks of the Il-2 cluster (A) and the CCL1 cluster (B). In both networks 
the link to Th1 cell and Th2 cell is shown. The thickness of the line between co-occurring genes 
or between genes and cell terms indicates the strength by means of the R-scaled score. In the 
networks IL-2 and CCL1 are highlighted with a red border color.
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Conclusions
In this study we systematically explored pathways involved in T cell activation by molecular 
profiling. We showed that TCR (both CD3/28 and PMA/CD3) driven stimulation profiles 
are truly distinct from co-stimulatory profiles mediated via PMA/CD28. Secondly, using 
selective inhibitors and siRNA we found that the proximal kinase Lck is involved in CD3 and 
not PMA/CD28 activation, whereas PKCθ appears to be a crucial central signaling kinase 
in both TCR and PMA/CD28 (co)-stimulatory activation of T cells. Finally, stimulations 
involving TCR/CD3 appear to preferentially induce a Th1-like fingerprint, whereas lack 
of TCR/CD3 signaling in the presence of PMA/CD28 stimulation diverts T cells towards a 
Th2-like state. 
It has been suggested that the strength of TCR-signaling can regulate the fate 
determination of naive T cells; highpotency signals skew towards Th1 differentiation, 
whereas low potency signals promote Th2 differentiation [6,22]. Although TCR and co-
stimulatory pathways have been the focus of many studies in the previous decades, the
direct contribution of TCR stimulation vs. co-stimulatory signals towards Th differentiation 
is not fully understood. By stimulating T cells with PMA/CD3 and PMA/CD28 we dissected 
signaling pathways and explored the activation profiles. CD3-mediated signaling rapidly 
increased intracellular Ca2+, a second messenger to activate many enzymes including 
Calcineurin, which resulted in an increased nuclear translocation of NFATc1. Interestingly,
PMA/CD28 stimulation did not result in a Ca2+-mediated response (and was therefore 
marked a calcium-independent stimulation) but enhanced many of the co-stimulatory 
mediators including MAPK/AP1 and NFB signal transduction. These results are in 
line with earlier studies that showed differential effects of cyclosporine A (CsA) and 
dexamethasone on CD3 vs CD28-mediated signaling, which revealed that PMA/CD28 
stimulation was insensitive towards CsA-mediated Calcineurin inhibition in contrast to 
PMA/CD3 stimulation [20,23]. 
Gene expression induced by combinations of stimulatory signals revealed pathway-
specific biomarkers or fingerprints. PMA/CD3-induced gene profiles included IL-2, IFNγ, 
XCL1, granzyme B, and FASL, which have been associated with a Th1 type of response 
[24,25]. Also, sustained NFAT signaling, which is also induced via PMA/CD3 stimulation, 
has been shown to promote Th1-like gene transcripts, including IFNγ, FasL and P-selectin 
glycoprotein ligand 1 [26]. Our results are further substantiated by the finding that T-bet 
(TBX21), the Th1 master transcription factor [27], and RUNX3, which together with Tbet 
are crucial for inducing IFNγ and repressing IL-4 [28], were highly expressed under PMA/
CD3-stimulatory conditions. 
PMA/CD28 stimulation does not induce a Ca2+ flux nor does it increase nuclear 
translocation of NFAT. However it provides the cell with a high level of co-stimulatory 
signaling, and induces a completely distinct genomic fingerprint compared to PMA/
CD3 stimulation. Following PMA/CD28 stimulation, Jurkat T cells highly expressed CCL1/
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I309, a chemokine which is highly expressed during a Th2-eosinophil response in allergic 
airway diseases [29,30]. Lymphotoxin (LT), a cytokine which is associated with a Th2-type 
of response controlling IgE production [31], was also highly expressed under PMA/CD28 
stimulation. In conjunction with this finding, the master transcription factors for Th2, 
GATA3 [32] and the Retinoid X Receptor (RXR) [33], were induced under the PMA/CD28 
stimulatory condition. Notably, Th2-associated cytokines like IL-4, IL-5 and IL-13 were not 
induced in Jurkat T cells after PMA/CD28-stimulation, this in contrast with PMA/CD28 
stimulation of human whole blood and purified CD4+ T cells, which could be due to the 
developmental blockage of Jurkat T cells. Additional file 6: Figure 2 shows a schematic 
overview summarizing the involvement of the signaling pathways and genes induced 
under differential stimulation as observed in this study and highlights their relation 
towards T helper 1 and -2 development. 
Our results are in line with the notion that high calcium levels drive Th1 and CTL responses 
and low calcium levels drive Th2 responses [7,34,35], which was further substantiated 
by our results using inhibitors for Lck and Cn, which modulate Calcium signaling in T 
cells. These inhibitors repressed Th1-associated genes under PMA/CD3-stimulation, but 
induced Th2 transcription factors GATA3 and RXRA, revealing a skewing of Th1 towards 
Th2 profiles. In contrast, PMA/CD28 stimulation in the presence of Lck and Cn inhibition, 
Th2-associated genes, e.g. CCL1 or IL-13 in CD4+ T cells, were not affected or even 
induced. The crucial role of Calcium and Lck in driving Th1 response is in line with the 
observation that knock down of Lck affects the virus-specific Th1/CTL response in mice 
and Lck deficiency increases Th2 associated cytokine production [36,37]. Interestingly, 
lack of Calcium signaling can give rise to an anergic T cell phenotype (reviewed in [38]). 
Therefore it would be of interest to further explore the role of Lck in calcium-dependent 
activation via PMA/CD3 on Th1/CTL responses and calciumindependent activation of T 
cells via PMA/CD28 on the induction of anergy in more detail. 
CD28 signaling has been functionally linked with PKCθ induced activation of NFB [39], 
which was also validated using PMA/CD28 as stimulus [40]. Previously it has been 
reported that CD28-costimulation induces GATA3 expression and Th2 differentiation via 
the activation of NFB [41,42]. Additional studies in mice revealed that PKCθ is involved 
in mounting both Th2- and Th1-mediated lung inflammation, although Th2-mediated 
inflammation is more PKCθ-dependent [43]. Our studies show that inhibition of PKCθ 
can indeed inhibit a PMA/CD28 stimulation, which was reflected by the effect of PKCθ 
inhibition on the PMA/CD28-induced Th2-like gene expression profile. These observations 
are in line with the results from CD28 knock-out mice and inhibition of CD28 signaling 
using CTLA4Ig, showing that the CD28 co-stimulatory signaling is crucial for mounting a 
proper Th2 response. In contrast, Th1 and CTL responses were found to be less dependent 
on CD28 signaling [44,45]. Of interest, PKCθ inhibition in our hands, also affected PMA/
CD3-induced Th1-like expression profiles. These results underline the duality of PKCθ in 
the integration of TCR and CD28-mediated signaling events which is evident from PKCθ 
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KO mice experiments. 
Text mining analysis has been used to find additional evidence for the observed specificity 
of the IL-2 cluster for Th1 cells and the CCL1 cluster for Th2 cells. Keyword enrichment 
analysis with both gene clusters did not show this specificity for either Th1 or Th2. 
However enrichment analysis resulted in immune related cells for both gene clusters, 
thus confirming the experimental observed results presented in this paper. Literature 
networks for both the IL-2 and the CCL1 cluster showed that the highly connected genes 
in each network are connected to both cell types. Although in the IL-2 network, Th1 has 
a higher connectivity than Th2 and in the CCL1 network Th2 a higher connectivity than 
Th1, the cell specificity of both clusters is not clearly visible. Moreover in the literature 
networks is shown that both Th1 cell and Th2 cell are highly connected to each other.
The reason that the cell specificity could not be detected using co-occurrence based 
text mining could lie in the fact that in abstracts in which Th1 occurs, in more than 
30% of these abstracts also Th2 occurs and vice versa. This makes it impossible to find 
a specificity of the genes for one of the cell types using co-occurrence based methods 
such as CoPub. Hence in order to detect this type of specificity in text, other types of 
information extraction methods such as natural language processing (NLP) are needed. 
NLP is able to identify the type of relation between a gene and a cell type en enables to 
search for specific relations.
Finally, our results also show that this differential stimulation does not only occur in 
Jurkat T cells, but also plays a role in primary human T cells. These cells were found to 
secrete a Th1-like response (Tbet-IFNg) via PMA/CD3 stimulation, whereas PMA/CD28 
stimulation led to a Th2 activation profile (GATA3-IL-5/IL-13). In these cells inhibition 
of the Lck/Cn/NFAT pathway was only effective after PMA/CD3 stimulation whereas 
inhibition of PKCθ inhibited both PMA/CD3-induced IFNg production and PMA/CD28-
induced IL-13 production. These results illustrate that the findings in the Jurkat T cell 
line were successfully translated and relevant to a human primary cellular setting. 
Interestingly, PMA/CD3 stimulation also enhanced IL-17 production in the primary 
human whole blood assay and increased the expression of the IL-21 receptor, which is 
crucial for Th17 induction [46,47], in Jurkat T cells. These results suggest that additional 
signals, like IL-21 in conjunction with TGFΒ and IL-6, might be necessary to differentiate 
from a Th1-like phenotype towards a Th17 phenotype, whereas the absence of TGFΒ in 
the presence of high levels of IL-2 will favor Treg development or stabilization. Therefore 
further exploration of these differential stimulations in the presence of defined/ different 
cytokine stimuli could further elucidate T helper cell differentiation and establish sub-set 
specific genome profiles. The findings described in this paper offer a robust platform for 
in vitro activation of T cells, in which observed responses can be easily translated form 
Jurkat T cells, towards purified CD4+ T cells and even human whole blood. This can be of 
interest for efficiency and selectivity profiling of kinase inhibitors or for pathway-specific
biomarker identification for future drug development and clinical studies.
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Methods
Compounds
Inhibitors selectively targeting defined pathways used in this study were A-420983 (1 
M; Lck inhibitor) [48], AEB-071 (10 M; PKCϴ inhibitor) [49] and Cyclosporin A (1 µM; 
Calcineurin inhibitor). Additionally, inhibitors of the MAPK pathway, SP600125 (10 µM; 
pan JNK), PD98059 (10 µM; MEK1/2), Org 48762-0 (10 M; P38) [50] were used. All 
compounds were dissolved in 100% DMSO. Maximal and final concentration of DMSO 
used in the culture assays was 0.1% v/v.
Cell culture
Jurkat E6.2.11 T cells were cultured in DMEM F12 medium (#041-94895 M, Gibco) 
supplemented with 10% FBS (#10099-141, Invitrogen) and 80 U/ml penicillin/80 g/ml
streptomycin (#15140-122 Gibco). Cells were cultured at concentrations between 1-2 × 
105 cells/ml at 37°C/5% CO
2
. Cells were stimulated for 15 minutes up to 24 hours with 
anti-CD3 (1 µg/ml, OKT3), anti-CD28 (1 µg/ml, pericluster CD28 #M1456 Sanquin, the 
Netherlands), PMA (10 ng/ml, Sigma, USA) and ionomycin (1 µg/ml, Sigma, USA), or 
combinations thereof. 
For gene expression profiling Jurkat T cells were seeded in T25 culture flasks at a 
concentration of 1 × 106 cells/ml (1 × 107 cells in total) and cultured overnight at 
37°C/5%CO
2
, one day prior to stimulation. On the day of the experiment cells were 
preincubated with the compound of interest for 30 minutes, followed by a stimulation 
with either CD3/CD28, PMA/CD28 or PMA/CD3, at concentrations of 10 ng/ml PMA, 1 
µg/ml CD3 and 1 µg/ml CD28. Jurkat T cells were cultured in the presence or absence of 
stimulation for one or eight hours in total, after which the cells were washed in ice cold 
PBS. Thereafter cell pellets were collected and snap frozen at -80°C. Cell pellets were 
stored until further processing.
Isolation and quality check of mRNA
Total RNA was isolated from Jurkat T cells using the RNeasy mini extraction kit (Qiagen # 
74106) according to the manufactures’ protocol. RNA was dissolved and diluted in RNAse 
free water and the RNA concentration was determined via Nanodrop analysis. The quality 
of total RNA was evaluated by capillary electrophoresis using an Agilent 2100 Bioanalyzer 
(Agilent Technologies, Palo Alto, Calif.) 
Double-stranded cDNA was synthesized from 1.5 µg total RNA using the One-Cycle Target 
Labeling Kit (Affymetrix Santa Clara, CA), and used as a template for the preparation of 
biotin-labeled cRNA using the GeneChip IVT Labeling Kit (Affymetrix Santa Clara, CA). 
Biotinlabeled cRNA was fragmented at 1 µg/l following the manufacturer’s protocol. 
After fragmentation, cRNA (10 µg) was hybridized at 45°C for 16-17 hours to the Human 
Genome U133A 2.0 Array or the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa 
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Clara, CA). Following hybridization, the arrays were washed, stained with phycoerythrin-
streptavidin conjugate (Molecular Probes, Eugene, OR), and the signals were amplified 
by staining the array with biotin-labeled anti-streptavidin antibody (Vector Laboratories, 
Burlingame, CA) followed by phycoerythrin-streptavidin. The arrays were laser scanned 
with an GeneChip Scanner 3000 6 G (Affymetrix, Santa Clara, CA) according to the 
manufacturer’s instructions. Data was saved as raw image file and quantified using GCOS 
(Affymetrix).
Statistical analysis
The .CEL files were analyzed with the R http://www.rproject.org and the BioConductor 
software package http://www.bioconductor.org. Normalization was done using gcrma. 
Building of the experimental design and calculation of the ratios was done with the limma 
package. Regulated probe sets were selected on basis of the fold change and the adjusted 
p-value (Benjamini-Hochberg correction). Multivariate data analysis and clustering was 
done with standard methods in the R software package http://www.r-project.org. For the 
principal component analysis and hierarchical clustering, ratio data were used. The ratio 
data were calculated for each treatment to its corresponding control. For the treatment 
with the stimuli, the untreated cells were taken as a control. For the treatment with 
stimulus + compound combinations, the treatment with the stimulus alone was taken 
as  a control. Results were expressed as mean ± SEM. Significance of differences was 
determined using a one-way ANOVA followed by post-hoc testing as indicated. Data 
sets can be found in GEO http://www.ncbi.nlm.nih.gov/gds/ under accession number 
GSE30678.
FLIPR calcium flux assay
96-wells plates were coated with poly-L-lysine in PBS for 1 h at 37°C. Jurkat T cells were 
seeded at a concentration of 7 × 105 in culture medium and rested for 1 hour at 37°C/5%CO
2
. 
Thereafter cells were incubated for 1 hour in the dark with FLIPR calcium buffer, according 
to the manufacturers’ protocol. Stimuli were added via the Flexstation384 and calcium 
release was monitored in time (Molecular devices, Sunnyvale, USA). 
Western blotting and nuclear translocation assay
Cells were washed in ice-cold PBS and pellets were lysed on ice in lysis buffer (Biosource, 
cat nr FNN0011, supplemented with 1 × protease inhibitor cocktail Roche cat no 
11873580051, 1 mM PMSF Fluka cat no 93482, phosphatase inhibitor cocktail I, Sigma 
cat no P2850, phosphatase inhibitor cocktail II, Sigma cat no P5726) followed by an 
incubation for 30 min on ice. The lysates were stored at -80°C until further analysis.
Phosphorylation of proteins from stimulated Jurkat cells were evaluated via western blot 
analysis. Briefly, samples were run on a 4-12% NuPage gels (#NP321BOX, Invitrogen) for 35 
min on 200 V in 1 × MES buffer (#NP0002, Invitrogen, USA) and subsequently transferred 
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to a PVDF membrane (#162-0184, Biorad). The blots were blocked in PBS/0.05% 
Tween-20 with 1% skim milk (#232100, Difco) and 1% BSA. Blots were incubated O/N at 
4°C in a roller bottle with the primary antibody diluted 1:1000 in block buffer, followed by 
incubation with a secondary detection antibody. Thereafter blots were incubated in ECL
(#RPN2106V1 and RPN2106V2 Amersham Pharmacia) and hyperfilms (#RPN3103K, 
Amersham Pharmacia) were exposed and developed. For the detection the following 
antibodies were used: pLck/Src (Tyr416 Cat N° 2101 L), Lck (Cat N° 2752), pZAP70 (Tyr319 Cat 
N° 2701), pPKCθ (Thr538, Cat N° 9377), pMARCKS (Ser152/156 Cat N° 4273) and ATF-2 (Thr71 
Cat N° 9221) (all cell signaling technology, Danvers, USA). pP38 (Thr180/Tyr182 Cat N° 44-
684 G), pERK (Thr185/Tyr187 Cat N° 44-680 G), pJNK1/2 (Thr183/Tyr185 Cat N° 44-682 G), JNK1 
(Cat N° 44-690 G) were obtained from Invitrogen (Carlsbad, USA) and c-Jun (pSer73) was 
obtained from calbiochem (cat no 420114). For the analysis of nuclear translocation of 
the transcription factors NFAT, NFkBp65 and c-JUN, nuclear fractions of activated Jurkat T 
cells were isolated via hypotonic shock and levels of activated transcription factors in the
nuclear lysates was tested in a TransAM transcription factor ELISA according to the 
manufacturers’ protocol (Active Motif, Carlsbad, USA).
Knock down of PKCθ and lck in Jurkat T cells
Jurkat T cells (2 × 10e7 cells/ml) were mock transfected or electroporated (250 
V/975 μF) with siRNA targeting Lck (RefSeq accession-number NM-005356; sense 
5’-GCACGCUGCUCAUCCGAAAdTdT) and PKCθ (RefSeq accession-number NM-006257; 
sense 5’-GCAGCAAUUUCGACAAAGAdTdT) in different concentrations of 500, 100 and 
20 nM or scrambled control siRNA (Thermo scientific, Dharmacon Inc, Lafayette, USA). 
Electroporated cells were cultured in M505 supplemented with 10% FCS. Cells were 
stimulated 72 hours after electroporation and knockdown efficiency of the specified 
proteins was checked via western blot analysis. Culture supernatants of PMA/CD28 or 
PMA/CD3-stimulated cells were collected after 24 hours and production of respectively 
CCL1 and IL-2 was determined.
Experiments with WBA
Peripheral whole blood was obtained by venipuncture from healthy adults (male/female) 
and was collected into lithium heparinised tubes. Blood was obtained from healthy 
volunteers and the time between puncture and processing was less than 1 hour. Blood 
was diluted 1:4 with RPMI 1640 (Life Technologies, cat no. 32404-014) supplemented 
with penicillin/streptomycin (GibcoBRL, cat 15140-122) and 2 mM L-glutamine (GibcoBRL, 
cat 25030-024) and distributed (200 μl/well) into 96-wells plates (Nunc, Cat 167008). 
Blood cultures were stimulated with soluble αCD3/PMA and soluble aCD28/PMA, or 
left unstimulated. Blood (200 μl/well) in RPMI 1640 medium was incubated with 25 μl 
compound (maximum of 0.1% v/v DMSO).
160    Chapter 7
Cytokine determination
Cytokines and chemokines IL-2, CCL1/I309 and XCL1, secreted into the supernatant of 
stimulated Jurkat T cells were determined via ELISA (R&D systems, USA). Cytokines IL-17, 
IFNγ, IL-13 and IL-5, produced by human CD4+ T-cells activated in whole blood, cultured 
in the presence or absence of compounds were determined in the culture supernatant, 
using a bead-based human cytokine multiplex kit (Bioplex-system; Bio-Rad, Veenendaal,
The Netherlands) according to the manufacturer’s instructions. Culture suppernatants 
were collected at day 1 of culture. Samples were analyzed using a Luminex-100 analyzer
(Luminex, Austin, USA) with Bio-plex Manager Software 3.0 (Bio-Rad). Proteins were 
discriminated based on the fluorescent label of the bead and the PE levels were corrected 
for background levels of negative controls. The sensitivity of the cytokine assay was less 
than 5 pg/ml for all cytokines measured.
cDNA synthesis and q-PCR
Primary human CD4+ T cells were isolated from buffy coats from three healthy donors 
using MACS negative CD4+ purification technology (Miltenyi biotech, Germany), yielding 
a overall 96% pure CD4+ T cell population. RNA from stimulated CD4+ T cells was isolated
using an RNeasy minikit (QIAGEN Gmbh, Germany). RNA content of samples was analyzed 
using Nanodrop (Agilent technologies, Ca, USA) and purity was analyzed using the Agilent 
RNA 6000 nanokit protocol on the RNA nano labchip using the Agilent 2100 bioanalyzer
(Agilent technologies, Waldborn, Germany). Three microgram of RNA was used for cDNA 
synthesis using random hexamer primer mix (invitrogen), 10 mM dNTP, M-MLV RT buffer 
and M-MLV Reverse transcriptase (Promega). RT reaction was performed at 42°C for 1 hour 
followed by a deactivation for 5 minutes at 90°C. cDNA of the Th1 master transcription 
factor Tbx21 (Tbet), Th2 transcription factor GATA3 or the control household gene RPL19 
was applified using Power SYBR green mastermix (Applied Biosystems, Warrington, UK)
and expression was monitored on the ABI prism 7900 HT sequence detection system 
(Applied Biosystems, Warrington, UK), Ct values were normalized for the expression of 
the RPL19 gene.
Additional material can be found at the online version of this paper at the publishers 
website or can be retrieved on request by the author of this thesis.
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Abstract
Background
Metagenomics by means of 16S rRNA sequencing allows identifying microbial communities 
that are directly retrieved from environmental samples. This technique is used in so 
called community profiling studies and results in lists of organisms that are affected by a 
certain treatment or process. Knowledge of the biological properties of these organisms 
is important to understand their role in these processes. This knowledge is for a large 
part contained in the scientific literature. Because these organism lists contain dozens of 
organisms, retrieving the biological properties from the literature is labor-intensive and 
therefore requires methods that can do this automatically.
Method
To this end we developed a method which is able to automatically retrieve biological 
properties of microorganisms from Medline abstracts. 
Results
We analyzed lists of microorganisms derived from metagenomics experiments that were 
aimed at the characterization of microbiota in female urine and the characterization of 
the oral fungal microbiome in healthy individuals. With the organisms from both lists, 
we searched for associations with diseases in Medline abstracts. Several specific disease 
associations were found indicating the pathogenic potential of these microorganisms.  
Furthermore, we automatically identified biological properties and industrial applications 
for groups of lactic acid bacteria (LAB). We identified a cluster of LAB with opposite roles 
in the process of wine making and a cluster of LAB that are involved in food spoilage as 
well as  in fermentation processes to make sauerkraut and kimchi. 
Conclusions
Automatic information extraction on microorganisms gives rapid insight into the 
pathogenic potential of microorganisms by linking to diseases in Medline abstracts. 
Furthermore word clouds of highly occurring keywords in these abstracts give an 
overview of the biological properties of LAB and the processes in which they play a role. 
This overview can help to select LAB for fermentation processes in order to improve the 
characteristics of fermented products. 
Keywords: Microorganism annotation, text mining, community profiling, metagenomics 
data, lactic acid bacteria.
170    Chapter 8
Background
Microorganisms play crucial roles in a number of biological processes ranging from the 
decomposition of waste products [1, 2], to industrial processes where they are used 
for the development of fermented foods and beverages [3-5]. Furthermore pathogenic 
microorganisms such as Mycobacterium tuberculosis, Salmonella and Clostridium tetani 
can be harmful, causing tuberculosis, food poisoning and tetanus respectively.
In metagenomics studies, microbial DNA is directly extracted from environmental samples 
and sequenced by means of 16S RNA sequencing. This technique is well established to 
study the dynamics of microbial communities. One of the outcomes of these so-called 
community profiling studies is a list of microorganisms that are affected by a given 
process or treatment. Insight into the biological properties of these microorganisms is 
essential to better understand how they are involved in these processes. 
Because these organism lists contain dozens of microorganisms, retrieval of biological 
properties these organisms from the scientific literature is labor- intensive and requires 
methods that can do this retrieval automatically.
Publications about microorganisms are growing exponentially [6] and literature databases 
such as the Medline database have over 1.5 million abstracts related to microbiota and 
microorganisms (Table 1). 
Depending on the microorganism, the number of abstracts range from a few hundred to 
tens of thousands (Table 1). This indicates that the Medline database is a suitable source 
for the retrieval of biological properties of microorganisms.
In earlier work we reported about CoPub [7] , a publicly available text mining system 
that has successfully been used for the analysis of gene expression data by automatically 
searching for co-occurrences between genes and pathways, biological processes, diseases 
and drug terms in Medline abstracts [8-11]. 
Search term Number of hits found
microbiota OR microbiome OR microflora OR bacteria OR 
microorganisms 1581863
Salmonella 72488
Mycobacterium tuberculosis 42774
lactococcus lactis 4299
Stretococcus thermophilus 1135
Clostridium tetani 995
Oenococcus oeni 293
Table 1 Number of abstracts found for each term when searching in Pubmed (till December 
2012).
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Here we report the development of a tool that identifies organism names in any kind of 
text and maps these to the NCBI taxonomy ids.
With this tool, analogous to the gene list based text mining described for CoPub, lists 
of microorganisms can be annotated with important biological properties of these 
microorganisms and the processes in which they are involved. 
Subsequently, this text is analyzed in two ways:
One analysis method consists of searching for significant occurrences of disease and 
pathway terms from thesauri in Medline abstracts. Additionally highly occurring 
informative keywords are identified in these abstracts and presented as a word cloud. 
We show that with both methods we can annotate lists of microorganisms from 
community profiling studies and find evidence about the pathogenic potential of these 
microorganisms, and predict biological functions for single and clusters of lactic acid 
bacteria. 
Thus text mining is a valuable approach to quickly retrieve biological properties 
of microorganisms from text and can help experts to gain insight into how these 
microorganisms are involved in the studied processes.
Materials and Methods
Detection of organism names in Medline abstracts
A set of regular expressions was implemented in Perl and used to tag organism names 
in Medline abstracts. Subsequently, for organisms with a known taxonomy identifier in 
the NCBI Taxonomy Database [12], the hits in the Medline abstracts were stored in a 
database. This resulted in one to multiple organism hits per Medline abstract.
 
Calculation of significant co-occurrences
The significance of  a co-occurrence between organisms or for a co-occurrence between 
organisms and disease terms from controlled vocabulary [7] was determined by 
calculating a p-value using the R implementation of Fisher’s exact test. We considered 
co-occurrences with a p-value < 0.05 significant. Co-occurrence matrices were clustered 
with the R package pvclust with “complete” setting for hierarchical clustering. For further 
analysis sub clusters were created (tree cut-off: 0.9).
Selection of organism lists from community profiling studies
Bacteria identified in female urine were selected using Table S1 from the paper by 
Siddiqui et al. [13]. Fungi identified in oral rinse samples were selected from Table 3 in 
combination with fungi from Supplementary table 3 for which the genera were presented 
in Figure 3 in the paper by Ghannoum et al. [14]. 
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Generation of word clouds of highly occurring keywords
The set of abstracts for a given organism (organism_abstracts) was used to generate word 
clouds for the organism of interest. Keywords with less than 5 characters and keywords 
occurring in < 2% of the abstracts were discarded. The significance of occurrence of a 
keyword in the organism_abstracts was determined by calculating the relative keyword 
frequency for the keyword in organism_abstracts and the relative keyword frequency of 
the keyword in a background set. The ratio of these relative frequencies was used to rank 
the keywords. Wordclouds were generated using the R-package “wordcloud”.
Results
Text mining vs. manual searching in Pubmed
In order to retrieve information about microorganisms from Medline abstracts we 
automatically tagged 3502122 unique organism names in these abstracts. We were 
interested to see whether tagging of organism names, called tagging hits, yielded good 
results in comparison with when searching for these organism names in Pubmed, referred 
to as Pubmed hits.
For 100 organisms we compared the number of tagging hits with the number of Pubmed 
hits. The results are shown in Figure 1.
For about 40 % of the organisms the number of tagging hits was similar to the number 
of Pubmed hits. Differences between both search strategies can be explained by that 
fact there is a discrepancy of about 5% between the Medline database in Pubmed and 
the Medline database as provided to licensees for download, in which the tagging hits 
were found. Moreover, Pubmed hits were also found in Mesh Terms (Medical Subject 
Headings from controlled vocabulary thesaurus used for indexing articles for Pubmed) 
of abstracts, this in contrast to the tagging hits for which we only searched in the title 
and the abstract. For example for Clostridium tetani several tagging hits [15-19] were not 
retrieved, because the organism name is only used in the Mesh Term header.
For 35 out of the 100 organisms more tagging hits were retrieved in comparison with 
Pubmed hits. This difference can be explained by the fact that tagging hits were found 
by searching with all names and synonyms of the particular organism, while Pubmed 
hits were found by searching only with one name or synonym. For example in the case 
of Oenococcus oeni, tagging hits also included abstracts in which Leuconostoc oenos 
(the previous name of Oenococcus oeni), was found [20, 21]. Similarly for Lactococcus 
lactis subsp. cremoris additional tagging hits were found with its synonym Streptococcus 
cremoris [22, 23].
On the other hand for Leuconostoc, Moraxella, Listeria, Neisseria and Salmonella more 
Pubmed hits were retrieved. All these organisms are classified as genus in the NCBI 
taxonomy database and the Pubmed hits included also abstracts about organisms that 
belong to this genus, e.g. Leuconostoc mesenteroides. Tagging hits for Leuconostoc 
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resulted in abstracts about Leuconostoc and not in abstracts about organisms that belong 
to this genus. These latter abstracts were mapped to these specific organisms.
Taken together, these results show that that tagging of organism names yielded 
good results in comparison with searching for these organism names in Pubmed and 
outperforms Pubmed searches for certain microorganisms. 
Annotation of metagenomics experiments
Metagenomics and community profiling studies often result in lists of microorganisms. 
To see if we could automatically find biologically meaningful descriptions in Medline 
abstracts, we used tagging to retrieve these descriptions  for two sets of microorganisms: 
one from a study aimed at the characterization of microbiota in urine from healthy females 
[13] and one from a study aimed at the characterization of the oral fungal microbiome 
in healthy individuals [14]. For both studies we were interested to see if we could find 
evidence in the literature about the pathogenic potential of these microorganisms.
Annotation of organisms derived from female urine samples
Although urine within the urinary tract is generally considered as ”sterile”, several 
Figure 1 Retrieval of the number of abstracts for 100 microorganisms. The x-axis represents 
the number of Pubmed hits, the y-axis represents the number of tagging hits. Ten percent of the 
microorganisms for which the most tagging hits were found are shown in green. Ten percent of the 
microorganisms for which the most Pubmed hits were found are shown in red. Tagging of organism 
names was done on Medline abstracts till October 2012. Pubmed queries were done on abstracts 
till the end of November 2012.
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Tax ID Organism Disease term (p-value)
165188 uncultured Megasphaera sp. NA
28130 Prevotella disiens pelvic inflammatory disease (3.12e-11)
cancer (2.38e-06)
cellulitis (0.000152)
abscess (0.000311)
Endometritis (0.00066)
furunculosis (0.0112)
carcinoma (0.0178)
salpingitis (0.019)
bacterial infection (0.0419)
1376 Aerococcus urinae urinary tract infection (5.16e-26)
balanitis (3.17e-05)
prostatic disease (0.0152)
361505 Anaerococcus sp. gpac155 NA
119206 Aerococcus sanguinicola urinary tract infection (3.36e-06)
prostatic disease (0.00147)
322095 Porphyromonas somerae NA
159274 uncultured Porphyromonas sp. NA
844 Wolinella succinogenes NA
174293 uncultured candidate division OP11 bacterium NA
189716 Flexistipes sp. E3_33 NA
33043 Coprococcus eutactus irritable bowel syndrome (0.00404)
inflammatory bowel disease (0.0124)
172733 uncultured Clostridiales bacterium NA
38303 Corynebacterium pseudogenitalium urinary tract infection (0.00257)
corneal ulcer (0.00683)
Endometritis (0.00783)
urethritis (0.0121)
Nosocomial infections (0.0274)
208548 uncultured Neisseriaceae bacterium NA
361501 Peptoniphilus sp. gpac121 NA
47770 Lactobacillus crispatus urinary tract infection (0.000916)
gonorrhea (0.00145)
trichomonas infection (0.00598)
inflammation (0.0378)
Table 2 Associations between organisms from urine samples of healthy volunteers and disease 
terms found in the literature. NA indicates no association was found.
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Tax ID Organism Disease term (p-value)
221218 uncultured candidate division OD1 bacterium NA
202789 Actinobaculum massiliense urinary tract infection (0.000289)
76517 Campylobacter hominis Gastrointestinal disease (0.00578)
disseminated intravascular coagulation (0.00912)
gastroenteritis (0.0135)
periodontal disease (0.0164)
195049 uncultured Clostridiaceae bacterium NA
163550 Eubacterium sp. oral clone BU061 NA
179000 uncultured Methylophilus sp. NA
54007 Anaerococcus octavius NA
827 Bacteroides ureolyticus urethritis (5.13e-31)
gastroenteritis (0.000701)
abscess (0.00217)
brain abscess (0.00444)
Gastrointestinal disease (0.0125)
periodontal disease (0.0127)
158755 uncultured Cytophagales bacterium NA
178214 Facklamia hominis NA
87541 Aerococcus christensenii urinary tract infection (0.0276)
181675 Lactobacillus coleohominis Crohn's disease (0.0393)
339338 uncultured Allisonella sp. NA
187319 uncultured Fibrobacteres bacterium NA
33012 Propionimicrobium lymphophilum NA
359408 Methylotenera mobilis NA
254354 uncultured Peptoniphilus sp. NA
166587 uncultured Chloroflexi bacterium NA
159272 uncultured Prevotella sp. NA
159268 uncultured Veillonella sp. NA
293422 uncultured Eggerthella sp. NA
853 Faecalibacterium prausnitzii Crohn's disease (1.68e-21)
inflammatory bowel disease (1.09e-10)
cancer (1.69e-10)
colitis ulcerative (6.08e-08)
irritable bowel syndrome (0.0205)
colon cancer (0.045)
28128 Prevotella corporis NA
1260 Finegoldia magna Acne (4.03e-09)
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microorganisms with a pathogenic potential were found in these samples [13]. In 
order to see if we could find more specific evidence that further could underline 
these observations; we searched for associations between the organisms and disease 
terms in Medline abstracts (Table2). We found, similar to the observations and manual 
annotations by Siddiqui et al., disease terms related to the infection/inflammation of 
the urinary tract, e.g. urinary tract infection [24-26] and urethritis (inflammation of the 
urethra) [27, 28] and several diseases associated with female urogenital pathology, e.g. 
salpingitis (infection and inflammation of fallopian tubes)[29], endometritis (infection of 
the inner lining of the uterus) [29-31] and pelvic inflammatory disease (inflammation of 
the uterus, fallopian tubes, and/or ovaries) [29, 32].  In addition  we  found  associations 
with intestine-related diseases, such as inflammatory bowel disease [33, 34], Crohn’s 
disease [35, 36], irritable bowel disease [37], gastroenteritis [38] and necrotizing fasciitis 
[39, 40]. These results show that tagging in combination with thesaurus based matching 
is as effective as manual annotation.
Annotation of the fungal microbiome in healthy individuals
Next we were interested to see if we also could find evidence about the pathogenic 
potential of fungi identified in oral rinse samples from healthy individuals. We searched 
for associations between these fungi and diseases (Table 3). A number of diseases 
related to the oral cavity and respiratory system were found such as candidiasis [41-43], 
aspergillosis [44-47], asthma [48, 49], rhinitis [50, 51] and respiratory tract disease [52]. 
Several of these pathogenic fungi are also able to infect other parts of the body such as 
the skin [53] and the vagina [54, 55]. 
Tax ID Organism Disease term (p-value)
fasciitis necrotizing (0.000368)
Endometritis (0.000552)
fasciitis (0.00331)
abscess (0.00371)
Respiratory tract infection (0.00869)
293428 uncultured Anaerococcus sp. NA
59505 Actinobaculum schaalii urinary tract infection (1.69e-21)
Fournier's gangrene (0.00546)
bacteremia (0.00618)
kidney calculi (0.0298)
169971 uncultured Peptostreptococcus sp. NA
211450 uncultured Pelobacter sp. NA
171953 uncultured Acidobacteria bacterium NA
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The risk of getting infected by these pathogenic fungi especially increases in individuals 
with a compromised immune system, for instance in cancer, leukemia and diabetes 
mellitus patients [56-58]. Typically these patients stay in a hospital environment which 
also increases the risk on nosocomial infections [59]. 
The presence of potential pathogenic fungi in healthy individuals could be the first step 
towards infection by them as indicating by the authors. We demonstrated that tagging 
in combination with thesaurus based matching can be used to get insight into specific 
diseases that could be caused by these fungi. 
Table 3 Associations between fungi from orinse samples of healthy volunteers and disease terms 
found in the literature. NA indicates no association was found.
Tax ID Organism Disease term (p-value)
41959 aspergillus penicillioides NA
5516 fusarium culmorum NA
5507 fusarium oxysporum cancer (5.24e-235)
leukemia (3.29e-17)
keratitis (3.4e-13)
41960 aspergillus caesiellus NA
5074 penicillium brevicompactum NA
92950 cladosporium sphaerospermum carcinoma (0.0189)
Respiratory tract disease (0.0316)
119927 alternaria tenuissima Iga deficiency (0.0166)
retroperitoneal fibrosis (0.0213)
4897 schizosaccharomyces japonicus NA
4956 zygosaccharomyces rouxii NA
279121 ophiostoma pulvinisporum NA
4896 schizosaccharomyces pombe cancer (0)
starvation (6.13e-79)
Hypovolemic shock (5.47e-14)
4932 saccharomyces cerevisiae cancer (0)
starvation (1.26e-243)
Hypovolemic shock (9.17e-66)
415599 glomus fulvum NA
5480 candida parapsilosis candidiasis (9e-305)
cancer (7.29e-231)
Mycoses (4.9e-39)
onychomycosis (4.73e-36)
Nosocomial infections (7.65e-21)
fever (3.86e-13)
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Tax ID Organism Disease term (p-value)
neutropenia (6.19e-11)
diabetes mellitus (3.81e-10)
Immunologic deficiency syndrome acquired (2.06e-08)
Systemic inflammatory response syndrome (0.035)
4931 saccharomyces bayanus NA
69773 penicillium glabrum hypersensitivity (6.88e-05)
pneumonia (0.00391)
29917 cladosporium cladosporioides sick building syndrome (3.66e-08)
keratitis (0.00582)
allergy (0.00625)
5580 aureobasidium pullulans corneal ulcer (0.000127)
fever (0.016)
asthma (0.0304)
5062 aspergillus oryzae Hypovolemic shock (3.27e-09)
70808 cladosporium tenuissimum NA
396024 aspergillus ruber hypersensitivity immediate (0.00323)
216836 alternaria triticina NA
749552 phoma foveata NA
62271 saccharomyces ellipsoideus NA
5059 aspergillus flavus cancer (2.46e-266)
aspergillosis (5.85e-222)
keratitis (1.79e-12)
leukemia (7.53e-10)
sinusitis (1.05e-07)
pneumonia (1.69e-05)
89919 cryptococcus diffluens dermatitis (2.34e-06)
cryptococcosis (0.0102)
candidiasis (0.033)
227369 zygosaccharomyces 
pseudorouxii
NA
260535 candida khmerensis NA
89918 cryptococcus cellulolyticus NA
104300 ophiostoma floccosum NA
29918 cladosporium herbarum allergy (5.7e-46)
asthma (2.29e-20)
rhinitis (2.94e-12)
eczema (1.49e-07)
sick building syndrome (3.75e-06)
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Finding relevant information for lactic acid bacteria
We showed that automatically linking microorganisms to keywords in thesauri is as 
effective as manual annotation. However a lot of the properties of microorganisms are 
described in abstracts with keywords that are not present in thesauri. We were interested 
to see if we could automatically retrieve these keywords. Furthermore we evaluated 
whether presenting these keywords in word clouds provide sufficient information about 
the biological properties of microorganisms.
For Streptococcus thermophilus, a widely used lactic acid bacterium in the dairy industry, 
we identified 976 abstracts. We created a word cloud of highly occurring keywords in 
these abstracts (Figure 2).
The word cloud reveals the role of Streptococcus thermophilus in fermentation processes 
where  it is used as starter culture for the preparation of yoghurt [60, 61]. In cheese, 
Streptococcus thermophilus is mainly responsible for the acidification which is important 
for the ripening and the characteristics of cheese [62, 63]. Additionally, some Streptococcus 
Tax ID Organism Disease term (p-value)
hypersensitivity immediate (0.00056)
hypersensitivity (0.00108)
aspergillosis (0.00316)
531293 phoma plurivora NA
273372 candida metapsilosis Nosocomial infections (0.000623)
candidiasis (0.00141)
5476 candida albicans candidiasis (0)
cancer (0)
inflammation (2.81e-233)
Mycoses (1.32e-151)
pneumonia (3.47e-51)
Immunologic deficiency syndrome acquired (5.37e-22)
Systemic inflammatory response syndrome (9e-05)
5054 eurotium amstelodami Lung disease (5.09e-08)
5482 candida tropicalis cancer (3.27e-204)
candidiasis (3.48e-197)
neutropenia (3.82e-10)
fever (3.12e-09)
Immunologic deficiency syndrome acquired (4.59e-08)
leukemia (8.16e-07)
27381 glomus mosseae NA
63822 penicillium spinulosum NA
36050 fusarium poae NA
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thermophilus strains produce exopolysaccharides (ESP) which is an important ingredient 
controlling the texture of yogurt and cheese and has been suggested to be beneficial for 
the treatment of chronic gastritis [64]. 
These results show that the word cloud, constructed of keywords retrieved from abstracts 
about Streptococcus thermophilus give an overview of the the industrial processes and 
applications in which Streptococcus thermophilus is involved. Besides keywords that give 
insight into the application and the biological properties of Streptococcus thermophilus, 
the word cloud also contains (parts of) names from other bacteria, e.g. bifidobacterium, 
Lactobacillus acidophilus and Lactobacillus delbrueckii subsp. bulgaricus are shown. 
This indicates that Streptococcus thermophilus is functionally related to these LAB in 
fermentation processes.
Microbial community literature study of LAB
To better understand in which ways these LAB are related to each other and how they 
together are involved in biological processes we searched in the literature for evidence 
about which LAB are often mentioned together and in which processes and applications 
they are mentioned together. In order to do this, we started with Lactobacillus plantarum, 
Streptococcus thermophilus and Oenococcus oeni and retrieved the organisms with 
which they co-occur. To see if taxonomy differences are also reflected in the scientific 
literature we also included non-LAB Bacillus subtilis. For each of these four bacteria 
Figure 2 Word cloud of highly occurring keywords in Medline abstracts about Streptococcus 
thermophilus, describing biological properties and applications of Streptococcus thermophilus. 
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we obtained a list of the most significant co-occurring organisms (p-value < 0.05). For 
Bacillus subtilis we found the highest number of co-occurring organisms, 328 organisms 
in 8963 abstracts, and for Oenococcus Oeni we found the lowest number of co-occurring 
organisms, 17 organisms in 133 abstracts. Subsequently, for each organism list we ranked 
the organisms based on the p-value and retrieved from each organism list the top ranked 
co-occurring organisms.  This yielded a unique set of 51 organisms (organisms classified 
as ‘superkingdom’ or ’genus’ were discarded). To find out how these 51 organisms are 
related to each other, we determined whether they co-occur in Medline abstracts. 
Based on these co-occurrences, the organisms were clustered (Figure 3). It appeared 
that Bacillus subtilis, which is not classified as a LAB, clusters separately from the other 
LAB. This indicates that the taxonomy difference between Bacillus subtilis and LAB is also 
reflected by the literature context. Furthermore Lactobacillus plantarum, Streptococcus 
thermophilus and Oenococcus oeni, with which we initially started our search with, 
cluster in separate, sub-clusters all of them with similar LAB.
Figure 3 Hierarchical tree of LAB related microorganisms. For each cluster (designated with a 
character), a word cloud of highly occurring terms in abstracts (indicated with a corresponding 
character) in which organisms in the cluster are mentioned, is made.
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To see how LAB that clustered together are functionally related to each other, we created 
word clouds based on the abstracts connected to these clusters.
Determine the biological properties for groups of LAB
To retrieve the processes and applications for LAB that clustered together, we first divided 
the tree in Figure 3, into 9 clusters. For each cluster we retrieved the abstracts in which 
the microorganisms from the cluster are mentioned. This yielded between 14582 and 
46 abstracts per cluster. We used these abstracts to generate a word cloud of highly 
occurring keywords (Figure 3). Cluster i in Figure 3 consists of microorganisms that are 
involved in the wine making process, but with different functions. Oenococcus oeni is a 
malolactic starter for the wine making process, giving the wine its characteristic taste and 
aroma [65]. However, glucan-producing strains of Pediococcus damnosus are considered 
as wine spoilers [66]. Similarly, Pediococcus parvulus is also considered as unwanted in 
wine because of its ability to give wines ropiness [67].
Cluster  h (Figure 3) consists of LAB that are used for the preparation of yoghurt and 
cheese [68]. Many food fermentations are performed using mixed cultures of LAB. For 
example yoghurt is produced by the symbiotic growth of Streptococcus thermophilus 
and Lactobacillus delbrueckii subsp. bulgaricus [60]. Cluster h also contains Lactobacillus 
acidophilus and several bifidobacterium species that are used as probiotics [69]. Some 
dairy products that are created by using Streptococcus thermophilus, serve as a carrier 
for these probiotic bacteria [70, 71].  However, Streptococcus thermophilus itself is not 
used as a probiotic, since it does not survive the stomach acid in healthy humans. 
Cluster e (Figure 3) is an interesting cluster. It consists of microorganisms that are on 
the one hand known to cause food spoilage and on the other hand known for their use 
in the production of fermentative products. Leuconostoc mesenteroides causes spoilage 
of blood-sausage and vacuum packed meat [72-74], but is also used for improving 
the texture of sourdough [75] and for the fermentation of sauerkraut [76]; Similarly, 
Lactobacillus brevis is used for the fermentation of kimchi (a fermented cabbage product 
originating from Korea) [77], but is also a known beer spoiler [78] .
These apparent opposite functions of these microorganisms can be explained by fact that 
these effects are caused by different strains of the microorganism. This analysis shows that 
it is important to provide the underlying literature in which these effects are described 
to get more insight into the details about which type of strain of the microorganism is 
causing the effect and in which context this occurs.
Additionally, several bacteriocins, e.g. nisin, bavaricin, lactococcin and mundticin are 
shown in the word clouds. Bacteriocins are small proteins produced by bacteria to inhibit 
the growth of similar or closely related bacteria. Bacteriocins from LAB are often used 
to increase shelf life of fermented products.  Examples of this are nisin (produced by 
Lactococcus lactis) against Staphylococcus aureus (food spoiler) and lactococcin for the 
conservation of cheese and raw milk [79-81]. These bacteriocins give insight into the 
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mechanisms by which LABs are used for the conservation of food products.
These results show that word clouds of keywords for consortia of LAB give insight into 
which LAB are functionally related and for which processes and products they are 
important.
Discussion and conclusions
The presented strategy for the retrieval of biological information for microorganisms is to 
our best knowledge the first approach that uses automatically information extraction from 
scientific literature for this. A number of methods exists that are able to tag automatically 
organism names in text but these methods do not provide an extensive analysis of this 
text in order to retrieve functional keywords that describe the biological properties of 
these organisms [82, 83]. Some studies include text mining to extract organism related 
information from scientific literature, but only for specific model organisms [84, 85] or 
they focus on species specific extraction of genetic entities [86] . 
Our tagging method can be improved by also searching in Mesh terms. Because Mesh 
terms are partly manually curated, this is once again a proof that expert curation together 
with text mining is a good combination to find information in the literature.
We showed that automatic information extraction from Medline abstracts gives rapid 
insight into the biology of microorganisms that can be used to better understand how 
these microorganisms are involved in the studied processes. For two lists of organisms 
derived from healthy individuals we found evidence about the pathogenic potential of 
these microorganisms, by finding specific disease associations. This analysis showed that 
with text mining we are able retrieve similar results to manual annotation. Moreover 
this also showed that we are able to retrieve additional associations with other diseases. 
Linking the microorganisms to a controlled vocabulary with drug terms, would enable to 
study the relation between found microorganisms and known therapeutic treatments. 
We also showed that text mining without using thesauri yields highly occurring keywords 
from abstracts in which LAB are mentioned. By presenting these keywords in word 
clouds, we get an overview of the biological properties and industrial processes in which 
LAB are used. The knowledge provided by these keywords can be used to make the right 
decisions in selecting LAB for fermentation processes and for finding new applications 
for them.
By using the NCBI taxonomy database we are limited to microorganisms in this database. 
Many specific bacterial strains are not present in the taxonomy database, but are still 
detected in the abstracts using our regular expressions. These bacterial strain hits are 
mapped to the closest related bacterium that is present in the NCBI database. This 
means that a search for abstracts in which Streptococcus thermophilus is mentioned can 
also result in abstracts in which a specific bacterial strain of Streptococcus thermophilus 
is described that is not present in the NCBI taxonomy database.  Therefore careful 
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interpretation of the subsequently presented keywords is required since these keywords 
could also be related to specific bacterial strains.
Although the Medline database covers over 1.5 million abstracts related to microbiology, 
the database is focused on biomedical related research. To increase coverage of literature 
in which food related studies are described, other literature sources such as the FSTA 
database [87] could be used.
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Background
In this thesis, the application of text mining (TM) and automatic information extraction 
(IE), to study drug effects and microorganisms was presented. In drug discovery the 
effects of a drug on the expression of genes is studied in genome-wide association studies. 
This often results in hundreds of regulated genes that need to be analyzed. Similarly, 
microorganisms are studied in community profiling studies, were metagenomics is used 
to identify microorganisms that are affected by a processes or treatment resulting in 
tens to hundred of organisms that are affected by the experimental conditions. In both 
research disciplines annotation of the results from these studies is crucial in order to 
draw conclusions and to initiate follow-up research. 
The Medline database contains millions of abstracts and literature citations that are 
used by researchers to keep up to date with the state-of the- art developments in their 
research area. For this reason, the Medline database is very suitable for the annotation 
of biological experiments, because it can be used to find what already is known in the 
literature about the genes and microorganisms of interest. 
The number of scientific papers in the Medline database grows exponentially. Therefore 
TM and IE are needed to automatically extract useful information from these papers.
The concept of high-throughput screening 
Literature studies to get insight into the developments of a specific research area, involve 
manual selection and careful reading of interesting papers. Depending on the topic 
and how much is written about it, this can take weeks. With the rapid accumulation of 
new scientific papers, it is very likely that the amount of time to read and select useful 
information from scientific literature will only increase in the future. Moreover manual 
searching has the drawback of not being all inclusive, possibly missing valuable information. 
In drug discovery, high-throughput screening (HTS) is a widely used technique to rapidly 
screen the activity of large compound libraries to identify compounds that change the 
activity of a molecular target.
The concept of HTS has been used by the cheminformatics community to perform virtual 
screening to identify bioactive compounds through computational means [1]. Similarly, 
the concept of HTS can be applied to automatically screen literature for interesting 
information using computational methods (Figure 1). HTS of literature using TM and IE 
involves selection of papers about a certain topic, extraction of useful information from 
these papers and subsequently presentation of this information in such a way that it can 
be used by scientists.
HTS of literature saves time since it automatically reduces the large amount of literature 
to a subset of papers that needs to be analyzed. The exact screening method and 
subsequent selection of relevant papers is depending on the research question. For 
example if we are interested in information about the process of cheese making, we first 
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screen the literature for the occurrence of ‘cheese’ or ‘cheese making’ and select those 
papers in which these terms occur. This results in 7184 abstracts from over 22 million 
abstracts that need to be analyzed. The next step in HTS of literature is the automatically 
extraction of detailed information about cheese making from this subset of articles.
Extraction of information from papers can be done in different ways. In this thesis we 
used CoPub. CoPub has been built on the principle that keywords that co-occur in 
Medline abstracts have a functional relationship [2]. This principle can also be used to 
find hidden relations by searching for shared intermediates between two keywords which 
are not directly related [3, 4] or to perform ‘concept profiling’ in which two keywords 
or concepts which have a similar profile of matching keywords, may be related to each 
other [5] . Another way to extract information from text is by means of natural language 
processing (NLP). NLP is able to search for specific relations between two keywords and 
has successfully been used for the extraction of protein-protein interaction information 
and for pathway reconstruction [6-9].
Although HTS of literature is focused on fast retrieval of relevant literature and extraction 
of interesting concepts, experts are still needed to set up intelligent search strategies and 
to analyze the search results returned by these strategies.
Figure 1 High-throughput screening of literature involves the total package of selection, extraction 
and visualization of information from literature.
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Automatic extraction of gene names from text 
IE and TM are well established to retrieve information about genes from literature [10-
12]. In the majority of the studies described in this thesis, CoPub was used to identify 
higher level biological relationships for lists of genes [13-15].
One of the biggest challenges in text mining is the recognition of gene names in text, since 
genes in scientific literature are described by different names and symbols and some of 
them even share symbols and names. Results from the gene normalization task of the 
BioCreative II contest underlined this challenge, since none of the participating systems 
was able to correctly extract all human gene names from a set of expert-curated Medline 
abstracts [16]. These types of contests help IE systems to improve their automatic gene 
recognition procedures, but could also lead to overfitting of the system on the training 
dataset resulting in a reduced performance on ‘real’ datasets. 
A possible solution for solving the problem of correctly identifying gene names in text 
is to include Entrezgene numbers as unique gene identifiers in papers submitted for 
publication [17].
In general TM and IE would greatly benefit when papers would be written according to 
standardized structures and rules. Part of this standardization could be that for every 
publication two versions are produced. One is a human readable version, but according 
to a standardized format. The second version is completely structured in which important 
relations are marked by the authors. This approach of standardization of scientific 
papers would demand great discipline of the authors and should be a jointed-effort of 
international research institutes, universities, companies, publishers and the text mining 
community [18-20].
Co-occurrence based approach vs NLP based approach
Although co-occurrence based TM is very powerful for the analysis of large datasets it 
also has drawbacks.
In chapter 7 of this thesis, CoPub was used to find additional evidence for the fact that 
CCL1 and genes with a similar profile show a specific Th2 cell response and IL-2 and genes 
with a similar profile show a specific Th1 cell response. However, CoPub was not able to 
find this additional evidence. This is caused by the fact that for over 30% of the abstracts 
in which Th1 occurs also Th2 occurs and vice versa. For a co-occurrence based system, 
Th1 and Th1 are too close related in order to detect specific relationships between genes 
and either Th1 or Th2. This requires a high resolution approach such as NLP. NLP will only 
detect a relation between CCL1 and Th2 in the sentence “CCL1 is expressed in Th2 cells, 
but CCL1 is not expressed in Th1” where co-occurrence based TM would find relations 
between CCL1 and Th1 and between CCL1 and Th2. However NLP is computationally 
intensive, resulting in complex extracted information structures which makes it less 
suitable for the analysis of large datasets.  A combination of a co-occurrence based TM 
with NLP might be a good solution for the extraction of information, in which the co-
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occurrence based system captures the biology at a higher level, while NLP can be used to 
find more specific relations.
Text mining to study effects of synthetic glucocorticoids
In chapters 3-6, TM was used in multiple ways to get information from the scientific 
literature about genes and pathways induced by glucocorticoids (GCs). Treatment 
with synthetic GCs results in side effects and understanding how these side effects are 
initiated, can help to develop new GC compounds that have reduced side effects while 
maintaining the desired immune suppressive properties. 
In chapter 4 and 6 of this thesis, prednisolone induced genes were analyzed by searching 
for co-occurrences of the genes with disease- and pathway terms. Although this 
approach was very effective to get a general insight into the affected biological processes 
by prednisolone, it lacks specific information on the mechanisms by which prednisolone 
initiates the side effects. This requires in-depth analysis of the affected processes by 
experts. 
A more detailed approach to study GC induced metabolic side effects was presented in 
chapter 3, where a network of insulin resistance (IR) related genes was created based 
on the co-occurrences of these IR related genes in the literature. Subsequently, on this 
network, associations of the IR genes with dexamethasone were mapped. This system 
approach identified the effects of dexamethasone on a single gene and on its neighboring 
genes in the network. Although the study in chapter 3 was entirely based on abstracts 
from published studies, it nevertheless gave new insights into the development of GC 
induced IR. We suggested the possible involvement of the sex steroid pathway in GC 
induced IR.
In chapter 5 we used TM to create a knowledge framework in which we captured the 
observations of GC effects on genes and proteins. This framework enabled us to identify 
pathways affected by prednisolone that could be involved in metabolic disturbances in 
adipocytes.
These studies show that TM can assist research on various levels from gene and protein 
level to pathway level to identify relevant information about GC biology that can be 
used by experts to annotate their experiments. Moreover methods such as CoPubGene 
(chapter 3 of this thesis) and CoPub Discovery, a method to find hidden relations between 
keywords by searching for shared intermediates [3], can provide novel insights in  the 
side effects of GC treatment. 
Study the dynamics of microorganisms using literature mining
In chapter 8, thesaurus based text mining was used to find evidence for the pathogenic 
potential of microorganisms derived from two community profiling studies. Co-
occurrences of these microorganisms with disease terms from a thesaurus resulted 
in many specific disease associations. However, thesaurus based TM is limited to only 
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keywords in the thesaurus. Especially in food research, thesaurus based TM is not 
applicable because of lack of specialized thesauri that can be used to find associations 
in the literature between industrial important microorganisms and food components. 
Therefore we were interested to see if we could apply TM without using a thesaurus, to 
identify keywords that describe the properties of lactic acid bacteria (LAB). Moreover we 
evaluated whether presentation of these keywords in a word cloud would give a sufficient 
overview of the processes and applications in which these LAB are involved. 
Word clouds
Word clouds are a powerful solution for quickly summarizing text by maximizing the 
display of the most relevant keywords in the minimum amount of space. Many web 
applications use word clouds to summarize news articles [21]. Also in biomedical 
research, word clouds have been used to summarize gene related information [22], to 
sum up annotation for biological networks [23],  or to summarize information in Mesh 
descriptors [24]. 
The word clouds indeed provided a sufficient overview of the biological properties of LAB 
and the processes in which these LAB were involved. These word clouds are a starting 
point for specific searches by experts to gain insight into the context in which the found 
keywords are mentioned.
However, in the word clouds also a number of keywords were found that belong to the 
same concept, e.g. ‘fermentation’ and ‘fermented’ have the same meaning and ‘yogurt’ 
and ‘yoghurt’ are the same but different spelled. Nevertheless, the power of this TM 
approach lies in the fact that without prior knowledge interesting keywords about LAB 
can be retrieved from abstracts. 
Additionally, the information in the word clouds could be improved by giving keywords 
which belong to the same category the same color or by indicating how keywords in 
the word cloud are related to each other. Moreover word clouds could be extended by 
maximizing the display of relevant keywords based on a calculated p-value by comparison 
with a background word cloud.
Other literature sources
TM of information about microorganisms was done on Medline abstracts. The Medline 
database has a strong focus on biomedical research and is therefore very suitable for 
finding relations between microorganisms and diseases. However, food related topics are 
under-represented in the Medline database. Therefore additional literature resources 
such as the Food Science Technology Abstracts (FSTA) database are needed [25]. FSTA 
covers food-related literature from 1969 till present and might be useful for the retrieval 
of food related information on microorganisms. It would be interesting to see if indeed 
such a dedicated literature resource yields more food-related abstracts (recall) or yields 
more abstracts that are relevant for food-related research (precision) in comparison with 
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the Medline database.
Conclusion
In this thesis TM was used for high-throughput analysis and annotation of gene expression 
and protein datasets by linking these sets to diseases, drug terms and biological processes 
in the scientific literature. This gave insight into the underlying mechanisms of GC induced 
metabolic side effects on multiple levels. Furthermore TM was used to retrieve disease 
associations for sets of microorganisms from community profiling studies and for the 
retrieval of biological properties of groups of LAB to get an overview of the biological 
processes and industrial applications in which they are involved. 
In a time in which the generation of biological data is exploding, TM can have a valuable 
contribution to translating this data to biological knowledge.
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Summary
Bioinformatics approaches are important for the interpretation of results from 
experiments that are used to study drug effects and in the microbiology. Annotation 
of these experiments is crucial in order to draw conclusions and to initiate follow-up 
research.
Automatic information extraction (IE) and text mining (TM) are important techniques 
to find relevant information in the ever growing (scientific) literature to aid scientific 
research. In this thesis IE and TM are used to study the metabolic side-effects of 
glucocorticoid (GC) treatment on genes and biological processes. Furthermore it is shown 
that these techniques also can be used to study microorganisms by annotation of lists 
of organisms that are the result of metagenomics experiments, to better understand in 
which way they influence biological processes and diseases.
In chapter 2 CoPub 5.0 is presented, a publicly available text mining system that calculates 
keyword co-occurrences in Medline abstracts. CoPub 5.0 is the integration of existing 
CoPub technology with new features and a new advanced interface that can be used 
to answer a variety of biological questions. With CoPub 5.0 direct and indirect relations 
between genes, drugs, diseases and biological processes can be found.
Chapter 3 describes CoPubGene, a method to create literature networks of disease 
related genes. CoPubGene has been used to create a literature network of genes related 
to insulin resistance (IR), a known side-effect of glucocorticoid treatment for which the 
mechanisms are not completely understood. Subsequent mapping of dexamethasone 
relations on this gene network, gave new insights into the effects of this synthetic 
glucocorticoid on IR related genes. The method revealed the possible involvement of 
sex steroid synthesis in the development of GC induced IR. Additionally, implementation 
of the CoPubGene technology into webservice operations enables to incorporate this 
technology into bioinformatics workflows which makes it possible to create a wide variety 
of literature networks of disease related genes.
Chapter 4 describes a genome wide expression profiling study to identify prednisolone 
induced gene signatures in CD4+ T lymphocytes and CD14+ monocytes derived from 
healthy volunteers. Identified gene signatures were linked to underlying metabolic 
related biological pathways. This enables to study the adverse effects of prednisolone on 
metabolism.  TM revealed several affected genes, such as PDK4 and ACSL1 which have 
a predominantly metabolic function and are less important for the anti-inflammatory 
action of prednisolone. These genes might be suitable gen-based biomarker candidates 
for the unwanted metabolic effects of GC treatment.
Chapter 5 decribes  a study in which the integration of genome wide expression data, 
adipokine profiling data, and TM techniques identifies pathways and mechanisms involved 
in prednisolone induced metabolic disturbances in murine 3T3-L1 adipocytes. Several 
members of the wnt signaling pathway were found to be regulated by prednisolone both 
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at gene expression level and at protein secretion level. Hence the wnt signaling pathway 
has been suggested as a suitable pathway candidate for follow-up research to study its 
involvement in the development of metabolic disturbances in adipocyte cells as a result 
of GC treatment.  
Chapter 6 presents a genome wide gene expression profiling study to examine the 
role of glucocorticoid receptor (GR) dimerization on the regulation of gene expression 
in mouse liver. Biological pathways targeted by prednisolone in the liver of wild type 
(WT) mice and mice lacking the ability to form glucocorticoid receptor dimers (GRdim) 
were identified and compared using the CoPub technology. In GRdim mice, the level of 
prednisolone-induced gene expression was significantly reduced compared to WT, but 
not completely absent. Furthermore several novel GC-inducible genes were identified 
from which Fam107a,  that encodes for a putative histone acetyltransferase complex 
interacting protein, was most strongly dependent on GR dimerization.
Chapter 7 describes a study that identifies pathways and genes involved in the 
differentiation of Jurkat T cells towards Th1 and Th2 subtype cells, using various stimuli 
and pathway inhibitors. PMA/CD3 induced an IL-2 gene profile associated with a Th1 type 
of response while PMA/CD28 induced a CCL1 gene profile associated with a Th2 type of 
response. TM analysis using CoPub was used to find additional evidence in the scientific 
literature for these Th1 and Th2 specific gene expression patterns of IL-2 and CCL1. 
Analysis with CoPub technology did not result in additional evidence for this specificity. 
This shows the limitations of co-occurrence based TM methods. However, this type of 
new and challenging applications can be used to improve the CoPub technology.
In chapter 8 it is shown that TM/IE techniques used in drug discovery can be transferred 
to other research areas such as microbiology. TM was used for the annotation of 
organism lists from metagenomics experiments by searching for co-occurrences of 
the microorganisms and disease terms. Furthermore, analysis of abstracts in which 
microorganisms occur, resulted in information about the biological properties of these 
microorganisms and the (industrial) processes in which they are used. This information 
can be used to assist research towards improvement of the use of microorganisms in 
existing applications, but also to find new applications. Furthermore  this results in new 
hypothesis for industrial important microorganisms such as lactic acid bacteria.
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Samenvatting
Het toepassen van bioinformatica-methoden zijn belangrijk voor het begrijpen en 
interpreteren van resultaten van experimenten die gebruikt worden in studies naar 
medicijnwerking en in studies naar de toepassing van micro-organismen. Annotatie van 
deze experimenten is van cruciaal belang om de juiste conclusies te kunnen trekken en 
om vervolg onderzoek te kunnen initiëren.
Automatische informatie extractie (IE) en text mining (TM) zijn belangrijke technieken 
voor het vinden van relevante informatie in de steeds groeiende (wetenschappelijke) 
literatuur. In dit proefschrift worden IE en TM gebruikt voor het bestuderen van de 
ongewenste effecten als gevolg van de behandeling met glucocorticoïden (GC), op 
genen en biologische processen die betrokken zijn bij de stofwisseling. Verder wordt 
gedemonstreerd dat deze technieken ook gebruikt kunnen worden voor het annoteren 
van lijsten van micro-organismen die het resultaat zijn van metagenomische experimenten 
met als doel zo beter te kunnen begrijpen wat de invloed en werking van deze micro-
organismen zijn op biologische processen en ziektes.
In hoofdstuk 2 wordt CoPub 5.0 gepresenteerd, een TM systeem dat relaties tussen 
trefwoorden (keywords) berekent in Medline samenvattingen. Een nieuwe geavanceerde 
interface, die bestaande CoPub-technologie combineert met nieuwe kenmerken, kan 
worden gebruikt voor het beantwoorden van een aan verscheidenheid aan biologische 
vragen. Met CoPub 5.0 kunnen directe en indirecte relaties tussen genen, medicijnen, 
ziekten en biologische processen gevonden worden.
Hoofdstuk 3 beschrijft CoPubGene, een methode voor het maken van netwerken 
van ziekte-gerelateerde genen op basis van informatie in de literatuur. CoPubGene 
werd gebruikt voor het maken van een literatuur netwerk van genen, gerelateerd aan 
insulineresistentie (IR), een bekende maar onbegrepen bijwerking van de behandeling 
met GC. Het mappen van dexamethasone-relaties op het verkregen gen-netwerk gaf 
nieuwe inzichten in de effecten van deze synthetische GC op IR gerelateerde genen. De 
methode onthulde de mogelijke betrokkenheid van leden van het sex-steroïde-synthese 
proces bij de ontwikkeling van GC geïnduceerde IR. Implementatie van de CoPubGene- 
technologie in webservice operaties stelt ons bovendien in staat om deze technologie 
te gebruiken in bioinformatica-workflows, om aldus literatuur netwerken voor een 
verscheidenheid aan ziekte gerelateerde genen te kunnen maken en bestuderen.
In Hoofdstuk 4 wordt een genoomwijde genexpressie-profilering-studie beschreven, 
waarin gen signaturen worden geidentificeerd, die geïnitieerd worden door prednisolon 
in CD4+ T lymphocyten en CD14+ monocyten, afkomstig van gezonde vrijwilligers. 
Deze geïdentificeerde genen werden in dit onderzoek gekoppeld aan de onderliggende 
metabole biologische processen. Op deze wijze werden we in staat gesteld om de 
ongunstige effecten van prednisolon op de stofwisseling te bestuderen. Door gebruik 
te maken van TM, werden genen zoals PDK4 en ACSL1 gevonden die voornamelijk bij de 
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stofwisseling betrokken zijn, en minder bij de anti-inflammatoire effecten van prednisolon. 
Deze genen kunnen mogelijk gebruikt worden als gen-gebaseerde biomarker-kandidaten 
voor de ongewenste effecten op de stofwisseling als gevolg van de behandeling met GC. 
In hoofdstuk 5 wordt een studie beschreven die door het combineren van genoomwijde 
genexpressie data, adipokine-profilerings data en TM technieken, processen en 
mechanismen identificeert die betrokken zijn bij prednisolon-geïnduceerde metabole 
verstoringen in murine 3T3-L1 adipocyten. Verschillende leden van de wnt signaling 
pathway werden gereguleerd door predisolon op zo wel gen-expressie niveau als op eiwit 
niveau. Daarom is de wnt signaling pathway een goede kandidaat voor vervolgonderzoek 
om zo de betrokkenheid van dit proces bij de ontwikkeling van prednisolon-geïnduceerde 
metabole verstoringen  in adipocyte cellen te bestuderen.
Hoofdstuk 6 presenteert een genoomwijde genexpressie studie om de rol van het 
vormen van dimeren van de glucocorticoide receptor (GR) op de regulatie van gen 
expressie in muizenlever te achterhalen. Biologische processen die door prednisolon 
beïnvloed werden in de lever van wildtype (WT) muizen en in de lever van genetisch 
gemodificeerde muizen die niet meer in staat zijn om dimeren van GR (GRdim) te 
vormen, zijn m.b.v. de CoPub- technologie vergeleken met elkaar. In GRdim muizen was 
het niveau van prednisolon geïnduceerde gen-expressie significant lager in vergelijking 
met WT muizen, maar niet helemaal afwezig. Verder werden er verschillende nieuwe 
GC-induceerbare genen gevonden, waarvan Fam107a, dat codeert voor een eiwit dat 
mogelijk een binding aan gaat met een histone acetyltransferase complex, daarbij sterk 
afhankelijk is van GR dimerisatie.
Hoofdstuk 7 beschrijft een studie waarin processen en genen geïdentificeerd werden, 
die betrokken zijn bij de differentiatie van Jurkat T cellen naar specifieke Th1 en Th2 
subtypen cellen, door gebruik te maken van verschillende stimulerende stoffen en 
pathway remmers. PMA/CD3 induceerde een IL-2 gen profiel dat geassocieerd word 
met een Th1 type response, terwijl PMA/CD28 een CCL1 gene profiel induceerde dat 
geassocieerd word met een Th2 type response. Er werd vervolgens gebruik gemaakt van 
CoPub, om additioneel bewijs in de wetenschappelijke literatuur te vinden voor deze 
Th1 en Th2 specifieke expressiepatronen van IL-2 en CCL1. De analyse met de CoPub 
technologie leverde echter geen additioneel bewijs op voor deze specificiteit en toont 
daarmee ook de beperkingen van co-occurrence gebaseerde TM methoden aan. Dit 
soort nieuwe en uitdagende toepassingen kunnen echter worden gebruikt om de CoPub 
technologie verder te verbeteren.
In hoofdstuk 8 wordt gedemonstreerd dat TM/IE-technieken zoals die in 
medicijnonderzoek gebruikt worden, ook in andere onderzoeksvakgebieden, waaronder 
bijvoorbeeld de microbiologie ingezet kunnen worden. TM kan worden gebruikt voor 
het annoteren van lijsten van organismen komende uit metagenomische experimenten, 
door in de wetenschappelijke literatuur te zoeken naar relaties tussen deze organismen 
en ziektes. Tevens levert automatische analyse van wetenschappelijke literatuur waarin 
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micro-organismen worden genoemd, informatie op met betrekking tot de biologische 
eigenschappen van deze organismen en de (industriele) toepassingen waarin ze 
worden gebruikt. Deze informatie helpt onderzoek naar het verbeteren van bestaande 
microbiologische toepassingen, als naar het vinden van nieuwe toepassingen. Verder 
roept dit nieuwe hypothesen op aangaande  industrieel belangrijke micro-organismen 
zoals melkzuur bacteriën. 
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En dan nu het dankwoord…
Dit proefschrift heeft alleen tot stand kunnen komen door de mensen die mij gesteund 
hebben tijdens mijn promotieonderzoek. Een persoonlijke dank aan jullie is hier dan ook 
wel op zijn plaats.
Jacob, jouw manier van toegepaste wetenschap bedrijven heeft mij altijd aangesproken. 
Ooit begonnen als master student bij het CMBI, hield ik een presentatie over mijn stage 
project. Jij zat toen in het publiek en stelde na afloop de o zo relevante vraag “Maar 
wat kun je hier nou mee?” Tijdens mijn promotieonderzoek heb ik die ene vraag altijd 
onthouden. Ik ben dan ook dankbaar dat ik in jouw academische groep, waar toegepaste 
wetenschap belangrijk is, mijn promotieonderzoek heb mogen uitvoeren.
Wynand, van jou heb ik zo ontzettend veel geleerd. Jouw tomeloze inzet, enthousiasme 
en pragmatische manier van werken, heeft mij zeer gemotiveerd om uiteindelijk dit 
‘boekje’ te schrijven. Onze samenwerking begon bij MDI in Oss waar we text mining 
methoden ontwikkelden en toepasten in drug discovery projecten. Na de aankondiging 
van MSD om de onderzoeksafdelingen te sluiten, besloot je om je carrière bij NIZO in Ede 
voort te zetten. Ik ben je erg dankbaar dat je ook na deze carrièreswitch mij nog steeds 
wilde begeleiden bij mijn promotieonderzoek, ook al betekende het dat je dit naast je 
werkzaamheden bij NIZO in je vrije tijd moest doen. Je was nooit te beroerd om tijd in 
te plannen voor overleg, dan wel telefonisch dan wel bij Starbucks op het station of later 
ook bij NIZO. Deze samenwerking heeft er ook in geresulteerd dat we nu samen verder 
werken aan text mining voor voedselonderzoek in een eScience project.
Het eerste gedeelte van mijn promotieonderzoek heb ik binnen de muren van de MDI 
afdeling van Schering-plough (voorheen Organon, later MSD) uitgevoerd. De prettige 
werksfeer die daar heerste, mede te danken aan een aantal inmiddels ex-collega’s, heeft 
zonder meer bijgedragen bij de totstandkoming van dit ‘boekje’. Ik wil jullie hier zeker 
niet vergeten: Ton, Cees, Rene, Tinka, Ruud, Ross, Scott, Rita, de Jannen, Susanne, Peter, 
Maarten, Thea, Karin en Ria. Speciaal wil ik hier Stefan noemen. Jouw onuitputtelijke 
kennis van computers en programmeren heeft er voor gezorgd dat ik altijd bij jou terecht 
kon wanneer ik vragen of problemen had. Ik wil je graag bedanken voor al je hulp en alles 
wat ik van je geleerd heb.
Ook de (ex) collega’s van de CDD groep en het CMBI verdienen het om hier genoemd te 
worden. Allereerst Raoul “CoPub Berry”. Samen hebben we aan text mining gewerkt, 
ook jouw promotie onderwerp, wat geresulteerd heeft in het behalen van je Dr.-titel  in 
september 2011. Je was een fijne collega om mee samen te werken. Succes bij je baan 
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als bioinformaticus bij Rijk-Zwaan.
Simon “Koetje”. Je was al weg toen ik aan mijn promotieonderzoek begon, maar het 
contact dat we hebben gehouden en ook onze gemeenschappelijke historie bij het CMBI 
hebben er voor gezorgd dat ik je hier toch even wil noemen. De bezoekjes waarbij men 
met jou altijd zo mooi kon kletsen over van alles en helemaal niks, waren altijd zeer 
ontspannend. Tegenwoordig zit je bij TNO en ben je trotse vader van dochter Isis! 
Dave “Dr. D. indeed” Wood. Although you were only there for a short period, it was very 
nice meeting you. I wish you all the best in London with your wife Alex and son George. 
Sander, naast inmiddels ex-college, ben je vooral een goede vriend. Ik ben dan ook erg 
trots dat je mijn paranimf wil zijn. Je was altijd geïnteresseerd in mijn werk en naast het 
werk stond de deur bij jou, Lisa, Marrit en Mirte altijd open voor een gezellig samen zijn. 
Veel succes met je carrière bij Lead pharma en het aanstaande vaderschap.  
Marijn “Weet je wat ut is ” Sanders. Samen waren we de AIO’s in de CDD groep en hadden 
we veel steun aan elkaar tijdens alle veranderingen waarmee we geconfronteerd werden 
tijdens onze promotie. Nu werken we samen aan text mining in het eScience project.
Juma my roommate at the CMBI: Thanks for your help and support. Jurgen, bedankt 
voor de lekkere koffie en de mooie verhalen (succes bij d’n Epic). Barbara voor alle 
administratieve zaken.
Erik “stuur de sh*t maar op” Toonen. Bedankt voor de vele discussies. Op het gebied van 
glucocorticoïd biologie en het schrijven van wetenschappelijke artikelen heb ik veel van 
je geleerd. Het is ook niet voor niets dat je als mede-auteur bij vier hoofdstukken in dit 
proefschrift staat vermeld!
Ontspanning tijdens het promotieonderzoek is belangrijk om je gedachten even te kunnen 
verzetten. Waar kun je dit beter doen dan bij LOKOMOTIV NIJMEGEN? De vele uurtjes op 
de fiets, maar ook de gezellige biertjes bij Frowijn hebben er altijd voor gezorgd dat ik 
mijn promotieonderzoek in perspectief heb kunnen plaatsen. Mannen bedankt! Graag 
wil ik hier ook nog speciaal Walter bedanken voor de prachtige kaft van mijn proefschrift!
Niels (geweldig dat je mijn paranimf wilt zijn) en Judith bedankt voor alle plezierige 
etentjes en de gezellige avondjes uit. Geniet van jullie prachtige dochter Ika.
Daniel thanks for your support and the nice discussions about science and about life. I 
wish you and Ghislaine all the best for the future!
En dan als laatste wil ik mijn familie bedanken. Allereerst mijn zus Karin, schoonbroer Bas 
en mijn neefjes en nichtje Jelmar, Yulotte, Tibbe en Lauritz. Een prachtige familie, waar ik 
altijd terecht kan.
Meinen Schwiegereltern Peter und Heike: Es ist bei Euch in Idstein wie ein zweites 
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Zuhause für mich. Vielen Dank für Eure Unterstützung!
Lieve pap en mam, soms was het lastig te begrijpen wat ik nu precies voor een werk deed, 
maar jullie waren altijd geïnteresseerd en probeerde het te begrijpen. Jullie stonden en 
staan nog steeds voor mij klaar wanneer ik jullie nodig heb. Ik kan jullie dan ook niet 
genoeg bedanken voor de fantastische ondersteuning die mij gemotiveerd heeft om dit 
proefschrift te schrijven!
En dan de belangrijkste dames in mijn leven:
Lieve Lara, toen ik bijna twee jaar bezig was met mijn promotieonderzoek kwam je ter 
wereld. Het promotieonderzoek en het vaderschap bleek soms lastig te combineren, 
maar ik ben zo trots om jouw papa te mogen zijn. Je bent mijn inspiratie geweest om dit 
proefschrift te schrijven. Dikke kus van papa!
Liebe Tina, 
Du bist das Ziel einer langen Reise
Die Perfektion der besten Art und Weise
In stillen Momenten leise
Die Schaumkrone der Woge der Begeisterung
Bergauf, mein Antrieb und Schwung
Ich wollte dir nur mal eben sagen
Dass du das Größte für mich bist
Und sichergehen, ob du denn dasselbe für mich fühlst
Für mich fühlst 
(Von dem Lied "Ein Kompliment", Sportfreunde Stiller)
Wilco
Nijmegen, maart 2013
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Wilco Fleuren werd geboren op 8 april 1978 te Nijmegen. Na het behalen van het HAVO- 
diploma aan het Thomas college in Venlo in 1996, is hij begonnen aan de opleiding Ho-
gere Informatica aan de Fontys hogescholen in Eindhoven. Zijn afstudeerstage verrichtte 
hij bij Philips Medical Systems (PMS) op de afdeling Systems Development Cardio Vas-
cular (SDCV) in Best. Onder leiding van dr. Paul Luttikhuizen werden verschillende soft-
ware pakketten geëvalueerd voor het bewaken van veiligheidseisen van cardio-vasculaire 
diagnostische systemen. In februari 2001 behaalde hij zijn diploma. Van februari tot en 
met juni van datzelfde jaar heeft hij deze werkzaamheden bij PMS voort gezet in de rol 
van requirements-analist. In september 2001 is hij vervolgens begonnen aan de mas-
ter opleiding bioinformatica aan de Radboud Universiteit in Nijmegen. Bij het Centre for 
Molecular and Biomolecular Informatics (CMBI) onder leiding van prof. dr. Gert Vriend 
heeft hij onder andere gewerkt aan een database voor eiwit families  en in samenwerk-
ing met dr. Berend Snel aan een methode voor het voorspellen van eiwit-eiwit interacties 
in prokaryoten door gebruik te maken van gecorreleerde mutatie analyse. In augustus 
2003 behaalde hij zijn master diploma. Van december 2003 tot en met december 2008 
is hij werkzaam geweest als wetenschappelijk programmeur in de Computational Drug 
Discovery (CDD) groep van prof. dr. Jacob de Vlieg, onderdeel van het Centre for Molecu-
lar and Biomolecular Informatics (CMBI) aan de Radboud Universiteit Nijmegen. In deze 
functie heeft hij zijn werkzaamheden uitgevoerd binnen de afdeling Molecular Design 
and Informatics (MDI) van Organon (later Schering-plough en nu Merck Sharp & Dhome) 
onder leiding van dr. Peter Groenen en dr. Wynand Alkema. Hij heeft gewerkt aan een da-
tabase waarin eiwit sequenties van verschillende organismen opgeslagen werden. Deze 
eiwitsequenties werden met elkaar vergeleken om zo een beter inzicht te krijgen in de 
verschillen tussen de organismen op eiwitniveau. Vervolgens is hij van december 2008 
tot en met september 2009 als bioinformaticus werkzaam geweest binnen deze MDI 
afdeling en heeft o.a. de CoPub methode geoptimaliseerd, in samenwerking met Super-
computer Center SARA, Amsterdam. In oktober 2009 is hij begonnen aan zijn promotie 
onderzoek onder leiding van prof. dr. Jacob de Vlieg (promotor) en dr. Wynand Alkema 
(co-promotor). Het grootste deel van het promotieonderzoek, met als doel het ontwikke-
len en toepassen van bioinformatica en automatische informatie-extractie-methoden om 
bijwerkingen van glucocorticoïden te bestuderen, is uitgevoerd op de afdeling van MDI 
en in samenwerking met dr. Erik Toonen. Het tweede gedeelte van het promotieonder-
zoek, het ontwikkelen en toepassen van automatische informatie-extractie-technieken 
om micro-organismen te bestuderen, is uitgevoerd op het CMBI in samenwerking met 
NIZO. De resultaten van het onderzoek staan beschreven in dit proefschrift. 
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